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Abstract 
 
Bacillus thuringiensis (Bt) toxins expressed in commercial transgenic crop varieties 
are all δ-endotoxins (Cry toxins) but the identification of novel vegetative insecticidal 
proteins (Vip toxins) has extended the range of insecticidal proteins derived from Bt.  
One such Vip toxin, Vip3A, primarily targets the midgut epithelium cells of 
susceptible insects as Cry toxins do, although they appear to have different binding 
sites.  The present study investigated the comparative toxicity of Vip3A, Cry1Ab and 
Cry1Ac against Heliothis virescens (tobacco budworm) and the impact of antibiotics 
on Bt insecticidal activity.  The selection of a resistant Vip3A population led to the 
determination of cross-resistance, the genetics of resistance and fitness effects.  There 
was very little variability in the natural susceptibility to Vip3A, Cry1Ab and Cry1Ac 
in the populations tested, although the toxicity of Vip3A was much lower compared to 
the Cry1A toxins.  A Vip3A resistant population was successfully established within 
13 selected generations, with little or no cross-resistance to Cry1Ab or Cry1Ac.  The 
inheritance of resistance ranged from almost completely recessive to incompletely 
dominant with a possible paternal influence, was polygenic and relatively stable.  
Vip3A resistance showed a fitness benefit, reduced larval development time, and 
fitness costs, including survival to adult eclosion, reduced egg viability and reduced 
male mating success.  The effects of antibiotics on H. virescens larval susceptibility to 
Bt toxins varied depending on antibiotic treatment, the Bt toxin used and the larval 
instar tested.  Bt cotton expressing both Vip3A and Cry1Ab to provide activity against 
a wide range of pest Lepidoptera, including H. virescens, a major cotton pest in the 
USA is in the process of commercialisation.  The present work will help to support a 
suitable insecticide resistance management strategy for continued use of Bt toxin in 
transgenic crops. 
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Chapter 1 
 
Introduction 
 
1.1 Background to the project 
 
Transgenic crops expressing Bacillus thuringiensis Berliner insecticidal crystal (Cry) 
toxins (Bt crops) were commercialised in 1996 to aid efficient control of pests and 
reduce reliance on chemical insecticides (James, 1997; Tabashnik, 2008).  In 2008 Bt 
crops were grown on approximately 46 million hectares worldwide, a 46-fold increase 
since their introduction and generating one of the largest potential selections for insect 
resistance ever known (James, 2008; Tabashnik et al., 2008a). 
 
Field resistance has largely been absent in Bt crops to date, with proactive insect 
resistant management strategies, involving a high dose plus refuge strategy proving 
effective in delaying the evolution of resistance (Bates et al., 2005; Tabashnik, 2008).  
Bt Cry toxins are individually active against a relatively narrow range of insect 
species.  In addition to the introduction of double constructs (pyramided) expressing 
two Cry toxins, the discovery of the novel vegetative insecticidal proteins (Vips) has 
provided the opportunity to extend the efficacy of Bt crops (Estruch et al., 1996).  Bt 
cotton expressing Vip3A and Cry1Ab is currently in development for commercial 
production (Kurtz et al., 2007). 
 
1.2 Aims and objectives 
 
The overall aim of this project is to provide an understanding of the biology and 
genetics of resistance to Vip toxins in insects.  Knowledge of the potential risk and 
nature of Vip3A resistance will help to support a suitable insecticide resistance 
management strategy for continued use of Bt toxin in transgenic crops. 
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The present study involved field-derived populations of the tobacco budworm, 
Heliothis virescens Fabricius (Lepidoptera: Noctuidae), a major target pest of cotton 
in the USA.  
 
The specific objectives of the work were to: 
 
1) determine the base-line susceptibility of field and laboratory populations of H. 
virescens  to Vip3A, Cry1Ab and Cry1Ac; 
 
2) select a field-derived population of H. virescens for resistance to Vip3A; 
 
3) test the hypothesis that there is no significant cross-resistance between Vip3A 
and Cry1A toxins; 
 
4) determine the mode of inheritance and degree of dominance of the Vip3A 
resistant H. virescens population; 
 
5) test the hypothesis that insects resistant to Vip3A will have associated fitness 
costs that influence the stability of resistance in the absence of selection 
pressure; 
 
6) test the hypothesis that co-application of antibiotics with Bt toxins reduces 
insecticidal activity. 
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Chapter 2 
 
Literature Review 
 
2.1 Bacillus thuringiensis (Berliner) 
 
Bacillus thuringiensis (Bt) is a ubiquitous, gram positive spore forming bacterium that 
is found in many habitats including soil, plant surfaces and insects (Hofte and 
Whiteley, 1989; Bernhard et al., 1997; Schnepf et al., 1998; Bravo et al., 2007).  
Bacillus thuringiensis has an insecticidal toxicity that is largely attributed to its ability 
to form parasporal crystals that release crystal proteins (δ-endotoxins) that are toxic to 
insects upon ingestion, during the stationary phase (sporulation phase) of its growth 
(Hofte and Whiteley, 1989; Schnepf et al., 1998; Bravo et al., 2007; Crickmore et al., 
2009).  Thousands of different strains have been identified worldwide, all having a 
limited host range, but together are active against a wide range of insect orders, 
predominantly Lepidoptera, Coleoptera and Diptera, along with Hymenoptera, 
Homoptera, Orthoptera and Mallophaga, and against other organisms such as 
nematodes, mites and protozoa (Feitelson et al., 1992; Schnepf et al., 1998; 
Marroquin et al., 2000; de Maagd et al., 2003).   
 
Bacillus thuringiensis belongs to the Bacillus cereus (Frankland and Frankland) 
group, with classical biochemical and morphological methods and modern molecular 
methods failing to distinguish Bt from B. cereus.  The production of parasporal 
crystals is the defining quality of Bt that distinguishes it from the remaining B. cereus 
group species, and although this is considered too narrow a criterion for taxonomic 
purposes, Bt has its own nomenclature (Crickmore et al., 1998; Schnepf et al., 1998; 
Jensen et al., 2003; Vilas-Bôas et al., 2007; Crickmore et al., 2009). 
 
2.1.1 Introduction 
 
Bacillus thuringiensis was first discovered by Ishiwata (1901) who isolated the 
bacterium from diseased larvae of silkworm, Bombyx mori L. (Lepidoptera: 
Bombycidae) and named it ‘sotto disease’ (sudden-collapse bacillus).  Berliner (1911) 
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formerly described Bt, after isolating the bacterium from a diseased granary 
population of the Mediterranean flour moth, Anagasta kuehniella Zeller (Lepidoptera: 
Pyralidae), naming it after the province Thuringia in Germany where it was found 
(Beegle and Yamamoto, 1992; van Frankenhuyzen, 1993; Glare and O'Callaghan, 
2000). 
 
The first attempts to use Bt for insect field control were carried out in the late 1920s to 
early 1930s against the European corn borer, Ostrinia nubilalis Hübner (Lepidoptera: 
Crambidae) in South Eastern Europe.  Field testing continued against lepidopteran 
larvae and in 1938 the first commercial product called Sporeine® became available in 
France, primarily for the control of Indian mealmoth, Plodia interpunctella Hüb. 
(Lepidoptera: Pyralidae) (Beegle and Yamamoto, 1992; van Frankenhuyzen, 1993; 
Glare and O'Callaghan, 2000). 
 
A resurgence in interest during the 1950s lead to the Bt var. thuringiensis commercial 
production of Thuricide® in 1957 for the control of lepidopteran larvae (now based on 
Bt var. kurstaki, Btk) and, in 1962, the discovery of Bt var. aizawa (Bta), also active 
against lepidopteran larvae (Bonnefoi and de Barjac, 1963; Beegle and Yamamoto, 
1992; van Frankenhuyzen, 1993; Glare and O'Callaghan, 2000). An important finding 
by Dulmage (1970) was the discovery of Btk isolate HD-1.   It was 20 – 200 times 
more active than the Bt isolates used in commercial production at the time, and 
consequently Btk HD-1 was adopted for commercial use and formed the basis for the 
majority of Bt commercial formulations.  The HD-1 strain was also accepted as the 
standard to be used in the establishment of an international system for standardising 
and comparing the potency of Bt isolates and commercial products (International 
Units (IU) per unit product) (Beegle and Yamamoto, 1992; van Frankenhuyzen, 1993; 
Glare and O'Callaghan, 2000).  Bacillus thuringiensis var. israelensis (Bti) was 
discovered (Goldberg and Margalit, 1977) to have activity against dipteran larvae and 
has proved to be an effective and potent biological pesticide for the control of 
mosquitoes and blackflies (Schnepf et al., 1998; Glare and O'Callaghan, 2000)  This 
was followed by the discovery of Bt var. tenebrionis (Btt) (Krieg et al., 1983) with 
activity against a range of coleopterans, including the Colorado potato beetle, 
Leptinotarsa decemlineata Say (Coleoptera: Chrysomelidae) (Beegle and Yamamoto, 
1992; van Frankenhuyzen, 1993; Glare and O'Callaghan, 2000). 
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Bacillus thuringiensis crystal proteins have a narrow spectrum of insecticidal activity 
and have demonstrated a benign environmental profile, causing little or no harm to 
non-target beneficial insects, animals or humans (Sjoblad et al., 1992; Glare and 
O'Callaghan, 2000; Ferré et al., 2008).  Since the 1950s Bt formulated products have 
become the most successful biopesticide used in agricultural, forestry and public 
health, even though only a few Bt strains have found success commercially through a 
variety of formulation mixes, namely Bt var. kurstaki (Btk), Bt var. thuringiensis and 
Bt var. aizawai (Bta) for lepidopteran control, Bt var. israelensis (Bti) for dipteran 
control and Bt var. tenebrionis (Btt) for coleopteran control (Schnepf et al., 1998; 
Glare and O'Callaghan, 2000; Ferré et al., 2008). 
 
The success of Bt formulated products, however, has been limited by their high 
specificity and reduced persistence, in comparison to synthetic chemical insecticides 
that have wider insect spectrums and longer persistence times.  Biopesticides also 
incur higher production costs and carry the image of being harder to use in 
comparison to synthetic insecticides.  These factors are reflected in the economic 
sales, with the market for biopesticides being less than 5 % of the total global 
insecticide market of roughly $8 billion (Ferré et al., 2008).  However, in the last two 
decades the development and utilisation of expressing Bt cry genes in the crops 
themselves through genetic modification has dramatically increased the use of Bt in 
many parts of the world (section 2.1.4).  Importantly this has been achieved without 
jeopardising its excellent safety profile, while removing the issues of short 
environmental persistence (Bates et al., 2005; Ferré et al., 2008). 
 
Bacillus thuringiensis produces various virulence factors including α-exotoxins, β-
exotoxins, hemolysins, enterotoxins, chitinases and phospholipases.  Some of these 
factors are known to be insecticidal, and may all have a role in insect pathogenesis 
(Hansen and Salamitou, 2000; de Maagd et al., 2001).  However, the most heavily 
researched and commercially utilised virulence factors of Bt are the insecticidal δ-
endotoxins (Crystal proteins) (section 2.1.2) through use in Bt formulated products, as 
already briefly mentioned, and more recently in Bt transgenic crops (section 2.1.4); 
and since their discovery in the mid 1990s, the vegetative insecticidal proteins (Vips) 
(section 2.1.3). 
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2.1.2 Crystal proteins (δ-endotoxins) 
 
In the natural environment, Bt produces parasporal crystals that contain crystal 
proteins (Cry protein/toxin) during sporulation.  Cry proteins are defined as ‘a 
parasporal inclusion protein from Bt that exhibits toxic effects to a target organism, or 
any protein that has obvious sequence similarity to a known Cry protein’ (Crickmore 
et al., 1998; Bravo et al., 2007).  A single Bt strain will normally synthesise between 
one and five Cry toxins in either a single parasporal crystal or multiple parasporal 
crystals (de Maagd et al., 2001).  Thousands of Bt strains have been discovered since 
the 1950s and in total over 190 different Cry protein holotypes have been identified 
(Crickmore et al., 2009), with insecticidal activity to specific species within the orders 
Lepidoptera, Diptera, Coleoptera and Hymenoptera and also nematodes (de Maagd et 
al., 2001; de Maagd et al., 2003; Bravo et al., 2007; van Frankenhuyzen, 2009). 
 
2.1.2.1 Cry protein classification 
 
The current system (Crickmore et al., 1998; Crickmore et al., 2009) for crystal protein 
classification is based on the amino acid sequence homology where each protoxin is 
assigned a name consisting of the mnemonic Cry (or Cyt) and four hierarchical ranks 
consisting of numbers, capital letters, lower case letters and numbers (e.g. Cry1Ab5) 
depending on its place in a phylogenetic tree (de Maagd et al., 2001; Crickmore et al., 
2009).  Proteins with the same primary rank often affect the same order of insect; 
those with the same secondary and tertiary rank may have altered potency and 
targeting within an order.  The quaternary rank was established to group known toxins 
that differ only slightly, either because of a few mutational changes or an imprecision 
in sequencing (Crickmore et al., 1998).  The ranking system splits the proteins based 
on similarities in their sequence identity.  Those ranked at the primary level have up 
to 45 % sequence identity (Cry1, Cry2 etc.), up to 78 % for secondary rank (Cry1A, 
Cry1C etc.) and up to 95 % for tertiary rank (Cry1Aa, Cry1Ab, Cry1Ac etc.) 
(Crickmore et al., 1998; de Maagd et al., 2001; Bravo et al., 2007; Crickmore et al., 
2009; van Frankenhuyzen, 2009). 
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2.1.2.2 Cry protein structure 
 
The three-dimensional structures of six different Cry proteins, Cry1Aa, Cry 2Aa, 
Cry3Aa, Cry3Bb, Cry4Aa and Cry4Ba, have been determined by X-ray 
crystallography with all displaying a similar structure consisting of three domains.  
Domain I (N-terminal) is involved in membrane insertion and pore formation, 
Domains II and III are involved in receptor recognition and binding, with Domain III 
also thought to have a role in pore function (Schnepf et al., 1998; de Maagd et al., 
2003; Bravo et al., 2007). 
 
2.1.2.3 Cry protein mode of action 
 
The mode of action of Cry toxins has been reviewed and described in numerous 
studies (e.g. Gill et al., 1992; Schnepf et al., 1998; de Maagd et al., 2001; Bravo et 
al., 2007; Heckel et al., 2007; Hernández-Rodríguez et al., 2008), and its complexity 
is ever increasing as new modes and activities are discovered.  An overview of the 
mode of action is presented below. 
 
Ingestion by the susceptible insect larva is required for the Cry protein to have an 
insecticidal effect.  The parasporal crystals ingested by susceptible larvae dissolve in 
the alkaline environment of the insect gut releasing solubilised inactive protoxins 
(Bravo et al,, 2007). The solubilised inactive protoxins are cleaved by midgut 
proteases in stages from the carboxy- (C-terminal) and amino- (N-terminal) termini 
yielding a 60-70 kilodalton (kDa) activated protease-resistant protein toxin (Bravo et 
al,, 2007).  In H. virescens, trypsins and chymotrypsins are the two major classes of 
proteinases (Johnston et al., 1995). 
 
The activated toxin then binds to specific receptors on the apical brush border 
membrane of the midgut epithelium columnar cells.  Binding involves various 
interactions including both reversible (Hofmann and Luthy, 1986; Hofmann et al., 
1988; Schnepf et al., 1998) and crucially for toxicity, irreversible (Van Rie et al., 
1989; Rajamohan et al., 1995; Schnepf et al., 1998) binding.  For Cry1A toxins 
several binding protein receptors have been described in different Lepidoptera; a 
cadherin-like protein, a glycosylphosphatidyl-inositol (GPI)-anchored 
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aminopeptidase-N (APN), a GPI-anchored alkaline phosphatase (ALP) and 
glycolipids (Aimanova et al., 2006; Bravo et al., 2007).  In H. virescens APN, ALP 
and cadherin-like proteins have been identified as Cry1A binding protein receptors 
(Jurat-Fuentes et al., 2004; Xie et al., 2005; Aimanova et al., 2006).  Cry2A toxins 
have also been found to bind to specific receptors, and although not identified, studies 
have determined that they are different to those of Cry1A toxins; an important 
difference with regards to resistance management (Hernández-Rodríguez et al., 2008).   
 
After the activated toxin binds to the membrane, the toxin forms a soluble oligomeric 
structure before insertion into the membrane leading to the formation of lytic pores in 
microvilli of apical membranes with subsequent cell lysis.  In one model proposed for 
Cry1A toxins, cadherin and APN receptors have an important role (Bravo et al., 2004; 
Bravo et al., 2007).  Cry1A toxins bind to the cadherin receptor, which induces 
proteolytical processing and oligomerization of the bound toxin.  The oligomeric 
structure binds APN, followed by insertion into the membrane causing pore formation 
(Bravo et al., 2004; Bravo et al., 2007).  A contrasting model has challenged the pore-
forming model, proposing that only binding to the cadherin receptor is required, 
provoking cell lysis by activating a signalling pathway involving stimulation of G 
protein, adenylyl cyclise, increased cyclic adenosine monophosphate levels and 
activation of protein kinase A (Zhang et al., 2006; Rodrigo-Simón et al., 2008). 
 
The events after binding are not yet clear, but the result ends in cell lysis and 
disruption of the midgut epithelium leading to larval death.   The mechanism of death 
is also open to debate, with earlier proposals suggesting that disruption of the midgut 
epithelium leads to cessation of feeding and death by starvation or that extensive cell 
lysis provides access for Bt spores to more favourable conditions in the hemocoel for 
germination and reproduction leading to septicemia and death (Schnepf et al., 1998; 
Broderick et al., 2006; Broderick et al., 2009).  Another proposal suggests that in the 
larvae of some species, indigenous gut bacteria contribute to mortality, as the 
disruption of the midgut through consumption of Bt allows access for the gut bacteria 
into the hemocoel and consequently exerting pathogenic effects leading to death by 
septicemia (Broderick et al., 2006; Broderick et al., 2009). 
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2.1.3 Vegetative insecticidal protein (Vip) 
 
Vegetative insecticidal proteins (Vips) were discovered in the mid 1990s and are a 
family of insecticidal proteins predominantly expressed during the vegetative phase 
(log-phase) of Bt growth (Estruch et al., 1996; Warren, 1997), as well as during 
sporulation (Jensen et al., 2003).  This expression during the vegetative growth phase 
contrasts with that of Bt Cry proteins which form parasporal crystals primarily during 
the sporulation phase (there are a few exceptions including Cry3Aa) (Schnepf et al., 
1998).  Vegetative insecticidal proteins have shown broad insecticidal activity against 
a wide variety of lepidopteran and also coleopteran pests and although still at the early 
stages of discovery and utilisation they may become as valuable as Cry proteins for 
insect control in transgenic crops (Estruch et al., 1996; Warren, 1997; Yu et al., 1997; 
Lee et al., 2006; Fang et al., 2007; Liu et al., 2007; Beard et al., 2008; 
Chankhamhaengdecha et al., 2008).  The first Bt transgenic cotton crop expressing 
Vip3A (and Cry1Ab) is being developed for commercial release in the near future 
(Kurtz et al., 2007). 
 
Bt has been found in the vegetative form on the phylloplane, expressing Vips, so may 
well have some importance in supporting natural Bt infections through the gut 
epithelium (Bizzarri et al., 2007). However, Vips are most commonly expressed 
during the vegetative stage of growth in infected larvae, and this is ordinarily 
considered to occur following ingestion of Bt spores(Milne et al., 2008).  The action 
of Vips may therefore not be specific to gut epithelial cells and may have evolved to 
target other cells after initial infection and lysing of midgut cells through the action of 
Cry toxins (section 2.1.2).  The use of Vips in pest control thus places them in a 
location that they are may not commonly be found through natural Bt infections.   
 
2.1.3.1 Vip classification and structure 
 
The current system for crystal protein classification (section 2.1.2.1) has been used as 
a basis for classification of the Vip proteins with over 20 different holotypes 
identified and separated into three classes: Vip1, Vip2 and Vip3 (Crickmore et al., 
2009).  The structure of Vip2 has been assessed and reveals structurally homologous 
N- and C-terminal domains which are believed to more than likely represent the entire 
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class of binary toxins (Vip1 and Vip2) (Han et al., 1999).  Structural information of 
Vip3 is limited, however, based on the lack of sequence homology and predicted 
secondary structure there is no similar domain organisation in Vip3A as exists for Cry 
type proteins (Estruch et al., 1996; Lee et al., 2003). 
 
2.1.3.2 Vip mode of action  
 
With the discovery of Vip3Aa1 (referred hitherto as Vip3A) by Estruch et al. (1996) 
the mode of action in the insect gut has been investigated using Vip3A, and appears 
similar to the Cry proteins (section 2.1.2.3), although important differences are 
observed.  The symptomatology developed upon ingestion of Vip3A resembles that 
caused by Cry proteins, with cessation of feeding, loss of gut peristalsis, insect 
paralysis and consequent death, although its timing appears to be delayed (Yu et al., 
1997).  The symptoms caused by Vip3A ingestion develop over a period of 48 to 72 h 
whereas the symptoms and death caused by Cry proteins can occur within 24 h (Yu et 
al., 1997). 
 
Yu et al. (1997) demonstrated that the process of solubilisation, proteolytic processing 
in the midgut and binding to the gut cells of susceptible insects for Vip3A correlates 
with its toxicity to insects, resembling that of Cry proteins.  Lee et al. (2003) 
confirmed that Vip3A is soluble from pH 5.0 to 10.0, allowing solubilisation in the 
alkaline lepidopteran insect midgut.  The 88-kDa Vip3A full length toxin was 
proteolytically activated to a core toxin of approximately 62-kDa with either trypsin 
or lepidopteran gut juice extracts, with the Vip3 C-terminus critical to its insecticidal 
activity (Li et al., 2007).  Importantly, Lee et al. (2003) demonstrated through ligand 
blotting experiments with brush border membrane vesicles (BBMV) from the tobacco 
hornworm, Manduca sexta L. (Lepidoptera: Sphingidae), that activated Vip3A bound 
to 80-kDa and 100-kDa molecules which are distinct from the known Cry1Ab 
receptors and did not bind to the activated Cry1Ab receptors, 120-kDa amino-
peptidase N (APN)-like and 250-kDa cadherin-like molecules.  Lee et al. (2006) also 
demonstrated that Vip3A does not share binding sites with either Cry1Ac or Cry2Ab2 
in H. virescens and the cotton bollworm, Helicoverpa zea Boddie (Lepidoptera: 
Noctuidae). Support was demonstrated for the existence of a pore forming step 
following binding to the midgut receptors, however, through analysis of voltage 
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clamp assays, Vip3A and Cry1Ab differed in their principal conductance state and 
cation specificity (Lee et al., 2003). 
 
These findings show that while there are similarities in the symptoms and processes 
of insecticidal activity of Vip3A and Cry toxins, the unique protein sequence, distinct 
receptor binding properties and pore forming/ion channel properties of Vip3A support 
its use as a novel insecticidal agent (Estruch et al., 1996; Yu et al., 1997; Lee et al., 
2003; Lee et al., 2006). 
 
2.1.3.3 Vip1 and Vip2 
 
Vip1 and Vip2 have been isolated from B. cereus, a strain designated AB78 (Warren, 
1997) and Bt (Warren, 1997; Shi et al., 2007), with insecticidal activity against 
coleopteran species.  However, the Vip1 and Vip2 toxins are collectively termed a 
binary toxin as they only have an insecticidal effect when used in combination.  Vip1 
binds to the gut receptor providing a pathway for Vip2 to enter the cells and cause cell 
lyses (Han et al., 1999; Jucovic et al., 2008). It has been shown that Vip1Aa and 
Vip2Aa have high insecticidal activity against the western corn rootworm, Diabrotica 
virgifera virgifera LeConte (Coleoptera: Chrysomelidae) and the northern corn 
rootworm, Diabrotica longicornis barberi Smith and Lawrence (Warren, 1997). 
 
2.1.3.4 Vip3 
 
Estruch et al. (1996) isolated Vip3A from Bt strains AB88 and AB424.  The spectrum 
of activity of Vip3A includes the black cutworm, Agrotis ipsilon Hufnagel, the fall 
armyworm, Spodoptera frugiperda J.E. Smith, the beet armyworm, S. exigua Hübner, 
H. virescens, H. zea, the old world bollworm, Helicoverpa armigera Hübner, the 
native budworm, Helicoverpa punctigera Wallengren, the soybean looper, 
Pseudoplusia includens Walker (all Lepidoptera: Noctuidae), the potato tuber moth, 
Phthorimea opercullela Zeller (Lepidoptera: Gelechiidae), the diamondback moth, 
Plutella xylostella L. (Lepidoptera: Plutellidae), the spotted stalk borer, Chilo 
partellus Swinhoe (Lepidoptera: Pyralidae) and M. sexta (Estruch et al., 1996; Yu et 
al., 1997; Selvapandiyan et al., 2001; Liao et al., 2002; Lee et al., 2003; Mascarenhas 
et al., 2003).  Agrotis ipsilon is an agronomically important pest that is quite resistant 
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to δ-endotoxins, however, Vip3A provided 100% mortality at a concentration that was 
at least 260-fold lower than the concentrations needed to achieve only 50% mortality 
with Cry1Ab and Cry1Ac (MacIntosh et al., 1990; Estruch et al., 1996).  No 
insecticidal activity has been observed against O. nubilalis (Estruch et al., 1996; Yu et 
al., 1997; Lee et al., 2003) or the non-target beneficial insect the monarch butterfly, 
Danaus plexippus L. (Lepidoptera: Nymphalidae) (Lee et al., 2003). 
 
Other research on Vip3 proteins found that Vip3Ba1 led to significant growth delays 
of O. nubilalis and P. xylostella but no larvicidal effect (Rang et al., 2005).  Fang et 
al. (2007) demonstrated that Vip3Ac1 had insecticidal activity against S. frugiperda 
and H. zea, but as with Vip3Aa1, had no insecticidal activity against O. nubilalis.  
However, a chimeric protein Vip3AcAa combining them both became insecticidal to 
O. nubilalis, as well as having increased insecticidal activity against S. frugiperda.  
Furthermore both Vip3Ac1 and Vip3AcAa were highly insecticidal to a population of 
the cabbage looper, Trichoplusia ni Hübner (Lepidoptera: Noctuidae) that was highly 
resistant to Cry1Ac, demonstrating the lack of cross-resistance between Cry1A and 
Vip3A toxins (Fang et al., 2007).  Zhu et al. (2006) demonstrated that Btk strain 
YBT1520 that would otherwise have no insecticidal activity against S. exigua, a major 
crop pest in China, attained high insecticidal activity against S. exigua after YBT1520 
was transformed to include the gene that expresses Vip3Aa7.  Donovan et al. (2001) 
demonstrated that Vip3A is an important component of the Bt strain HD1 by deleting 
the vip3A gene resulting in one-fourth toxicity to A. ipsilon and less than one-tenth 
toxicity to S. exigua in comparison to the full HD1 strain, although Milne et al. (2008) 
demonstrated no effect on toxicity to L. dispar and spruce budworm, Choristoneura 
fumiferana Clemens (Lepidoptera: Tortricidae). 
 
2.1.4 Bt crops 
 
Crops that have been genetically modified to express Bt genes coding for insecticidal 
proteins (e.g. Cry1Ac) are commonly known as Bt crops.  In some of the first 
experiments involving Bt cry gene expression, tobacco plants were genetically 
modified to express modified genes derived from a toxin gene bt2.  The genetically 
modified tobacco plants synthesized insecticidal proteins that protected them from 
feeding damage by the larvae of M. sexta (Vaeck et al., 1987).  Further research has 
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led to the production and commercialisation of agronomically relevant crops that 
confer Bt genes coding for insecticidal proteins to protect them from their important 
pest species.  Agrobacterium-mediated transformation is the preferred protocol for 
transferring Bt genes into the plant (Peferoen, 1997; Guo et al., 2007; Gatehouse, 
2008).  The Bt gene is designed to express the full length or a truncated form of the Bt 
protoxin in the plant.  However, research has shown that the protoxin may be partially 
or completely activated by plant proteases immediately upon plant cell disruption 
through, for example, mechanical damage by the insect during feeding.  Therefore, 
the potential for the first two steps of the mode of action; solubilisation and 
proteolytic activation, may occur in the plant prior to ingestion by susceptible insects 
(Andow and Hilbeck, 2004; Gao et al., 2006; Li et al., 2007; Anilkumar et al., 2008). 
 
Bt crops were first grown commercially in 1996, with approximately 1.1 million 
hectares grown in three countries (USA, Mexico and Australia).  The Bt crops grown 
were cotton producing Cry1Ac, maize producing Cry1Ab and potatoes producing 
Cry3Aa (James, 1997; Naranjo et al., 2008).  Since their first commercial 
introduction, the global hectarage of Bt crops has continued to increase substantially, 
with second generation Bt crops expressing multiple Bt toxins becoming increasingly 
utilised.  Bt crops are the most extensively planted genetically modified crops after 
those transformed for herbicide tolerance and in 2008 the global hectarage for 
genetically modified (GM) crops was 125 million hectares, of which 46 million 
hectares expressed Bt toxins, either alone (19.1 million hectares), or in combination 
with herbicide tolerance (26.9 million hectares) (Ferré et al., 2008; James, 2008). 
 
Other Bt crops that are in development include Bt rice, Bt cabbage and Bt eggplant 
(Cohen et al., 2008; Ferré et al., 2008; Shelton et al., 2008).  Bt rice expressing 
Cry1Ab was in commercial production in Iran in 2005 but production has ceased 
because it is no longer permitted (James, 2005; Cohen et al., 2008).  Bt rice varieties 
in development express either Cry1Aa, Cry1Ab, Cry1Ac, Cry1B, Cry1C or Cry2A, 
with a further Bt rice variety that contains a fusion gene expressing Cry1Ac and 
Cry1Ab mainly for the control of rice stem borers including the yellow stem borer, 
Scirpophaga incertulas Walker and the striped stem borer, Chilo suppressalis Walker 
(Lepidoptera: Pyralidae) (Cohen et al., 2008; Ferré et al., 2008).  
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Bt potato protected against L. decemlineata, however, commercialisation was stopped 
in 2001 due to a number of issues including marketing difficulties (Ferré et al., 2008; 
Grafius and Douches, 2008). 
 
Bt maize was commercially grown in 15 countries (including USA, Argentina, Brazil, 
Canada, South Africa, Uruguay, Philippines and Spain) in 2008 (James, 2008).  The 
majority of Bt maize expresses Cry1Ab for protection against O. nubilalis and the 
Mediterranean corn borer, Sesamia nonagriodes Lefebvre (Lepidoptera: Noctuidae), 
with alternate varieties expressing Cry1F for protection against S. frugiperda or 
Cry3Bb or Cry34Ab and Cry35Ab (binary toxin) for protection against Diabrotica 
spp.  Second generation (see below) Bt maize varieties are at the field trial stage or 
close to commercialisation (Ferré et al., 2008; Hellmich et al., 2008). 
 
In 2008 Bt cotton was commercially grown in 10 countries (USA, Australia, Mexico, 
Argentina, Brazil, China, Colombia, India, South Africa and Burkina Faso) occupying 
15.5 million hectares (James, 2008).  In the USA, Australia and South Africa more 
than 90 % of the cotton grown is Bt cotton (James, 2008).   Insecticidal toxins 
produced in commercially available Bt cotton are Cry1Ac, Cry2Ab and Cry1F 
(Adamczyk et al., 2001a; Chitkowski et al., 2003; Adamczyk and Gore, 2004; 
Naranjo et al., 2008).  The first generation commercialised Bt cotton varieties 
expressed Cry1Ac only.  The primary targets for Cry1Ac are the lepidopteran pests H. 
virescens, Helicoverpa spp., the pink bollworm, Pectinophora gossypiella Saunders 
(Lepidoptera: Gelechiidae) and a number of spiny and spotted bollworms, Earias spp. 
(Lepidoptera: Nolidae).  However, Cry1Ac has limited activity against other 
lepidopteran pests such as Spodoptera spp., T. ni and P. includens.  Second generation 
Bt cotton varieties that express two Bt genes (pyramiding) have become available, 
producing Cry1Ac and Cry2Ab or Cry1Ac and Cry1F and with these varieties 
available a wider spectrum of activity against lepidopteran pests has been 
accomplished.  Cry1F increases the spectrum with activity against Spodoptera spp. 
and Cry2Ab having activity against P. includens and increasing efficacy against H. 
zea and H. armigera (Adamczyk et al., 2001a; Chitkowski et al., 2003; Adamczyk 
and Gore, 2004; Naranjo et al., 2008).  A further Bt cotton variety that should be 
commercialised in the USA will express Vip3A along with Cry1Ab to further 
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compliment and extend the use of currently used insecticidal toxins against 
lepidopteran pests, primarily H. virescens and H. zea (Kurtz et al., 2007). 
 
Bt crops are grown on the basis that environmental and human health risks would be 
lower than with current or alternative technologies and the benefits would be greater.  
It does not appear that commercial cultivation of Bt crops has caused environmental 
impacts beyond those that are caused by conventional agricultural management 
practices (Naranjo et al., 2005; Sanvido et al., 2007; Shelton, 2007).  Bt crops have a 
number of benefits including specificity for key target pests, a lack of negative impact 
on beneficial insects, reduced insecticide use, increased yield, and season long 
expression. These benefits make Bt crops a valuable addition to sustainable integrated 
pest management (IPM) systems alongside, for example, biological control 
(maintaining natural enemy populations), cultural (modified planting dates, tillage, 
crop rotation) and chemical control (use of selective insecticides).  However, 
elimination of chemical sprays is seldom achieved when non-lepidopteran pests also 
affect yields, e.g. aphids, mites and shield bugs (Fitt, 2000; Romeis et al., 2006; 
Sanvido et al., 2007; Fitt, 2008; Hellmich et al., 2008; Naranjo et al., 2008). 
 
Taking cotton as an example, it is traditionally one of the most intensively sprayed 
field crops, however, the insecticide use in Bt cotton fields has on average reduced by 
50 % across the world, with decreases of 39 % and 60 % in India and China 
respectively, as target pests are more effectively controlled (Fitt, 2008; James, 2008).  
Yields in developing countries have seen substantial increases where insect pest 
management has been less effective in conventional systems as compared to countries 
with more established IPM systems, such as the USA and Australia, where yields 
have changed very little (Cattaneo et al., 2006; Bravo et al., 2007; Fitt, 2008; James, 
2008).  Survival of predators and parasitoids in Bt cotton is demonstrably higher than 
in conventional cotton, and these increased beneficial populations can help to provide 
control against secondary pests, alongside the use of more selective insecticides 
(Cattaneo et al., 2006; Fitt, 2008; Naranjo et al., 2008).  Secondary pests such as plant 
bugs have become more problematic in Bt cotton in various countries (e.g. USA, 
Lygus spp; Australia and China, Miridae) due in part to reduced insecticide use, as 
primary pests are controlled by Bt, and also due to reduced competition from target 
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species allowing the resurgence of non-target pest populations (Fitt, 2008; Naranjo et 
al., 2008). 
 
The diversity of Bt toxins is desirable for selectively controlling different target insect 
pests within crop systems and commercial varieties are currently restricted to Cry 
toxins.  The continued commercialisation of pyramided Bt toxins, with the added 
development of Bt crops containing more than two Bt toxins, and production of 
chimeric Cry toxin expressing Bt varieties aims to increase control of multiple species 
and help reduce the evolution of resistance (Bravo and Soberón, 2008; Malone et al., 
2008).  Bt cotton and maize expressing Vip3A and Cry1Ab are expected to be 
commercialised in the near future, with experimental field trials taking place over the 
past few years (Dively, 2005; Llewellyn et al., 2007; Whitehouse et al., 2007; 
Adamczyk and Mahaffey, 2008; Bommireddy and Leonard, 2008).  The development 
of resistance to Cry proteins (section 2.2) is of major importance with the wide use of 
Bt crops around the world.  The use of Vips alongside Cry proteins will help to better 
preserve and extend the usefulness of these important insect control agents using 
appropriate insect resistance management (IRM; section 2.2.5) measures for long term 
effectiveness within an IPM system (Fang et al., 2007; Kurtz et al., 2007).   
 
2.2 Resistance to Bacillus thuringiensis 
 
Resistance has been defined by the World Health Organisation (WHO) as ‘the 
development of an ability in a strain of an organism to tolerate doses of a toxicant 
which would prove lethal to the majority of individuals in a normal (susceptible) 
population of the species’.  Whereas Whalon et al. (2008) describes resistance as ‘the 
microevolutionary process whereby genetic adaptation through pesticide selection 
results in populations of arthropods which present unique and often more difficult 
management practices’.  A more simple description is ‘resistance is a genetically 
based decrease in susceptibility of a population to an insecticide’ (Tabashnik, 1994; 
Bravo and Soberón, 2008).  Moar et al. (2008) emphasises that pest resistance to Bt 
crops can be defined in two different ways, based on either laboratory conditions or 
field conditions.  Laboratory resistance is ‘a statistically significant, genetically 
mediated reduction in sensitivity of the target organism to the controlling agent, 
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relative to a susceptible laboratory strain’.  Field resistance is ‘a genetically mediated 
increase in the ability of a target pest to feed and complete development on a Bt crop 
under field conditions’ (Moar et al., 2008). 
 
There are many reports of insect resistance to Bt Cry toxins, the majority through 
selection in the laboratory (e.g. Gould et al., 1995; Ferré and Van Rie, 2002; Gahan et 
al., 2005; Sayyed et al., 2005; Alves et al., 2006; Tabashnik et al., 2006; Mahon et 
al., 2007), although there have been several cases of field-evolved resistance with Bt 
formulations and Bt crops (e.g. Ferré and Van Rie, 2002; Kain et al., 2004; Baxter et 
al., 2005; van Rensburg, 2007; Tabashnik, 2008).  The first thoroughly studied case of 
resistance to Bt Cry toxins was with a P. interpunctella population from grain bins 
that showed a 100-fold decrease in susceptibility to Btk (Dipel®) following 15 
generations of laboratory selection with Dipel (McGaughey, 1985). 
 
2.2.1 Field resistance 
 
Field-evolved resistance was first confirmed in P. xylostella populations in Hawaii 
(USA) that had been exposed to prolonged use of Btk (Dipel) with up to 30-fold 
resistance (Tabashnik et al., 1990).  Since then, further field resistance to Bt 
formulations in P. xylostella has been reported in continental USA (e.g. Florida) and 
Asia (e.g. Phillipines, Malaysia and Thailand) (Ferré et al., 1991; Shelton et al., 1993; 
Wright et al., 1997; Imai and Mori, 1999; Sayyed et al., 2000b; Sayyed et al., 2004).  
Janmaat and Myers (2003) reported resistance to Btk (Dipel) in populations of T. ni in 
commercial vegetable greenhouses in British Columbia (Canada) with up to 160-fold 
resistance. 
 
Reports of field-evolved resistance to Bt crops were reported with the African stem 
borer, Busseola fusca Fuller (Lepidoptera: Noctuidae), S. frugiperda and H. zea.  Van 
Rensburg (2007) reported that a level of resistance was attained allowing some larvae 
of B. fusca to survive on Bt maize in South Africa, that expresses Cry1Ab, although 
there was a detrimental effect on larval growth.  Spodoptera frugiperda developed 
resistance to Bt corn expressing Cry1F in Puerto Rico, resulting in field failure and 
the consequent discontinuation of commercial cultivation of the Bt crop variety 
(Matten et al., 2008; Moar et al., 2008; Tabashnik, 2008).  Tabashnik et al. (2008a) 
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reported that laboratory bioassays of some field populations of H. zea from the USA 
showed resistance ratios of over 500-fold to Cry1Ac.  Cry1Ac is expressed in Bt 
cotton, and although this level of resistance was found, resistance has not caused 
widespread control failures, due in part to the insecticide resistance management 
strategy in place (Tabashnik et al., 2008a) (section 2.2.5). 
 
2.2.2 Laboratory selection and resistance 
 
There have been several H. virescens populations selected for resistance in the 
laboratory (Ferré and Van Rie, 2002; Gahan et al., 2005; Jurat-Fuentes and Adang, 
2006; Ferré et al., 2008).  Stone et al. (1989) selected a population (SEL) with 
Cry1Ab that produced 20-fold resistance to Cry1Ab.  Selection with Cry1Ac of a 
population (CP73-3) by Gould et al. (1992) showed a 50-fold increase in resistance to 
Cry1Ac, 13-fold resistance to Cry1Ab and 53-fold resistance to Cry2Aa.  Further 
selection with Cry2Aa resulted in a population (CXC) with over 250-fold resistance to 
Cry2Aa and increased resistance to Cry1Ac (290-fold), and further cross-resistance to 
Cry1Aa, Cry1Ab and Cry1Fa (Jurat-Fuentes et al., 2003).  In another population 
(YHD2) selected with Cry1Ac, over 10,000-fold resistance to Cry1Ac was developed, 
with cross-resistance to Cry1Aa, Cry1Ab and Cry1Fa, and more moderate cross-
resistance to Cry2Aa (less than 25-fold) and very low potential cross-resistance (< 3-
fold) to Cry1Ba and Cry1Ca (Gould et al., 1995).  A 400-fold Cry1Ac resistant 
population (KCB) was developed with cross-resistance to Cry1Ab and Cry2Aa 
(Forcada et al., 1999).  Further selection with Cry2Aa resulted in a population 
(KCBhyb) with continued resistance to Cry1Ac, over 250-fold resistance to Cry2Aa 
and further cross-resistance to Cry1Aa, Cry1Ab and Cry1Fa (Jurat-Fuentes et al., 
2003). 
 
Selection of a H. armigera population (BX) with Cry1Ac resulted in up to 300-fold 
resistance in Cry1Ac, with cross-resistance to Cry1Ab, but not Cry2Aa or Cry2Ab 
(Akhurst et al., 2003).  A population of Cry1Ac resistance screening survivors (silver 
strain 2001/2) from Australian cotton areas showed 14-fold resistance to Cry1Ac  and 
after a single selection with Cry1Ac increased to 150-fold (Gunning et al., 2005). 
Another population (SP15) was selected with Cry2Ab, with over 6000-fold resistance 
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to Cry2Ab and cross-resistance to Cry2Aa, but not Cry1Ac or Dipel (Mahon et al., 
2007). 
 
Two populations (AZP-R and APHIS-98R) of P. gossypiella selected in the 
laboratory with Cry1Ac had substantial cross-resistance to Cry1Aa and Cry1Ab but 
not to Cry1Bb, Cry1Ca, Cry1Da, Cry1Ea, Cry1Ja, Cry2Aa or Cry9Ca (Tabashnik et 
al., 2000).  Further selection with Cry1Ac increased resistance 3100-fold in AZP-R 
(Tabashnik et al., 2002). 
 
Laboratory selection of the field resistant population of P. xylostella from Hawaii 
(Tabashnik et al., 1990) with Dipel increased resistance to over 1000-fold (NO-QA 
population) with high levels of resistance to Cry1Aa, Cry1Ab, Cry1Ac, Cry1Fa and 
Cry1Ja, but no significant resistance to Cry1Ba, Cry1Bb, Cry1C, Cry1D, Cry1I and 
Cry2A (Tabashnik et al., 1996).  Other laboratory selections of P. xylostella with Btk 
or specific Cry toxins showed similar patterns of cross-resistance between Cry1A 
toxins but a lack of cross-resistance between Cry1A and Cry1B or Cry1C (Ferré et al., 
1991; Tang et al., 1996; Tabashnik et al., 1997b; Ferré and Van Rie, 2002).  A 
population (NO-95) that had been exposed to both Btk and Bta (which contains 
Cry1C) in the field displayed 22-fold resistance to Cry1Ca and was 50-130-fold less 
susceptible to Btk formulations, and with further selection with Cry1Ca developed 62-
fold resistance to Cry1Ca (Liu et al., 1996; Liu and Tabashnik, 1997).  Another field 
resistant population (BCS) was shown to have 31-fold resistance to Cry1Ca, and after 
further selection with Cry1Ca the population (BCS-Cry1C-1) developed 1090-fold 
resistance to Cry1Ca and high levels of cross-resistance to Cry1Aa, Cry1Ab, Cry1Ac, 
Cry1F and Cry1J (more than 390-fold) (Zhao et al., 2001). 
 
2.2.3 Resistance mechanisms 
 
It is important to know whether resistance to various Cry toxins is through the same 
mechanism either within or between species and also determine whether cross-
resistance to other toxins is due to the same resistance mechanism in the insect or that 
multiple mechanisms of resistance have evolved.  In principal, insects could become 
resistant to Bt toxins at any stage of the mode of action (Heckel et al., 2007) leading 
to resistance mechanisms such as failure of protoxin solubilisation, proteolytic 
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processing (Forcada et al., 1996; Forcada et al., 1999; Oppert, 1999), toxin 
degradation (Forcada et al., 1996), receptor binding site modification (Van Rie et al., 
1990; Ferré et al., 1991) and replacement of dead midgut cells  (Loeb et al., 2001).  
Although the most common reported mechanisms are firstly receptor binding site 
modification followed by proteolytic processing (Ferré and Van Rie, 2002; Bravo and 
Soberón, 2008).  
 
2.2.3.1 Binding site modifications 
 
Receptor binding site modification is where binding of the toxin to the receptor is 
prevented or reduced, resulting in the absence or reduction of toxicity.  Although the 
majority of cases of resistance have been correlated with binding site modification, 
determining which receptor molecules are defective has been difficult.  Several Cry 
toxin-binding molecules have been identified and characterised by biochemical 
methods and include aminopeptidase N (APN), alkaline phosphatase, cadherins, and 
glycolipids (Schnepf et al., 1998; Griffitts and Aroian, 2005). 
 
In H. virescens, three Cry1 binding sites have been detected: the A binding site is 
recognized by Cry1Aa, Cry1Ab, Cry1Ac, Cry1F and Cry1J; the B binding site is 
recognized by Cry1Ab and Cry1Ac, and the C binding site is recognized by Cry1Ac 
only (Van Rie et al., 1989; Jurat-Fuentes and Adang, 2001; Jurat-Fuentes and Adang, 
2006).  Jurat-Fuentes and Adang (2001) determined that Cry2Aa does not bind to any 
of these binding sites.  Proteins that have been proposed as components of binding 
site A include the H. virescens cadherin-like protein HevCaLP (Jurat-Fuentes et al., 
2004) and the 170- and 130-kDa APNs (Luo et al., 1997; Oltean et al., 1999).  A 130-
kDa protein has been associated with binding site B, and proteins of less than 100-
kDa have been predicted to form part of binding site C, although neither binding site 
B or C have been extensively studied (Jurat-Fuentes and Adang, 2001). 
 
Binding studies with the YHD2 population, that was highly resistant to Cry1Ac and 
cross-resistant to Cry1Aa, Cry1Ab and Cry1Fa, determined that only Cry1Aa binding 
(associated with binding site A) was reduced, but binding of Cry1Ab (associated with 
binding sites A and B) and Cry1Ac (associated with binding sites A, B and C) was 
relatively unchanged.  It was suggested that toxicity of Cry1 toxins in H. virescens 
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was due to the interaction with binding site A, rather than B or C which may not be 
involved in toxicity and that the cadherin-like protein (HevCaLP) should be 
considered as a component of the receptor at binding site A (Lee et al., 1995; Jurat-
Fuentes et al., 2004).  Further selection of the YHD2 population with Cry1Ac resulted 
in YHD2-B that had 73-fold higher resistance than YHD2 and reduced Cry1Ab and 
Cry1Ac binding.  These changes in Cry1Ab and Cry1Ac binding implied that Cry1Ac 
binding sites other than HevCaLP were also involved in toxicity to H. virescens and a 
membrane bound form of alkaline phosphatase (HvALP) was identified as a Cry1 
receptor, with reduced amounts contributing to resistance (Jurat-Fuentes and Adang, 
2006).  Altered glycosylation is also thought to be have some responsibility to 
increased resistance and cross-resistance to Cry1A toxins (Jurat-Fuentes et al., 2002). 
 
For KCBhyb, resistant to Cry1A and Cry2Aa toxins (Jurat-Fuentes et al., 2003), 
Cry1A resistance is thought to be a similar mechanism of resistance to the YHD2 
population due to the similar pattern of toxin binding with the loss of HevCaLP 
correlated with high levels of resistance to Cry1Ac (Jurat-Fuentes et al., 2004; Jurat-
Fuentes and Adang, 2006). Cry1A and Cry2Aa do not share binding sites (Jurat-
Fuentes and Adang, 2001), and binding of Cry2Aa in KCBhyb was unaltered, and so 
a second mechanism of resistance is believed to exist, although putative inhibition of 
proteolytic processing has not been found (section 2.2.3.2) (Jurat-Fuentes et al., 
2003). 
 
Proteins homologous to HevCaLP have also been proposed as mechanisms of 
resistance to Cry1Ac in H. armigera (Xu et al., 2005) and P. gossypiella (Morin et 
al., 2003; Fabrick and Tabashnik, 2007). 
 
In a S. exigua population that is resistant to Cry1Ca, the lack of APN 1 expression is 
at least partly responsible for resistance to Cry1Ca (Herrero et al., 2005; Bravo and 
Soberón, 2008). 
 
Plutella xylostella binding site resistance has also been modelled, indicating the 
presence of at least four binding sites: site one is only recognised by Cry1Aa; site two 
is recognised by Cry1Aa, Cry1Ab, Cry1Ac, Cry1F and Cry1J; site three is recognised 
Cry1Ba and site four is recognised by Cry1Ca (Ferré and Van Rie, 2002; Ferré et al., 
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2008).  Reduced binding is a common mechanism seen in many of the resistant 
populations (Ferré et al., 1991; Ferré and Van Rie, 2002; Sayyed et al., 2004; Sayyed 
et al., 2005), but the binding mechanism has not been identified, with studies rejecting 
possible mechanisms including the cadherin, APNs, and alkaline phosphatase (Baxter 
et al., 2005; Heckel et al., 2007; Bravo and Soberón, 2008). 
 
2.2.3.2 Proteolytic processing 
 
Another reported mechanism of resistance is through inhibition of proteolytic 
processing, where the protoxin is not successfully reduced to its active form, resulting 
in the loss of toxicity (Ferré and Van Rie, 2002).  For example, the H. virescens 
population CXC is resistant to Cry1Ac and Cry2Aa toxins, but toxin binding is 
unaltered suggesting the resistance mechanism must involve modification of a step in 
toxin action shared by both Cry1A and Cry2A toxins.  Studies have shown that CXC 
larvae had reduced amounts of a 35 kDa chemotrypsin-like enzyme, a reduced 
capacity to process Cry1Ac and Cry2Aa protoxin and an increased capacity to 
degrade Cry2Aa toxin.  The KCBhyb population, resistant to Cry1Ac and Cry2Aa, 
was also hypothesised to have a similar reduced capacity to process Cry2Aa and 
possibly Cry1Ac due to reduced proteinase activity (Jurat-Fuentes et al., 2003; Gahan 
et al., 2005; Jurat-Fuentes and Adang, 2006), based on one of the parental 
populations, KCB, which had shown reduced levels of proteinases in gut extracts 
(Forcada et al., 1999).  However, no differences in protoxin activation or toxin 
degradation were observed in KCBhyb when compared to a susceptible population, 
YDK (Karumbaiah et al., 2007).  
 
Studies on the P. interpunctella 198-r population, resistant to Bt var. entomocidus 
(Bte), and the 133-r population, resistant to Bta, showed lack of a major gut trypsin-
like proteinase causing a reduction in protoxin-activation abilities contributing to 
Cry1A toxin resistance (Oppert et al., 1996; Oppert et al., 1997). 
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2.2.4 Genetics of Bacillus thuringiensis resistance 
 
2.2.4.1 Natural variability 
 
Comparing the intraspecific variation in susceptibility to Bt toxins between insect 
field populations is one approach to estimate the potential of insect field populations 
to evolve resistance to Bt toxins and giving an indication of baseline susceptibilities.  
It is common practice to compare the LC50 (concentration that kills 50 % of the 
population) values.  Low variability in susceptibility among populations, however, 
doesn’t necessarily mean a low potential for selection pressure to act on, as variability 
within populations can still be high (Ferré and Van Rie, 2002). 
 
Studies measuring variation in susceptibility have reported both high and low natural 
variations among populations.  Populations of O. nubilalis in Germany showed no 
differences in susceptibility to Cry1Ab (Saeglitz et al., 2006).  There were small 
differences in susceptibilities to Cry1Ab between populations of Diatraea saccharalis 
F., sugar cane borer, in Louisiana and Texas, although all were as susceptible as a 
laboratory population (Huang et al., 2008).  Susceptibility to Cry1Ac had a 50-fold 
range and Cry 1Ab had a 30-fold range in populations of Cnaphalocrocis medinalis 
Guenée (Lepidoptera: Pyralidae) an important lepidopteran rice pest, in China (Han et 
al., 2008).  Heliothis virescens susceptibilities to Cry2Ab2 in the USA varied up to 
48-fold for nine laboratory, seven laboratory-cross and 28 field populations, although 
the means of these three groups varied only 2-fold (Ali and Luttrell, 2007).  In the 
same study H. zea susceptibilities varied up to 37-fold but the means of laboratory, 
laboratory-cross and field populations varied only 3-fold (Ali and Luttrell, 2007).  
Populations of H. virescens in the USA varied 12-fold to Cry1Ac, while H. zea varied 
130-fold (Ali et al., 2006). 
 
Another method for estimating the variability of resistance genes is by measuring 
heritability (h2) in laboratory experiments (Tabashnik, 1994; Ferré and Van Rie, 
2002).  Tabashnik (1994) estimated heritability of resistance to Bt products and 
Cry1A toxins for 27 selection experiments and showed that compared with eight other 
insect species, P. interpunctella had a relatively high h2 value.  Relatively high h2 
values were also determined in two populations from Malaysia (Wright et al., 1997; 
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Sayyed et al., 2000b).  These high h2 values indicate high additive genetic variation 
for susceptibility to Cry proteins in those populations (Ferré and Van Rie, 2002). 
 
2.2.4.2 Estimation of resistance allele frequency 
 
The initial frequency of resistance alleles is important and influences the rate at which 
resistance may evolve (Gould et al., 1997).  Therefore, it is a key element for 
predicting the rate of evolution in a population subjected to insecticide treatments 
(Ferré and Van Rie, 2002).  Genetic models have assumed that initial allelic 
frequencies range from 10-2 to 10-6 based on theoretical assumptions regarding the 
balance between mutation and selection (Roush and McKenzie, 1987; Gould et al., 
1997).  A direct estimate with H. virescens, using homozygous recessive resistant 
females (YHD2) individually mated with field captured males, calculated that the 
frequency of resistance alleles that confer resistance to Cry1Ac in the field population 
was 1.5 x 10-3 (Gould et al., 1997).  Tabashnik et al. (1997a) estimated the frequency 
of resistance alleles in a susceptible P. xylostella population to be 1.2 x10-1.  Andow 
and Alstad (1998) used an F2 screening procedure to estimate the frequency of 
Cry1Ab resistant alleles in O. nubilalis to be less than 1.3 x 10-2 for a Minnesota 
population (Andow et al., 1998) and less than 3.9 x 10-3 for an Iowa population 
(Andow et al., 2000).  An F2 screen estimated that resistance allele frequency for field 
derived H. virescens to Cry1Ac was 3.6 x 10-3 to 2.6 x 10-2 (Blanco et al., 2009).  
These direct estimates have high initial frequencies, as compared to the genetic model 
estimates, and if these estimates are typical, resistance may evolve more quickly than 
expected if precautionary measures are not in place. 
 
2.2.4.3 Mode of inheritance of resistance 
 
The dominance level of resistance is important as it influences the rate at which 
resistance may evolve.  It is generally assumed that alleles for Bt resistance are rare 
initially (Gould et al., 1997) and individuals homozygous for resistance to Bt (RR) 
extremely rare initially.  Therefore, the response of heterozygotes (RS) to Bt 
determines the initial course of evolution of resistance.  If heterozygotes are killed by 
Bt then the resistance is termed recessive, and if the heterozygotes survive exposure to 
Bt, the resistance is termed dominant (Tabashnik et al., 1998). 
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Bourguet et al. (2000) reported that dominance has been assessed in different ways in 
insecticide resistance studies.  Values ranging from 0 for complete recessivity to 1 for 
complete dominance, have been obtained from single-dose mortality tests (DML, 
dominance of survival at a given insecticide dose), from LC50 values of dose-
mortality curves (DLC, dominance of insecticide resistance) and from the fitness of the 
3 geneotypes in insecticide-treated areas (DWT, dominance of relative fitness in the 
treated area).  The DWT, calculation is the most relevant to resistance management, but 
at the same time is also the most difficult to estimate.  The DLC value was modified 
from the widely used Stone’s (1968) formula, for which the degree of dominance 
ranged from -1 to 1 (Ferré and Van Rie, 2002).  It has been suggested that partial or 
completely recessive modes of inheritance are more closely associated with 
modification of binding sites, and dominant alleles seem to be associated with other 
mechanisms conferring broad spectrum resistance, for example, modification of 
midgut proteolytic activity (Gould et al., 1997; Liu and Tabashnik, 1997; Tabashnik 
et al., 1998; Bourguet et al., 2000). 
 
Recessive resistance to Bt was first reported in P. interpunctella (McGaughey, 1985).  
For H. virescens, resistance in the SEL and CP73-3 populations both showed 
incompletely dominant inheritance to Cry1Ac (Sims and Stone, 1991; Gould et al., 
1992).  Gould et al.  (1995) reported that inheritance of resistance in the YHD2 
population to Cry1Ac and Cry1Ab was partially recessive, but Cry2Aa was more 
dominant. 
 
For P. xylostella populations from Hawaii (NO-QA) and Pennsylvania (PEN), 
resistance to Cry1Aa, Cry1Ab, Cry1Ac and Cry1F was partly to completely recessive, 
however a population from the Phillipines (PHI) showed recessive inheritance of 
resistance to Cry1Ab, but resistance to Cry1Aa and Cry1Ac was associated with 
partially dominant inheritance (Tabashnik et al., 1997b; Tabashnik et al., 1998).  
Another Hawaiin population (NO-95C) resistance to Cry1C was partially dominant 
(Liu and Tabashnik, 1997).  A P. xylostella population (SERD4) from Malaysia 
showed incompletely dominant inheritance to Cry1Ac in the Cry1Ac-selected 
subpopulation and to Cry1Ab in the Cry1Ab-selected subpopulation (Sayyed et al., 
2000b; Sayyed et al., 2005). 
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2.2.4.4 Number of resistance genes 
 
The number of resistance genes involved may depend on the toxins that the 
population is resistant to and how many mechanisms of resistance are present, since 
having more than one resistance mechanism would suggest the presence of more than 
one resistance gene (polygenic resistance).  Many of the studies, using backcross data, 
determining the number of loci involved in resistance have fitted the single locus 
model or monogenic resistance (Ferré and Van Rie, 2002). 
 
For a H. virescens population (SEL) resistance to Cry1Ab was polygenic (Sims and 
Stone, 1991), whereas for a second population (YHD2) resistance to Cry1Ab was 
monogenic (Gould et al., 1995).  Field-evolved resistance in P. xylostella populations 
NO-QA and Karak both exhibited monogenic resistance (Tabashnik et al., 1997b; 
Sayyed et al., 2004), whereas the field derived SERD4 population selected with 
Cry1Ac or Cry1Ab exhibited polygenic resistance with some parental sex influence 
(Sayyed et al., 2005).  Two populations of O. nubilalis selected with Cry1Ab have 
shown polygenic resistance to Cry1Ab (Alves et al., 2006). 
 
2.2.4.5 Fitness costs and stability of resistance 
 
The evolution of resistance in a population may compromise the normal functions of 
individuals, such as survival, development time and fecundity, thereby causing a 
fitness cost associated with resistance.  The nature of potential fitness costs are 
revealed in environments that lack the selecting agent.  In the case of Bt crops, 
resistant individuals moving into refuges may exhibit fitness costs in comparison to 
susceptible individuals that have not been exposed to Bt toxin.  Thus, a trade-off 
occurs with Bt resistance increasing fitness in the presence of Bt toxin, but causing a 
fitness cost when Bt toxin is absent (Tabashnik, 1994; Ferré and Van Rie, 2002; 
Gassmann et al., 2009).  The stability of Bt resistance is linked to fitness costs 
associated with resistance.  In many studies on resistance to Bt Cry toxins, resistance 
reverted when selection was stopped (Ferré and Van Rie, 2002; Gassmann et al., 
2009). 
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2.2.5 Insect Resistance Management (IRM) 
 
The recommended and most favoured strategy for managing resistance to Bt crops is 
the high dose plus refuge strategy, involving the combination of two separate 
concepts, high expression of the Bt toxin and the provision of refuges (non-toxin 
bearing plants) (Gould, 1998; Bates et al., 2005; Ferré et al., 2008; Tabashnik and 
Carrière, 2009).  The expression of the Bt toxin is at a high enough concentration (25 
times the amount needed to kill all susceptible individuals) to kill all heterozygous 
resistant (RS) and susceptible insects, resulting in only rare functionally recessive 
resistant homozygous insects surviving (RR) (Gould, 1998; Bourguet et al., 2000; 
Bates et al., 2005; Ferré et al., 2008).  The refuge maintains a susceptible population 
(SS) as it doesn’t encounter Bt toxin.  The susceptible insects mate with the surviving 
homozygous resistant insects and produce susceptible, heterozygous offspring, 
thereby successfully delaying the evolution of resistance (Bates et al., 2005; Ferré et 
al., 2008; Tabashnik and Carrière, 2009).  For this strategy to be effective, several 
assumptions are made.  The inheritance of resistance has to be recessive, initial allele 
frequency for resistance needs to be low, the number of susceptible insects has to 
outnumber the resistant survivors, the refuge has to be a close enough distance to the 
Bt plants, random mating must occur between resistant and susceptible insects, and 
the toxin concentration in the plant must be high enough to kill all heterozygous 
resistant insects (Gould, 1998; Bates et al., 2005; Ferré et al., 2008). 
 
Studies have shown that one or more of these assumptions may be or have the 
potential to be violated by some pest species.  The high dose standard has not been 
met with H. zea in Bt cotton expressing Cry1Ac, based on survival of susceptible 
larvae on Bt cotton and dominant inheritance of resistant (Tabashnik, 2008; Tabashnik 
et al., 2008a) and also with D. vergifera vergifera in Bt  maize expressing  Cry3Bb  
(Ferré et al., 2008; Meihls et al., 2008).  Non-random mating may occur due to 
differences in development time (Gould, 1998) between susceptible and resistant 
insects as shown with a resistant laboratory population of P. gossypiella reared on Bt 
cotton.  Resistant larvae took nearly six days longer to develop on Bt cotton compared 
to susceptible larvae on non Bt cotton (Liu et al., 1999; Ferré et al., 2008).  Dispersal 
behaviour may affect random mating, as migration from the refuge to the Bt crop and 
vice versa is a necessary requirement (Gould, 1998).  Ostrinia nubilalis has been 
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found to mate on a more restricted spatial scale, with predispersal mating, thereby 
increasing the frequency of resistant homozygotes (Dively, 2005; Ferré et al., 2008). 
 
In the USA, the current refuge requirements for control of Lepidoptera in Bt maize 
(Cry1Ab) is at least 20 % non-Bt maize, and 50 % in cotton growing areas due to the 
potentially increased selection pressure on H. zea from Bt cotton expressing Cry1Ac, 
as it is a pest  of both crops (Ferré et al., 2008).  The refuge must be placed within 0.5 
miles either near the maize field as a separate field or as part of it.  For Bt cotton there 
are three options for singularly expressed Bt toxin: a 5 % external unsprayed refuge, 
20 % external sprayed refuge or 5 % embedded refuge.  For pyramided Bt toxins in 
Texas and areas east of Texas the USEPA (US Environmental Protection Agency) has 
approved the use of natural refuge, no longer requiring the planting of non-Bt cotton 
refuge (Ferré et al., 2008).  Other countries, for example, China and India have no 
refuge requirements, instead relying on mixed planting systems of Bt and non-Bt 
crops and this mix potentially acting as natural refuges alongside wild hosts (Ferré et 
al., 2008). 
 
The availability of pyramided Bt crops (section 2.1.4) should allow better control of 
pest complexes, through the assumption that resistance to two or more toxins 
simultaneously will be very rare, provided inheritance of resistance is recessive and 
there is no cross-resistance between the toxins (Roush, 1997; Gould, 1998; Roush, 
1998; Bates et al., 2005).  Models indicated that pyramided Bt crops require smaller 
refuge areas, and as already mentioned, natural refuges are sufficient in some areas of 
the USA.  It has been shown, however, that the effectiveness of delaying resistance 
can be compromised if pyramided varieties are grown in close proximity with single 
expression varieties if the toxin expressed is the same or known to have cross-
resistance, as studies have shown that selection for resistance can occur more rapidly 
than growing the pyramided variety alone (Bates et al., 2005; Zhao et al., 2005; Bravo 
and Soberón, 2008; Ferré et al., 2008).  In Australia, Bt cotton now only expresses the 
pyramided variety (Cry1Ac and Cry2Ab) having phased out the single expressing 
variety (Cry1Ac) (Naranjo et al., 2008). 
 
Annual monitoring of insect resistance to Bt crops is also an important part of the 
IRM strategy, as first hand reports from growers confirming unsatisfactory field 
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control may often be too late to implement pro-active management strategies.  
Monitoring methods include the dose-response bioassay, discriminating dose bioassay 
and F2 screen (Bates et al., 2005; Huang, 2006).  Detecting increases in resistance 
may provide sufficient time for adjusting the IRM strategy remedial action to contain 
the spread of resistant individuals and adjust the strategy (Bates et al., 2005; Bourguet 
et al., 2005; Ferré et al., 2008). 
 
 
2.3 Lepidopteran pests of cotton 
 
There are several major lepidopteran pests of cotton (Gossypium spp.) throughout the 
world causing severe economic damage to cotton yields without effective control.  
The primary pests in North and South America are H. virescens, H. zea and P. 
gossypiella (Anilkumar et al., 2008).  Helicoverpa armigera is considered the primary 
pest in Australia, China, India, South Africa and Indonesia (Fitt, 2008) with other 
important pests including Earias spp. found in most of Africa and the Mediterranean 
region and eastwards to India, China and Southeast Asia, for example, the spiny 
bollworm, Earias insulana Boisduval (Lepidoptera: Noctuidae) (Ibargutxi et al., 
2006) and H. punctigera found in Australia (Downes et al., 2009). 
 
2.3.1 Heliothis virescens, tobacco budworm (Lepidoptera: Noctuidae) 
 
2.3.1.1 Distribution and economic importance 
 
Heliothis virescens has a confined geographic range with its distribution extending 
through North (as far as Ontario, Canada) and South America (as far south as 
Argentina) (the New World) with permanent populations in most areas between 
latitudes 40° N and 40° S (Neunzig, 1969; Fitt, 1989; King, 1994; McCaffery, 1998).  
In the USA, distribution is principally in the Eastern and South Western states, with 
annual northward dispersal (Neunzig, 1969; Capinera, 2001) with up to five  
generations per year with pupal overwintering (King, 1994). 
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Heliothis virescens is a major crop pest of cotton, tobacco, tomato, sunflower and 
soybean (King, 1994; McCaffery, 1998; Abney et al., 2007; Blanco et al., 2009).  
Damage is caused through the feeding preference of larvae for reproductive structures 
(e.g. flower buds and bolls) and terminal shoots of the host plant resulting in yield 
losses (Fitt, 1989; King, 1994; Bommireddy and Leonard, 2008).  Damage caused to 
the plant by the larvae can also lead to secondary infections by plant pathogens, 
leading to further yield losses (Fitt, 1989; King, 1994). 
 
The multivoltine and polyphagous nature, high mobility, high fecundity, and 
facultative diapause of H. virescens along with its developed resistance to many 
insecticides that have been have been used against it have contributed to its success as 
a major pest (Sparks, 1981; Fitt, 1989; King, 1994; Kanga et al., 1995; McCaffery, 
1998; Ottea et al., 2000; Blanco et al., 2009). 
 
2.3.1.2 Host range 
 
Heliothis virescens has an extensive host range that spans more than 14 taxonomically 
diverse families of dicots including Solanaceae, Malvaceaem, Asteraceae, Fabaceae 
and Geraniaceae, infesting more than 19 crops, including the principal crops 
previously mentioned (section 2.3.1.1), and observed feeding on at least 80 wild host 
plants (Neunzig, 1969; Waldvogel and Gould, 1990; King, 1994; Capinera, 2001; 
Blanco et al., 2007).  Host selection is thought to be determined through the females 
strong preference for flowering plants, responding to a number of host plant features 
during selection, for example, volatiles, leaf surface chemicals, nectar, surface texture 
and plant height (Fitt, 1990). 
 
2.3.1.3 Biology and ecology 
 
Egg development ranges between 2 - 5 days, and at 25 °C is usually 3 - 4 days.  
Infertile eggs remain white, before becoming increasingly yellow and cone shaped as 
they desiccate (Neunzig, 1969; King, 1994). 
 
The number of larval instars can vary from five to seven, although five or six instars 
are most common.  Studies on larval development time calculated that at 25 °C larvae 
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that develop through six instars required 3.1, 2.0, 1.9, 2.1, 5.7 and 2.5 days for 1st to 
6th instar respectively, equating to approximately 17 days for completion of larval 
development (Fye and McAda, 1972; King, 1994). 
 
On emergence, the 1st instar larvae usually consume some or all of the empty egg 
shell before feeding on the preferred plant tissues.  In cotton, larvae cause damage by 
feeding on the flower buds  and bolls, with later instar larvae hollowing them out, if 
abscission has not already occurred.  In the absence of buds and bolls, larvae will feed 
on flowers and leaves (King, 1994; Bommireddy and Leonard, 2008).  Later instar 
larvae base colour is variable (e.g. pale green, pinkish, dark red) and determined by 
various factors including temperature and food substrate (King, 1994).  When larval 
development is complete, they drop or crawl to the ground and enter the soil to pupate 
(Neunzig, 1969; King, 1994). 
 
The pupal period is approximately 22 days at 20 °C, 13 days at 25 °C and 11 days at 
30 °C (Fye and McAda, 1972).  Facultative diapause is induced by environmental 
factors affecting earlier life stages, such as low temperatures and short day length 
(Henneberry, 1994; King, 1994). 
 
Adults are stout-bodied, light brownish olive in colour with a wingspan of 28 – 
35 mm.  The fore wings have three oblique darker bands, with adjacent whitish 
borders, while the hind wings are pearly white with a dark band along the outer 
margin (less distinct in males) (King, 1994).  Adults are generally active after dark 
(King, 1994).  Females have been found to lay over 1500 eggs in the laboratory, with 
a mean of 963 eggs laid at 25 °C (Fye and McAda, 1972).  Females lay eggs singly on 
many parts of the plant, but mostly near flowering and fruiting parts or growing points 
of the host (King, 1994). 
 
2.3.1.4 Control of Heliothis virescens 
 
The status of H. virescens as a major cotton pest in the USA has led to intense 
selection with a range of chemical insecticides resulting in the development of 
resistance in the field to many of those chemical insecticides (Sparks, 1981; Fitt, 
1989; Sparks et al., 1993; King, 1994; Kanga et al., 1995; McCaffery, 1998; Ottea et 
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al., 2000; Blanco et al., 2009).  Mechanisms of resistance include reduced target site 
sensitivity, and metabolic detoxification systems (McCaffery, 1998; Huang and Ottea, 
2004). 
 
Heliothis virescens control problems first appeared in the late 1950s with reduced 
efficacy to the organochlorines, DDT and toxaphene, with confirmed resistance in the 
1960s (Sparks, 1981; Sparks et al., 1993).  The switch to organophosphorous and 
carbamate insecticides in the 1960s initially provided adequate control of H. 
virescens, however, resistance appeared across the cotton belt in the 1970s and 1980s 
to these insecticide classes, including methyl parathion, monocrotophos, EPN and 
methomyl (Sparks, 1981; Sparks et al., 1993).  Synthetic pyrethroids were introduced 
in 1978 to replace the resistant prone and environmentally unsuitable organochlorines, 
organophosphates and cyclodienes.  Significant resistance appeared from the mid 
1980s onwards (Sparks et al., 1993).  Resistance often occurred through the complex 
interrelationship of genetic, environmental and management factors.  This prompted 
the development of insect IRM strategies with the aim of either preventing the 
development of resistance or to contain it.  Since the mid 1990s commercialised 
insecticides effective against H. virescens include indoxacarb, (Wing et al., 2000), 
spinosad, (Salgado, 1998; Scott, 2008), pyridayl (Sakamoto et al., 2002; Cook et al., 
2005) and diamides (Temple et al., 2009).  
 
Bt cotton gives effective control of H. virescens and chemical insecticides are 
generally not required for control of this species (Blanco et al., 2007; Catchot et al., 
2008; Temple et al., 2009).  However, control of H. virescens in non-Bt cotton, for 
example in the sprayable refuge areas, and for other crop systems (e.g. tobacco), may 
still be needed using pyrethroids, organophosphates or carbamates that are still 
effective, along with spinosad, indoxacarb and  diamides (Catchot et al., 2008; 
Bacheler and Van Duyn, 2009; Burrack, 2009). 
 
Cultural control can affect H. virescens populations through post- and pre-season 
tillage, reducing successful overwintering of pupae either by destroying them or 
disrupting the adult exit holes.  Use of short season cultivars or ensuring early 
maturity to avoid late season infestations and management of border vegetation 
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through mowing to reduce available host plants are further practices carried out to 
avoid pest population build up (King, 1994; Catchot et al., 2008). 
 
Heliothis virescens has numerous natural enemies belonging to the orders 
Hymenoptera, Coleoptera, Hemiptera, Neuroptera, and Araneida (King and Coleman, 
1989).  Intensive production systems for biological control have had limited use, for 
example, hymenopteran parasitoid species (King and Coleman, 1989; King, 1994) 
and the use of  nuclear polyhedrosis virus (NPV) (Bell and Romine, 1980; Bell and 
Hayes, 1994; King, 1994) due to inconsistent results and proving to be less cost 
effective in controlling H. virescens as chemical insecticides.  However, through IRM 
and IPM practices naturally occurring biological control is encouraged as an 
additional method to control or prevent outbreaks (Catchot et al., 2008; Fitt, 2008). 
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Chapter 3 
 
General Materials and Methods 
 
3.1 Artificial diet 
 
Heliothis virescens larvae were reared on a standard artificial diet mix (Syngenta, 
Jealott’s Hill, U.K.; Table 3.1).  
 
Table 3.1: Artificial diet ingredients, and quantities for 400 larvae to  
develop through to pupae. 
Ingredients  Source Quantity 
Agar  Sigma-Aldrich1: A7002 30 g 
Distilled water  1360 ml 
   
Pinto beans  Bio-Serv2: G1430 166 g 
Wheat germ  Bio-Serv: G1659 133 g 
Yeast  Sunshine Health, Glos., UK 85 g 
Soybean flour type 1  Sigma-Aldrich: S9633 67 g 
Casein from bovine milk Sigma-Aldrich: C7078 49 g 
Vitamin mixture  Bio-Serv: F8095 13.3 g 
Ascorbic acid  Sigma-Aldrich: A7506 8 g 
Methyl Paraben  Sigma-Aldrich: H5501 6.6 g 
Sorbic acid  Sigma-Aldrich: S1626 4 g 
Ampicillin sodium salt  Sigma-Aldrich: A9518 0.28 g 
Distilled water  900 ml 
 
1
 Sigma-Aldrich Ltd (Gillingham, UK); 2 Bio-Serv (New Jersey, USA) 
 
 
The agar was added to 1360 ml distilled water, stirred and heated in a microwave until 
the agar had dissolved and the solution became clear and started to boil.  In a separate 
container the remaining ingredients, excluding the ampicillin sodium salt, were added 
together and mixed thoroughly with 900 ml distilled water.  The agar solution was 
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added to the diet mixture and stirred until a smooth even consistency was achieved.  
The ampicillin was mixed with 500 µl distilled water to dissolve it and added to the 
diet mixture.  After stirring the mixture further, the diet was poured into 32-cell 
rearing trays (2mil PET 27HT-1 32 cells 6" x 11", Oliver Products Company, 
Michigan, USA), approximately 5 ml per cell, and left to cool and solidify ready for 
addition of larvae.  The amount of diet in each cell was sufficient for completion of 
larval development to pupae. 
 
 
3.2 Heliothis virescens 
 
3.2.1 Populations 
 
In December 2004, a field population designated GS04, was obtained from Professor 
J. R. Bradley (North Carolina State University) and Dr Ryan Jackson (USDA) that 
had been collected from flue-cured tobacco in Wilson and Pitt Counties, North 
Carolina, USA in June 2004. 
 
In October 2005, three field populations were obtained from Prof Randall Luttrell and 
Dr Ibrahim Ali (University of Arkansas) that had been collected in June 2005.  These 
had been designated F114 (Louisiana State), F123 (Appling County, Georgia) and 
F128 (Teautler County, Georgia). 
 
Four field populations were obtained in September 2006 from the USA.  Three 
hundred 3rd to 5th instar larvae were collected from chick pea, Cicer arietinum, at the 
University of Arkansas Research Station, Washington County, Arkansas and 
designated FV06.  Approximately 900 eggs were collected from cutback tobacco, 
Nicotiana tabacum, in the vicinity of Clayton, Johnston County, North Carolina and 
designated JN06.  Two hundred and ten 3rd to 5th instar larvae were collected from 
C. arietinum in the vicinity of the USDA, near Leland, Washington County, 
Mississippi and designated LEL06.  Three hundred 3rd to 5th instar larvae were 
collected from velvetleaf, Abutilon theophrasti, on Wildy Farms, Leachville, 
Mississippi County, Arkansas and designated WF06. 
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In October 2007, a field population, designated 9607VR, was obtained from Prof 
Randall Luttrell and Dr Ibrahim Ali (University of Arkansas) that had been collected 
from A. theophrasti on Wildy Farms, Leachville, Mississippi County, Arkansas in 
September 2007. 
 
A susceptible laboratory population was obtained from Syngenta (Jealott’s Hill, 
Bracknell, U.K.) designated NCSU (originated from North Carolina State University 
laboratory population).  NCSU had been maintained in the laboratory for over 140 
generations without exposure to insecticides. 
 
The populations were maintained in controlled environment (CE) rooms at 25 ± 2 °C, 
65 ± 10 % relative humidity (RH) with a 16:8 (light:dark) cycle.  Populations were on 
occasion placed at 20 ± 2 °C, 65 ± 10 % RH with a 16:8 (light:dark) cycle to slow 
down the population  in order to synchronise development times or stages. 
 
3.2.2 Culture maintenance 
 
Adults were kept in large open plastic containers (L34 cm x W27 cm x D22 cm) each 
with a net cover held tightly in place across the top of the container with an elastic 
band creating a cage environment.  Adults were fed sufficiently with 10 % (v/v) 
honey solution soaked into cotton wool pads that were placed on top of the netting.  
The placement of honey soaked cotton pads on top of the netting helped encourage 
mated females to lay eggs on the netting as opposed to the base and sides of the 
plastic container.  The egg laden netting was removed and replaced every 24 or 48 h, 
and repeated until egg production decreased or no further eggs were required.  The 
collected egg laden netting was examined for presence of hatched larvae and any 
found were removed as they may have dispersed from other populations in the same 
CE room.  The netting was cut into smaller squares and placed in sealed (with a 
plastic lid) 250 ml round plastic containers and left in the CE room until larval 
emergence.  With the artificial diet prepared (section 3.1), a single larva was placed in 
each cell of the rearing trays using a fine brush (size: 00).  Larvae were separated to 
avoid competition and cannibalism.  The trays were sealed with a breathable polyester 
film (10mp/2mil PET) using a self actuating tray lidder (Model #1708), which were 
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both products from Oliver Products Company (Michigan, USA).  The larvae were left 
undisturbed to complete their development and pupae were collected after 21 to 24 
days, allowing enough time for the majority of larva to have developed to pupae.  Any 
remaining larvae were either allowed to continue to pupation or destroyed depending 
on whether population number requirements had been met.  Between 240 and 360 
pupae was considered adequate to continue the population to avoid potential low egg 
production, poor adult eclosion and genetic bottlenecks, although for some 
generations the pupae number collected was unavoidably lower.  For each population 
the pupae were split into groups of approximately 120 pupae with each group being 
placed into a separate cage (as described previously for adult setup) to avoid 
overcrowding and improve population hygiene.  Emerging healthy adults from these 
groups were transferred to a new cage within their group allocation ready for mating 
and egg laying.   
 
Hygiene protocols were observed to maintain healthy cultures, including removal of 
waste material promptly and freezing before disposal, cleaning equipment with 1 % 
(w/v) Virkon solution and rinsing with distilled water.  Laboratory and CE room 
surfaces were cleaned with 10 % (v/v) bleach solution. 
 
 
3.3 Bacillus thuringiensis toxins 
 
Vip3A was obtained from Syngenta (Research Triangle Park, NC, USA) and stored at 
-80 °C.  The Vip3A protoxin had been overexpressed in Escherichia coli and purified 
as described by Yu et al. (1997).   
 
Cry1Ab and Cry1Ac were obtained from Dr Neil Crickmore and Dr Ali Sayyed 
(University of Sussex, UK) and stored at -80 ºC. They had been expressed as 
crystalline inclusions in E. coli, with the protoxins purified by sonication and 
successive washes with 0.5 M NaCl and water as described by Sayyed et al. (2000b). 
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DiPel® WP (Btk) containing Cry1Ab, Cry1Ac, Cry1Aa, Cry2Aa and Cry2Ab (16000 
IU mg-1 of wettable powder) was obtained from Abbott Laboratories (Chicago, USA) 
and stored at room temperature. 
 
Toxins were freshly prepared in distilled water in readiness for diet incorporation. 
 
 
3.4 Bioassays 
 
Bioassays were conducted by the diet incorporation method where the toxin 
preparation is mixed into the molten diet as described by Dulmage et al. (1971), 
Beegle (1990) and Liao et al. (2002).  The advantages to this method include the even 
distribution of the toxin throughout the diet, and thus closely reflecting expression of 
the toxin in Bt crops, and that it is a simple process to carry out.  Although 
disadvantages are that it is labour and equipment intensive and diet can not be setup in 
advance and stored.  Another common method is the surface contamination assay 
(diet overlay/surface application), where the toxin is applied to the surface of already 
solidified diet preparations (Beegle, 1990; Blanco et al., 2008).  This has the 
advantage of being quick and easy to setup and diet preparations can be stored for 
future use.  However, the disadvantages make the surface contamination method less 
effective, with relatively uneven toxin distribution on the surface, and the potential for 
larvae to avoid toxin exposure depending on their feeding behaviour.  Larvae that feed 
on the surface of the diet will be exposed to more toxin than those that burrow 
beneath the surface of the toxin (Beegle, 1990). 
 
Heliothis virescens in the field, from 2nd to 3rd instar stages onwards, will tend to 
burrow into buds, if available, and this behaviour is noted on artificial diet in the 
laboratory.  Therefore, the diet incorporation method is most suitable as toxin is 
evenly distributed throughout the diet, thereby maximising exposure of the toxin to 
the feeding behaviour of H. virescens larvae. 
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3.4.1 1st and 2nd instar larvae  
 
Bioassays were conducted with 5 - 9 toxin concentrations (prepared through serial 
dilutions with distilled water), plus a control of distilled water only, with 48 larvae per 
concentration (split into 2 - 4 replicates).  Each test concentration used 100 ml of 
artificial diet solution that included the toxin solution.  The artificial diet preparation 
(section 3.1) was similar to that used in culture maintenance except for the exclusion 
of ampicillin and a 10 % reduction in distilled water content.  The water content was 
reduced to allow the addition of the toxin solution to the diet preparation at a ratio of 
1:9 (toxin:diet).  The artificial diet was also allowed to cool to a temperature range of 
40 - 45 °C before addition of the toxin solution to avoid high temperatures degrading 
the toxin. 
 
For each toxin concentration, a 10 ml toxin solution (10 ml distilled water for control 
setup) was prepared at a strength equivalent to that necessary for a 100 ml solution.  
The 10 ml toxin solution was added to a 250 ml glass beaker, along with 90 ml of 
artificial diet solution and mixed thoroughly with a glass stirring rod.  With Vip3A 
bioassay serial dilution concentrations starting above 1000 µg ml-1 the distilled water 
content was reduced by 20 % instead of 10 %, leaving the toxin:diet ratio at 2:8 to 
ensure enough distilled water was mixed with the Vip3A toxin for complete 
solubilisation.  The diet incorporated toxin solution was poured evenly into 48 wells 
(approximately 1.5 - 2 ml per well) of 24-well bioassay plates (BD Falcon™ culture 
plate, Becton Dickinson Labware) and allowed to solidify and cool to room 
temperature.  The volume of diet in each well was sufficient for survival of control 
larvae until the bioassay was stopped.  One 1st instar larva that had hatched less than 
24 h before setup was transferred using a fine brush to each well.  For 2nd instar 
larvae setup, larvae had been reared from emergence to 2nd instar, usually taking 4 
days, on artificial diet prepared without ampicillin and were transferred to the wells 
using a fine brush.  Second instar larvae were identified by their head capsule width, 
that was between 0.36 and 0.53 mm (Neunzig, 1969).  Breathable polyester film was 
cut to size and used to cover the wells and heat sealed using an iron.  The bioassay 
plates were placed in a CE room at 25 ± 2 °C, 65 ± 10 % RH and a 16:8 (light:dark) 
cycle.  Mortality and moult inhibition were determined after seven days, with 
mortality recorded as larvae that failed to respond to gentle contact with a fine brush, 
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and moult inhibition recorded as larvae that failed to moult to the next larval instar 
including dead larvae. 
 
3.4.2 3rd and 4th instar larvae 
 
This method was similar to that for the 1st and 2nd instar larvae with the following 
few exceptions.  The artificial diet incorporated toxin solution for each concentration 
was increased from 100 ml to 200 ml (20 ml toxin solution + 180 ml diet solution), 
with approximately 3 - 4 ml per well.  The bioassay plates were replaced by 32-well 
rearing trays (24 wells used) heat sealed with breathable polyester film.  Larvae had 
been reared from emergence to 3rd or 4th instar, usually taking six and eight days 
respectively, on artificial diet prepared without ampicillin and were transferred to the 
wells using soft forceps.  Third and 4th instar larvae were identified by their head 
capsule width, which was between 0.72 and 0.85 mm for 3rd instars, and between 
1.12 and 1.25 mm for 4th instars (Neunzig, 1969).  Some of these changes were made 
to accommodate larger larvae size and increased diet consumption of later instar 
larvae.  Mortality and moult inhibition were determined after seven days. 
 
 
3.5 Statistical analysis 
 
Statistical package R version 2.8.1 (R Development Core Team, 2009) was used for 
all data analysis, such as analysis of variance (ANOVA) and generalised linear 
models with poisson or binomial errors.  
 
Bioassay data used to estimate lethal concentration (LC) estimates (mortality) and 
moult inhibiting concentration (MIC) estimates (mortality plus 1st instar larvae failing 
to moult to 2nd instars) was corrected for control mortality by removing the number 
of dead or moult inhibited larvae in the control data from the corresponding number at 
each concentration and from the sample number at each concentration. Abbott’s 
(1925) correction for control mortality was not used as it is incompatible with analysis 
of generalised linear models with binomial errors used in R. 
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The LC and MIC bioassay data was analysed by specifying a generalised linear model 
with binomial errors (or quasibinomial if data was overdispersed) to estimate the 
slope and its standard error, with significance tested at the 5 % level.  A function 
called “dose.p” from the MASS library that used logit regession analysis calculated 
estimated LC50 (concentration that kills 50 % of the population) and MIC50 
(concentration that moult inhibits 50 % of the population) values and their standard 
errors (se).  Using these standard error values the 95 % Confidence Intervals (CI; 
LC50 ± [1.96 x se]; MIC50 ± [1.96 x se]) were calculated.  Pairwise comparisons of 
LC50 values were significant at the 1 % level if their respective 95 % CI’s did not 
overlap (Crawley, 2007). 
 
Details of further statistics are given in relevant chapters. 
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Chapter 4 
 
Susceptibility of Heliothis virescens field and laboratory populations 
to the Bt toxins Vip3A, Cry1Ab and Cry1Ac 
 
 
4.1 Introduction 
 
Variation in susceptibility to Bt toxins to different populations both within and 
between species may be caused by genetic differences and/or differences in bioassay 
methodology, such as type of bioassay (e.g. leaf dip, diet incorporation bioassay), 
time length of exposure, temperature of bioassay and the source of toxin (e.g. purified 
protoxin, activated toxin, formulations) (González-Cabrera et al., 2001; Ali et al., 
2006; Saeglitz et al., 2006).  
 
It is important to be able to compare the susceptibilities of field-derived populations 
using the same methodology, so any variation in susceptibility can be attributed to 
genetic differences, such as through natural geographical variability or through 
selection for resistance.  Establishing a baseline response to pesticides and reference 
laboratory populations is important for resistance management, allowing the re-
evaluation of susceptibility at later time periods to indicate any shift in susceptibility 
(Luttrell et al., 1999; Liao et al., 2002; Blanco et al., 2005; Ali et al., 2006; Saeglitz et 
al., 2006; Ali and Luttrell, 2007; Blanco et al., 2008). 
 
The objective of the present work was to establish the susceptibility of H. virescens 
field and laboratory populations to Vip3A, Cry1Ab and Cry1Ac; toxins which are 
already, or are planned to be, expressed in commercial Bt cotton varieties.  
Establishing a baseline for Vip3A susceptibility was also required for laboratory 
selection studies with Vip3A using field-derived populations of H. virescens (see 
Chapter 6).  The relative toxicity of Vip3A and Cry1Ab to different larval instars of 
H. virescens was also determined.  Such information may be useful in estimating 
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survival rates when expression levels of Bt toxins are sub-optimal for controlling 
neonate larvae. 
 
 
4.2 Materials and methods 
 
4.2.1 Populations 
 
See section 3.2.1 
 
4.2.2 Toxicity bioassays for Bt toxins against 1st instar larvae of laboratory and 
field populations 
 
Diet incorporated bioassays (section 3.4.1) with Vip3A, Cry1Ab and Cry1Ac were 
conducted with 1st instar larvae after population establishment in the laboratory.  
Bioassays for populations GS04, FV06, JN06, LEL06, WF06 and 9607VR had all 
been carried out by the 5th generation since collection from the field.  Bioassays for 
populations F114, F123 and F128 were not carried out until 11 generations had passed 
since field collection and classified as laboratory populations. 
 
Not all bioassays produced enough data points to calculate MIC50 as higher 
concentrations resulted in 100 % moult inhibition and some lower concentrations had 
the same moult inhibition as the control. 
 
4.2.3 Toxicity of Vip3A and Cry1Ab against different larval instars of NCSU and 
WF06 populations 
 
Diet incorporated bioassays (sections 3.4.1 and 3.4.2) with Vip3A and Cry1Ab were 
conducted with 1st, 2nd, 3rd and 4th instar larvae with the established laboratory 
population, NCSU, and with Vip3A for the field-derived WF06 population.  Mortality 
and moult inhibition was recorded after seven days.   
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4.2.4 Statistical analysis 
 
Bioassay data was analysed to estimate LC50 and MIC50 values as described in 
section 3.5. 
 
 
4.3 Results  
 
4.3.1 Comparative toxicity of Bt toxins against 1st instar larvae of laboratory and 
field populations 
 
Vip3A LC50 values (Table 4.1) for laboratory populations ranged from 0.58 to 
2.75 µg ml-1 compared with 1.22 to 2.95 µg ml-1 for the six field populations 
representing up to 5-fold variation in susceptibility across all populations.  While 
there were some significant differences in the LC50 values (P<0.01), all the LC50 
values except F123 at 0.58 µg ml-1, were within a range representing less than 3-fold 
variation in susceptibility.  The mean of all the LC50 values was 2.03 µg ml-1.  There 
was no significant difference (P>0.05, 59 d.f., n=72) between the regression slopes for 
any populations. 
 
Vip3A MIC50 (moult inhibition concentration) values (Table 4.2) ranged from NCSU 
at 0.18µg ml-1 to LEL06 at 1.21 µg ml-1, representing up to a 7-fold variation in 
susceptibility across all populations.  The LC50 for 9607VR was significantly different 
and lower than the remaining populations except for NCSU (P<0.01).  There were no 
other significant differences in LC50 values (P>0.01).  The mean of all the MIC50 
values was 0.84 µg ml-1.  The regression slopes for NCSU and JN06 were 
significantly lower than the remaining populations (P<0.05, 18 d.f., n=30). 
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Table 4.1: LC50 values for laboratory and field colonies of 1st instar Heliothis 
virescens to Vip3A in a diet incorporation assay for 7 days at 25 ºC. 
 
Population1 Gen2 LC50 (µg ml-1) 95 % CI3 Slope (± se) n4 
F123 11 0.58 0.13 – 2.58 abc 0.64 (± 0.16) 384 
NCSU LS 1.69 0.98 – 2.92 abc 0.52 (± 0.10) 336 
F114 11 2.15 1.09 – 4.21 abc 0.78 (± 0.14) 384 
GS04 19 2.75 1.82 – 4.16 bc 1.40 (± 0.30) 240 
F128 11 2.75 1.47 – 5.16 abc 0.80 (± 0.14) 336 
      
GS04 5 1.22 0.83 – 1.81 a 0.81 (± 0.11) 336 
9607VR 3 1.39 1.04 – 1.85 ab 1.21 (± 0.13) 336 
LEL06 1 2.06 1.46 – 2.91 abc 1.13 (± 0.17) 288 
WF06 1 2.06 1.46 – 2.90 abc 1.00 (± 0.11) 384 
FV06 1 2.69 1.93 – 3.75 c 0.94 (± 0.10) 384 
JN06 2 2.95 2.03 – 4.30 c 0.81 (± 0.10) 336 
 
 
1
 NCSU – North Carolina State University laboratory population; GS04 – Wilson and Pitt 
Counties, North Carolina, 2004; F114 – Louisiana, 2005; F123 – Appling County, Georgia, 
2005; F128 – Teautler County, Georgia, 2005; FV06 – Washington County, Arkansas, 2006; 
LEL06 – Washington County, Mississippi, 2006; WF06– Mississippi County, Arkansas, 
2006; JN06 – Johnston County, North Carolina, 2006; 9607VR – Mississippi County, 
Arkansas, 2007. 
2 Generation number since collection from the field; LS – Lab. population > 140 generations. 
3
 Values followed by same letter are not significantly different from each other - overlapping 
95 % CI (P>0.01). 
4
 Number of larvae used in bioassay, including control. 
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Table 4.2: MIC50 (moult inhibition concentration) values for laboratory and field 
colonies of 1st instar Heliothis virescens to Vip3A in a diet incorporation assay for 
7 days at 25 ºC. 
 
Population1 Gen2 MIC50 (µg ml-1) 95 % CI3 Slope (± se) n4 
NCSU LS 0.18 0.04 – 0.96  ab 0.38 (± 0.12) 336 
9607VR 3 0.48 0.37 – 0.63  b 1.44 (± 0.18) 288 
JN06 2 1.02 0.67 – 1.56  a 0.84 (± 0.11) 336 
FV06 1 1.07 0.84 – 1.37  a 1.65 (± 0.23) 240 
WF06 1 1.07 0.84 – 1.35  a 1.72 (± 0.21) 288 
LEL06 1 1.21 0.91 – 1.60  a 1.61 (± 0.25) 240 
 
 
1
 See Table 4.1. 
2 Generation number since collection from the field; LS – Lab. population > 140 generations. 
3
 Values followed by same letter are not significantly different from each other (P>0.01). 
4
 Number of larvae used in bioassay, including control. 
 
 
Cry1Ab LC50 values (Table 4.3) ranged from 0.032 to 0.080 µg ml-1 for laboratory 
populations compared with 0.024 to 0.116 µg ml-1 for field populations.  While there 
were some significant differences in the LC50 values (P<0.01), they were all within a 
range representing less than 5-fold variation in susceptibility.  The mean of all the 
LC50 values was 0.060 µg ml-1.  There was no significant difference (P>0.05, 63 d.f., 
n=77) in the regression slopes between populations. 
 
Cry1Ab MIC50 values (Table 4.4) for laboratory populations ranged from 0.008 to 
0.039 µg ml-1 compared with 0.004 to 0.050 µg ml-1 for the field populations 
representing up to 13-fold variation in susceptibility between all populations.  While 
there were some significant differences in LC50 values (P<0.01), all the LC50 values 
except NCSU at 0.039 µg ml-1 and 9607VR at 0.050 µg ml-1, were within a range 
representing less than 4-fold variation in susceptibility.  The mean of all the MIC50 
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values was 0.017 µg ml-1 and excluding NCSU and 9607VR was 0.009 µg ml-1.  
There was no significant difference in the regression slopes (P>0.05, 23 d.f., n=43). 
 
 
Table 4.3: LC50 values for laboratory and field colonies of 1st instar Heliothis 
virescens to Cry1Ab in a diet incorporation assay for 7 days at 25 ºC. 
 
Population1 Gen2 LC50 (µg ml-1) 95 % CI3 Slope (± se) n4 
F114 11 0.032 0.020 – 0.054  ab 0.70 (± 0.10) 336 
GS04 19 0.033 0.020 – 0.053  ab 0.75 (± 0.08) 336 
F123 11 0.045 0.021 – 0.100  abc 0.51 (± 0.11) 192 
F128 11 0.076 0.049 – 0.117  bc 0.65 (± 0.07) 384 
NCSU LS 0.080 0.058 – 0.110  c 1.04 (± 0.13) 288 
      
WF06 1 0.024 0.017 – 0.037  a 0.76 (± 0.08) 432 
LEL06 1 0.032 0.023 – 0.046  a 0.86 (± 0.08) 432 
FV06 2 0.034 0.022 – 0.054  ab 0.65 (± 0.08) 336 
JN06 2 0.086 0.057 – 0.131  c 0.73 (± 0.08) 336 
GS04 6 0.103 0.072 – 0.148  c 1.04 (± 0.14) 288 
9607VR 2 0.116 0.078 – 0.172  c 0.73 (± 0.09) 336 
 
 
1
 See Table 4.1. 
2 Generation number since collection from the field; LS – Lab. population > 140 generations. 
3
 Values followed by same letter are not significantly different from each other (P>0.01). 
4
 Number of larvae used in bioassay, including control. 
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Table 4.4: MIC50 values for laboratory and field colonies of 1st instar Heliothis 
virescens to Cry1Ab in a diet incorporation assay for 7 days at 25 ºC. 
 
Population1 Gen2 MIC50 (µg ml-1) 95 % CI3 Slope (± se) n4 
GS04 19 0.008 0.005 – 0.012  ab 0.81 (± 0.12) 240 
F114 11 0.010 0.007 – 0.014  ab 1.33 (± 0.18) 240 
F128 11 0.014 0.010 – 0.021  bc 1.15 (± 0.17) 240 
NCSU LS 0.039 0.030 – 0.050  d 1.57 (± 0.19) 288 
      
FV06 2 0.004 0.002 – 0.009  a 0.79 (± 0.17) 240 
WF06 1 0.009 0.007 – 0.013  ab 1.18 (± 0.18) 240 
LEL06 1 0.010 0.008 – 0.013  ab 1.64 (± 0.24) 240 
JN06 2 0.011 0.007 – 0.018  abc 0.77 (± 0.14) 240 
9607VR 2 0.050 0.035 – 0.072  d 0.87 (± 0.10) 336 
 
 
1
 See Table 4.1. 
2 Generation number since collection from the field; LS – Lab. population > 140 generations. 
3
 Values followed by same letter are not significantly different from each other (P>0.01). 
4
 Number of larvae used in bioassay, including control. 
 
 
Cry1Ac LC50 values (Table 4.5) for the laboratory populations ranged from 0.022 to 
0.143 µg ml-1, and the field populations ranged from 0.024 to 0.142 µg ml-1, 
representing up to a 7-fold variation in susceptibility across all populations.  The LC50 
values of GS04, NCSU, LEL06, JN06 and WF06 were significantly lower than F114, 
F123, F128 and 9607VR (P<0.01).  There were no other significant differences 
between the populations (P>0.01). The mean of all the LC50 values was 0.078 µg ml-1.  
The regression slope for NCSU was significantly higher than the remaining 
populations (P<0.05, 40 d.f., n=66).  
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Table 4.5: LC50 values for laboratory and field colonies of 1st instar Heliothis 
virescens to Cry1Ac in a diet incorporation assay for 7 days at 25 ºC. 
 
Population1 Gen2 LC50 (µg ml-1) 95 % CI3 Slope (± se) n4 
GS04 20 0.022 0.016 – 0.030  a 1.07 (± 0.13) 288 
NCSU LS 0.050 0.038 – 0.066  a 1.34 (± 0.17) 336 
F114 11 0.114 0.077 – 0.170  b 0.81 (± 0.10) 336 
F123 11 0.132 0.074 – 0.235  b 0.43 (± 0.06) 384 
F128 11 0.143 0.079 – 0.260  b 0.46 (± 0.06) 384 
      
LEL06 1 0.024 0.014 – 0.044  a 0.50 (± 0.06) 432 
JN06 2 0.035 0.021 – 0.059  a 0.56 (± 0.08) 336 
WF06 3 0.047 0.033 – 0.068  a 0.94 (± 0.12) 336 
GS04 6 0.048 0.035 – 0.067  a 0.83 (± 0.09) 192 
FV06 2 0.069 0.041 – 0.117  ab 0.54 (± 0.07) 336 
9607VR 2 0.142 0.094 – 0.214  b 0.75 (± 0.10) 336 
 
 
1
 See Table 4.1. 
2 Generation number since collection from the field; LS – Lab. population > 140 generations. 
3
 Values followed by same letter are not significantly different from each other (P>0.01). 
4
 Number of larvae used in bioassay, including control. 
 
 
Cry1Ac MIC50 (Table 4.6) values for the laboratory populations ranged from 0.004 to 
0.029 µg ml-1, and the field populations ranged from 0.004 to 0.069 µg ml-1, 
representing up to 17-fold variation in susceptibility between all populations.  While 
there were some significant differences in the LC50 values (P<0.01), all the LC50 
values, except for NCSU and 9607VR, were within a range representing less than 5-
fold variation in susceptibility.  The mean of all the MIC50 values was 0.017 µg ml-1 
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and, excluding NCSU and 9607VR was 0.009 µg ml-1.  The regression slope for 
NCSU was significantly higher than the remaining populations excluding GS04 
(P<0.05, 22 d.f., n=41).  There were no other significant differences in the regression 
slopes between populations (P>0.05). 
 
Table 4.6: MIC50 values for laboratory and field colonies of 1st instar Heliothis 
virescens to Cry1Ac in a diet incorporation assay for 7 days at 25 ºC. 
 
Population1 Gen2 MIC50 (µg ml-1) 95 % CI3 Slope (± se) n4 
F128 11 0.004 0.003 – 0.008  a 0.79  (± 0.12) 240 
F123 11 0.007 0.005 – 0.011  a 0.96  (± 0.14) 288 
GS04 20 0.009 0.007 – 0.011  a 1.75 (± 0.32) 192 
F114 11 0.011 0.006 – 0.019  ab 0.79 (± 0.12) 192 
NCSU LS 0.029 0.022 – 0.037  c 1.84 (± 0.27) 192 
      
LEL06 1 0.004 0.002 – 0.008  a 0.88 (± 0.19) 240 
JN06 2 0.008 0.004 – 0.014  ab 0.66 (± 0.12) 288 
FV06 2 0.009 0.005 – 0.014  ab 0.80 (± 0.13) 288 
WF06 3 0.019 0.013 – 0.027  bc 0.97 (± 0.15) 240 
9607VR 2 0.069 0.043 – 0.109  d 0.71 (± 0.11) 288 
 
 
1
 See Table 4.1. 
2 Generation number since collection from the field; LS – Lab. population > 140 generations. 
3
 Values followed by same letter are not significantly different from each other (P>0.01). 
4
 Number of larvae used in bioassay, including control.
 
 
 
The toxicity of Bt toxins Cry1Ab and Cry1Ac to 1st instar larvae were very similar, 
but they both had greater toxicity to 1st instar larvae when compared to Vip3A based 
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on the LC50 values.   Cry1Ab toxicity ranged from 5- to 123-fold greater and Cry1Ac 
toxicity ranged from 4- to 134-fold greater than Vip3A toxicity.  A similar pattern 
occurred when comparing the MIC50 values.  Cry1Ab moult inhibition ranged from 4- 
to 303-fold greater, and Cry1Ac moult inhibition ranged from 3- to 303-fold greater 
than Vip3A moult inhibition. 
 
4.3.2 Comparative toxicity of Vip3A and Cry1Ab against different larval instars 
of the NCSU population  
 
Vip3A LC50 values for 1st, 2nd and 3rd instar larvae (1.69, 1.77  and 1.5 µg ml-1 
respectively) of the NCSU population were not significantly different from each other 
(P>0.01; Figure 4.1).  The LC50 value for 4th instar larvae (5.11 µg ml-1) was 
significantly greater compared with 1st, 2nd and 3rd instar larvae (P<0.01). 
 
Vip3A MIC50 value for 1st instar larvae (0.18 µg ml-1) was significantly lower than 
2nd, 3rd and 4th instar larvae (1.77, 1.44 and 3.41 µg ml-1 respectively) of the NCSU 
population (P<0.01; Figure 4.1).  The MIC50 values for 2nd and 3rd instar larvae were 
not significantly different from each other (P>0.01), but were significantly lower than 
4th instar larvae (P<0.01).  The 1st instar MIC50 value was significantly lower than the 
LC50 value (P<0.01).  The MIC50 value for 2nd instar larvae was exactly the same as 
the LC50 as no surviving larvae were moult inhibited.  The MIC50 values for 3rd and 
4th instar larvae were lower than their respective LC50 values but were not 
significantly different (P>0.01).   
 
Cry1Ab LC50 values for 1st, 2nd, 3rd and 4th instar larvae (0.085, 0.071, 0.059 and 
0.092 µg ml-1 respectively) of the NCSU population were not significantly different 
(P>0.01; Figure 4.2). 
 
Cry1Ab MIC50 values for 1st, 2nd, 3rd and 4th instar larvae (0.039, 0.029, 0.032 and 
0.030 µg ml-1 respectively) of the NCSU population were not significantly different 
from each other (P>0.01; Figure 4.2).  MIC50 values for 1st and 4th instar larvae were 
significantly lower than their respective LC50 values (P<0.01).  There were no 
significant differences between the respective MIC50 and LC50 values for 2nd and 3rd 
instar larvae (P>0.01). 
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Figure 4.1: Toxicity of Vip3A to larval stages of the susceptible North Carolina State 
University (NCSU) H. virescens laboratory population: (A) LC50 (± 95 % CI); (B) 
MIC50 (± 95 % CI).  Values with same lower case letter are not significantly different 
from each other (P>0.01), (see also Appendix 1, Tables A.1.1 and A.1.2). 
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Figure 4.2: Toxicity of Cry1Ab to larval stages of the susceptible North Carolina State 
University (NCSU) H. virescens laboratory population: (A) LC50 (± 95 % CI); (B) 
MIC50 (± 95 % CI).  Values with same lower case letter are not significantly different 
from each other (P>0.01), (see also Appendix 1, Tables A.1.3 and A.1.4). 
 
 
4.3.3 Comparative toxicity of Vip3A against different larval instars of the WF06 
population 
 
The LC50 values for 1st, 2nd and 3rd instar larvae of WF06 UNSEL were not 
significantly different, 2.63, 2.91 and 3.76 µg ml-1 respectively (P>0.01) (Figure 4.3).  
However, for 4th instar larvae the LC50 was not determined as at the highest bioassay 
concentration of 100 µg ml-1, the mortality was only 13 %. 
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The MIC50 value for 1st instar larvae of WF06 UNSEL, 0.90 µg ml-1, was 
significantly lower than the respective LC50 value and significantly lower than the 
MIC50 values of 2nd (2.07 µg ml-1), 3rd (1.88 µg ml-1) and 4th (9.21 µg ml-1) instar 
larvae of WF06 UNSEL (P<0.01).  There was no significant difference between the 
respective MIC50 and LC50 values for 2nd and 3rd instar larvae (P>0.01).  The MIC50 
value for 4th instar larvae was significantly higher than 1st, 2nd and 3rd instar larvae 
(P<0.01). 
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Figure 4.3: Toxicity of Vip3A to larval stages of the WF06 UNSEL H. virescens 
population: (A) LC50 (± 95 % CI); (B) MIC50 (± 95 % CI).  Values with same lower 
case letter are not significantly different from each other (P>0.01), (see also Appendix 
1, Tables A.1.5 and A.1.6.) 
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4.4 Discussion 
 
Previous laboratory studies with Vip3A or Vip3-related toxins have not compared 
variation in susceptibility, only presenting data on the toxicity range to various 
lepidopteran larvae (Estruch et al., 1996; Yu et al., 1997; Selvapandiyan et al., 2001; 
Lee et al., 2003; Fang et al., 2007).  In the present study, there was generally little 
variability in the susceptibility to Vip3A, Cry1Ab and Cry1Ac in the field-derived 
and laboratory populations of H. virescens examined.  Variation within each toxin for 
both LC50 and MIC50 values was less than 7-fold.  The exceptions were the laboratory 
population NCSU and field-derived population 9607VR that had higher MIC50 values 
for Cry1Ab and Cry1Ac resulting in up to 13- and 17-fold susceptibility compared to 
the remaining populations.  MIC50 values were on average 2- to 5-fold lower than the 
LC50 values for Vip3A, Cry1Ab and Cry1Ac demonstrating that not all surviving 
larvae successfully developed on the diet. None of the data suggested that resistance 
to Vip3A or Cry1Ab / Cry1Ac was present in the populations examined.  The 
apparent low variability in susceptibility may also have been due in part as a result of 
these populations becoming established as laboratory cultures.  With limited 
individuals taken from the field, the populations may have gone through genetic 
bottlenecks, even with a single generation (Table 4.1), possibly eliminating rare genes 
or genes that may have imposed fitness costs in the field that have no impact in the 
laboratory, and vice versa.  Population bottlenecks and small populations are expected 
to decrease genetic variance and reduced evolutionary potential (Willi et al., 2006).  
The behaviour of the populations may have altered in the laboratory environment, for 
example, mating preferences or the use of artificial diet as opposed to natural food 
(e.g. cotton plants).  These laboratory effects may have altered the response of 
individuals to the toxins. 
 
Using moult inhibition data may present a more realistic view of the toxicity of 
Vip3A, Cry1Ab and Cry1Ac, as the vast majority of surviving 1st instar larvae fail to 
successfully develop on artificial diet (personal observation) and such data can help to 
highlight antifeedant effects and/or other sub lethal effects of the toxin.  Gore et al. 
(2005) found that H. virescens showed some avoidance of Cry1Ac and Cry2Ab in 
bioassays in choice experiments, selectively feeding on non-toxin treated diet 
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compared with Cry1Ac treated diet, although avoidance was less prominent with 
Cry2Ab. 
 
Moult inhibition data is useful provided identification of the instar stage is determined 
accurately, and not just based on larval size.  Head capsule width is the most accurate 
way of determining instar stage, although it has been argued that this can take too 
much time for use in bioassays (Blanco et al., 2005). However, with practice, 
consistent identification of larval instars can be achieved through observation of head 
capsule size by eye rather than the need to measure all individuals (personal 
experience).  Head capsule size is fairly distinct when looking at reference larvae for 
all stages, particularly for 1st to 4th larval instars. 
 
The variation in susceptibility to Bt toxins determined for the populations in the 
present study appears to be typical for H. virescens when compared to other work.  
Jackson et al., (2007) found that susceptibility to Vip3A in a laboratory insecticide 
susceptible population of H. virescens (YDK) and three Cry1Ac resistant populations 
(YHD2, KCBhyb and CXC) were similar with LC50 values ranging from 179 µg ml-1 
to 210 µg ml-1. This indicated that these Cry1Ac resistant populations did not show 
any signs of cross-resistance to Vip3A.  The Vip3A LC50 values reported in the above 
work are approximately 100-fold greater than those calculated in the present study 
(based on a mean Vip3A LC50 of 2 µg ml-1).  This difference may, in part, be because 
the Vip3A was prepared in distilled water in the present study rather than in an 
ammonium carbonate buffer as in Jackson et al. (2007).  This illustrates the potential 
dangers of direct comparisons made on absolute values gathered from differing 
bioassay methodology as opposed to relative comparisons to respective reference 
populations (González-Cabrera et al., 2001; Liao et al., 2002; Ali et al., 2006). 
 
Using a diet incorporation assay, Ali et al. (2006) found that H. virescens varied 12-
fold in susceptibility to Cry1Ac (MPV II formulation) (LC50 0.36 µg ml-1 to 4.54 µg 
ml-1) in five laboratory, seven laboratory-cross and 10 field populations collected 
from 2002 to 2004.  The difference was only 4-fold across all laboratory and 
field populations when LC50 values were pooled, demonstrating little change in 
relative differences compared with populations collected in 1992 and 1993 (LC50 0.02 
µg ml-1 to 0.13 µg ml-1) (Luttrell et al., 1999; Ali et al., 2006).  Similarly low (6-fold) 
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variability in toxicity of Cry1Ab to laboratory and field populations of H. virescens 
was reported by Luttrell et al. (1999). 
 
Susceptibility of H. virescens populations to other Bt toxins has also demonstrated a 
similar pattern of low natural variability.  Blanco et al. (2008) found a 3-fold variation 
in baseline LC50 values for Cry1F using a diet overlay method, while Ali and Luttrell 
(2007) found only a 2-fold variation in mean LC50 values for Cry2Ab2 across tested 
laboratory and field populations collected from 2002 to 2005 using a diet 
incorporation method. 
 
In the related heliothine species H. zea the pattern of susceptibility has been reported 
to be more varied.  Ali and Luttrell (2007) found H. zea LC50 values for Cry2Ab2 
varied up to 37-fold in eight laboratory, 10 laboratory-cross and 64 field populations 
collected from 2002 to 2005, and only 3-fold across all laboratory and field 
populations based on mean LC50 values.  Helicoverpa zea susceptibility to Cry1Ac 
(MPV II formulation) varied over 500-fold in five laboratory, nine laboratory-cross 
and 57 field populations collected from 2002 to 2004 and relative susceptibility 
appeared to have decreased in comparison with earlier collections in 1992 and 1993 
(Luttrell et al., 1999; Ali et al., 2006).  This reduced susceptibility has led to the 
suggestion that H. zea has evolved field resistance to Cry1Ac (Bt cotton), although 
there have been no reports of widespread control failures or changes in efficacy of Bt 
cotton (Tabashnik et al., 2008a).  There has also been some discussion among 
researchers over whether this conclusion meets the classification of field-evolved 
resistance (Moar et al., 2008; Tabashnik et al., 2008b). 
 
Analysis of published monitoring data for five other major lepidopteran pests targeted 
by Bt crops concluded that field-evolved resistance had not occurred to Cry1Ac (Bt 
cotton) in H. armigera, H. virescens and P. gossypiella and not to Cry1Ab (Bt corn) 
in O. nubilalis, and S. nonagrioides (Tabashnik et al., 2008a). 
 
In the present study, the LC50 and MIC50 values for Cry1Ab and Cry1Ac were similar.  
Vip3A toxicity was up to 134- and 300-fold lower compared with Cry1A toxins based 
on LC50 and MIC50 values respectively.  The lower toxicity for Vip3A could be due to 
a lower saturation of functional toxin-binding sites, or to the assembly of pores and/or 
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the flux through pores may differ from that of Cry1A toxins (Lee et al., 2003; Jackson 
et al., 2007).  Jackson et al. (2007) reported that H. virescens Vip3A toxicity was on 
average 110-fold lower than that of Cry1Ac in a laboratory susceptible population 
(YDK) using the diet incorporation method.  The lower toxicity of Vip3A may also be 
a result of their lack of specificity to gut cells, due to the prevalent nature of their 
production during vegetative growth (section 2.1.3).  In contrast, the H. armigera 
ANGR laboratory population using a surface application bioassay method found that 
Vip3A and Cry1Ac toxicities were not significantly different and Cry1Ab was less 
toxic (Liao et al., 2002).   
 
Cry1Ac and Vip3A expression levels in Bt cotton have been shown to decrease in 
various plant parts throughout the growing season, potentially reducing efficacy to 
target pests (Greenplate, 1999; Adamczyk et al., 2001b; Olsen et al., 2005; Llewellyn 
et al., 2007), and Cry1Ac expression was found to be greater in terminal foliage than 
in fruiting structures (Greenplate, 1999).  Observed differences in H. virescens larval 
survival among Bt cotton expressing Vip3A could be due to protein expression 
variation in different plant structures and although they would not likely survive to 
pupation, larval feeding may cause economic damage (Bommireddy and Leonard, 
2008).  Information on the effect of larval stage of H. virescens on susceptibility to 
Vip3A and Cry1Ab may thus help to predict the possible impact of declining 
expression of Bt toxins in the plant with age and/or variation in expression of Bt 
toxins in the plant on the survival of H. virescens larvae. 
 
In the present study, the LC50 values for Vip3A were found to be similar against 1st, 
2nd and 3rd instar larvae of the NCSU and the field-derived population WF06 of H. 
virescens. Fourth instar larvae of the NCSU population had approximately 3-fold 
reduced susceptibility while for WF06, the tolerance of the 4th instar larvae to Vip3A 
was at least 27-fold greater than the earlier instars.  MIC50 estimates showed that there 
was greater inhibition of 1st instar development compared with later instars in both 
populations.  Thus, larval age effects on susceptibility to Vip3A indicated that higher 
concentrations are needed against 4th instar larvae, and that there is greater inhibition 
of 1st instar development compared with later instars. 
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First, 2nd, 3rd and 4th instar larvae of the NCSU population all had similar 
susceptibilities to Cry1Ab based on LC50 and MIC50 values. Only 1st and 4th instar 
larvae showed significant effects due to moult inhibition.  Thus, larval age had little 
effect on susceptibility to Cry1Ab indicating that the dose of toxin doesn’t have to be 
greater to kill or inhibit development of later instar larvae. 
 
As larval age increases so does diet consumption, and although the toxicity of Vip3A 
and Cry1Ab were similar between some larval instars, differences in tolerance were 
present as later instar larvae consumed more diet than earlier instars (personal 
observation).  This increased tolerance with 4th instar larvae may be a result of 
increased effectiveness of cell-mending or a more effective immune response in later 
instar larvae (Loeb et al., 2001; Heckel et al., 2007).  Difference in tolerance 
demonstrates that later instar larvae would potentially cause more damage in a field 
crop situation (Liao et al., 2002). 
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Chapter 5 
 
Selection of a Vip3A resistant population of Heliothis virescens with 
studies on cross-resistance and the genetics of resistance 
 
 
5.1 Introduction 
 
Selecting for resistance in field-derived populations in the laboratory has produced 
many resistant populations (section 2.2.2).  The production of laboratory selected 
resistant populations enables the study of the genetics of resistance (section 2.2.4) 
gaining knowledge of what potentially may occur in field populations and how to 
delay potential field resistance with suitable IRM strategies (section 2.2.5). 
 
In this chapter the selection of resistance to Vip3A in a field-derived population of H. 
virescens is described, together with subsequent work on cross-resistance to Cry1Ab 
and Cry1Ac and crossing studies to investigate the inheritance of Vip3A resistance 
and whether resistance is monogenic or polygenic. 
 
 
5.2 Materials and Methods 
 
5.2.1 Heliothis virescens populations 
 
Populations LEL06, FV06 and WF06 (section 3.2.1) were initially selected with 
Vip3A.  After three generations this was reduced to the continuation of selection with 
WF06 only.  The LEL06 and FV06 populations were stopped as their cultures were 
not as healthy, and limitations on resources including equipment, CE room space, and 
labour meant the reduction to continuation of one selected population. 
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For experiments investigating the genetics of resistance (section 5.2.7), the resistant 
WF06-Vip3ASEL population at generation 15, which had undergone 12 selections 
with Vip3A, and the unselected WF06-UNSEL population were used. 
 
5.2.2 Bacillus thuringiensis toxin 
 
Vip3A, Cry1Ab and Cry1Ac toxins were used (section 3.3). 
 
5.2.3 Selection for resistance with Vip3A 
 
The WF06 population was divided into two sub-populations at the larval stage of the 
2nd generation of laboratory culture.  One sub-population was left unselected (WF06-
UNSEL) and the other selected with Vip3A (WF06-Vip3ASEL) at the 1st instar larval 
stage from the 2nd generation onwards. 
 
The selection method incorporated the Vip3A toxin into the diet in a similar way to 
the diet incorporation bioassay method (section 3.4).  The artificial diet preparation 
(section 3.1) was similar to that used in culture maintenance except for the exclusion 
of ampicillin and a reduction in distilled water content of 10 % (226 ml).  The 
appropriate Vip3A concentration for 2260 ml of artificial diet was made up in the 226 
ml of distilled water.  Once the artificial diet solution had cooled to between 40 and 
45 °C the Vip3A solution was added and mixed vigorously into the diet.  After 
mixing, the diet was poured into 32-cell rearing trays with approximately 3 ml per cell 
and left to cool ready for addition of larvae.  Larvae were setup on the diet as 
described in section 3.2.2.  The number of larvae selected per generation ranged from 
approximately 600 to 1200; with the exception of the initial selection when the 
number of larvae (330) available was low.  After seven days surviving larvae were 
removed from the diet and those that had moulted to 2nd instar or higher were used to 
continue the population to the next generation. Toxin free artificial diet (section 3.1) 
was setup and poured into 1 oz. plastic cups (9051, Bio-Serv, NJ, USA) with 5 ml diet 
per cup.  A single larva was placed in each diet cup and sealed with a snap on lid 
(9053, Bio-Serv, NJ, USA) that had a single slit for aeration.  Larvae were left in the 
cups for the remainder of their larval development.  Surviving 1st instar larvae were 
also used if the number of successfully moulted larvae was low (less than 250) in an 
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attempt to maintain a large population size.  Pupae collection, adult setup and egg 
collection methods were as described in section 3.2.2. 
 
5.2.4 Evaluation of resistance in Vip3A selected (WF06-Vip3ASEL) and 
unselected (WF06-UNSEL) populations 
 
First instar bioassays (section 3.4.1) with Vip3A were carried out throughout the 
selection process to determine changes in LC50 and MIC50 values and determine 
resistance ratios by comparing LC50 and MIC50 values to those of the WF06-UNSEL 
population. 
 
5.2.5 Cross-resistance studies in the Vip3A selected (WF06-Vip3ASEL) 
population 
 
First instar bioassays (section 3.4.1) were carried out on WF06-Vip3ASEL with 
Cry1Ab after 11, 13 and 14 selections with Vip3A and with Cry1Ac after 13 and 14 
selections, to evaluate cross-resistance.  LC50 and MIC50  values were determined and 
compared to WF06-UNSEL. 
 
5.2.6 Stability of resistance 
 
A sub-population of WF06-Vip3ASEL was setup at generation 13 that had undergone 
11 selection episodes with Vip3A.  The sub-population, WF06-Vip3AREV, was 
maintained continuously without selection and at generation 18, after five generations 
without exposure to Vip3A, 1st instar larvae bioassays (section 3.4.1) were carried out 
to establish LC50 and MIC50 values for Vip3A, Cry1Ab and Cry1Ac for comparison to 
WF06-UNSEL. 
 
5.2.7 Evaluation of maternal/paternal effects, genetic variation, dominance of 
resistance and mode of inheritance in the Vip3A selected (WF06-Vip3ASEL) 
population 
 
The response of F1 and F2 progeny to Vip3A was evaluated at concentrations of 100 
µg ml-1 and 500 µg ml-1 of Vip3A using diet incorporated bioassays based on the 
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method described in section 3.4.1.  The pupae from the WF06-UNSEL and WF06-
Vip3ASEL populations were used in conjunction with those setup for fitness studies 
(Chapter 6).  The pupal sex was determined with males and females placed separately 
in sealed 250 ml round plastic containers. 
 
Pupal sex was determined by examining the genetalia and abdominal segment pattern 
at the posterior end under a microscope.  Males were confirmed by observation of 
their genetalia; two joined circular shapes (gonads), at the partition of the 9th and 10th 
abdominal segments on the ventral surface of the pupae.  Females were confirmed by 
the lack of gonads and the ‘V’ shaped pattern of the partitions between the 8th and 9th 
abdominal segments and the 9th and 10th abdominal segments, in the direction of the 
anterior end (personal communication, Syngenta, and personal observation). 
 
Upon adult emergence, single-pair crosses were setup for WF06-Vip3ASEL (two 
pairs successful), WF06-UNSEL (five pairs successful) and the reciprocal crosses 
WF06-Vip3ASEL female x WF06-UNSEL male (seven pairs successful) and WF06-
UNSEL female x WF06-Vip3ASEL male (five pairs successful).  Each single-pair 
was setup in a 250 ml round plastic container covered with netting held in place by an 
elastic band.  They were fed ad lib with 10 % (v/v) honey solution soaked into cotton 
wool pads that were placed on top of the netting allowing the adults to feed but 
preventing egg lay on the cotton pad.  Once the female had started laying eggs, the 
adult pair was transferred to a new 250 ml container setup every two days, as eggs 
were laid on the container itself as well as the netting.  The netting (if eggs were 
present) was placed inside the container and sealed with a plastic lid.  Hatching 
usually occurred 3 - 4 days after being laid.  F1 progeny from each of the single-pair 
reciprocal crosses were split between use for bioassays and use for continuation in 
culture of the specific family line for the F2 progeny evaluation.  F1 progeny of the 
WF06-Vip3ASEL and WF06-UNSEL populations were required for bioassays only.  
For bioassay setup, the F1 larvae from each family were reared on artificial diet 
containing Vip3A concentrations of 100 µg ml-1 and 500 µg ml-1, or with no Vip3A as 
a control setup.  Four replicates of 12 1st instar larvae (48 in total) for each single-pair 
cross at each concentration were carried out.  The bioassays were kept in a CE room 
at 25 °C ± 2 °C, 65 ± 10 % RH and 16:8 (light:dark) cycle.  Mortality and moult 
inhibition was determined after seven days and used to determine the genetic variation 
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within the populations, maternal or paternal influence and the dominance of 
resistance. 
 
The progeny used for family line continuation from the reciprocal crosses were reared 
through to pupae and split into males and females that were kept in separate cages for 
each individual family.  A group of pupae from the WF06-Vip3ASEL population was 
also split into males and females.  Emerging adults were setup in single-pair crosses 
with F1 adult males backcrossed to WF06-Vip3ASEL females and vice versa, along 
with within family F2 crosses as shown in Table 5.1.  Some families and single-pair 
crosses within families were unsuccessful through lack of viable eggs, as observed in 
the variation in the number of successful families and single-pair crosses setup in 
Table 5.1.  The single-pair setup was the same as mentioned previously, as were the 
Vip3A treatments (0 (control), 100 and 500 µg ml-1).  Mortality and moult inhibition 
was determined after seven days and used to determine the genetic variation within 
the populations and the mode of inheritance (monogenic or polygenic). 
 
Table 5.1:  Backcrosses and F2 crosses setup for evaluation of response to Vip3A. 
Backcross and F2 crosses No.1 pairs2 
F1 (WF06-Vip3ASEL ♀ x WF06-UNSEL ♂) ♀ x WF06-Vip3ASEL ♂ 4 14 
F1 (WF06-Vip3ASEL ♀ x WF06-UNSEL ♂) ♂ x WF06-Vip3ASEL ♀ 4 16 
F1 (WF06-Vip3ASEL ♀ x WF06-UNSEL ♂) ♂ x ♀ 4 16 
F1 (WF06-UNSEL ♀ x WF06-Vip3ASEL ♂) ♀ x WF06-Vip3ASEL ♂ 3 11 
F1 (WF06-UNSEL ♀ x WF06-Vip3ASEL ♂) ♂ x WF06-Vip3ASEL ♀ 2 8 
F1 (WF06-UNSEL ♀ x WF06-Vip3ASEL ♂) ♂ x ♀ 2 8 
 
1
 Number of families setup. 
2
 Number of single-pairs in total for each cross type (2 – 5 single-pairs per family). 
 
5.2.8 Statistical analysis 
 
Bioassay data with multiple concentrations was analysed to estimate the LC50 and 
MIC50 as described in section 3.5. 
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The degree of dominance (h) was estimated using the single concentration method, 
based on Hartl’s (1992) definition of dominance and on survival at any single 
concentration (Liu and Tabashnik, 1997).  The calculation is as follows: 
 
h = (w12 – w22) / (w11 – w22) 
 
where w11, w12 and w22 are the fitness values at a particular concentration for resistant 
homozygotes, heterozygotes and susceptible homozygotes, respectively.  The fitness 
of treated resistant homozygotes (WF06-Vip3ASEL) is defined as 1.  The fitness for 
treated susceptible homozygotes (WF06-UNSEL) was determined as the survival rate 
of treated WF06-UNSEL larvae divided by the survival rate of treated WF06-
Vip3ASEL larvae.  For treated heterozygotes (WF06-Vip3ASEL x WF06-UNSEL), 
the fitness was determined as the survival rate of treated F1 larvae divided by the 
survival rate of treated WF06-Vip3ASEL larvae.  Mortality and moult inhibition was 
corrected for control mortality using Abbott’s (1925) method.  The survival rate was 
estimated as 100 % - mortality %.  Values of h range from 0 (completely recessive) to 
1 (completely dominant) (Liu and Tabashnik, 1997). 
 
The genetic variation within WF06-UNSEL, WF06-Vip3ASEL, F1 reciprocal crosses, 
backcrosses and F2 crosses was determined using analysis of variance (ANOVA) to 
test for significant variation in mortality and moult inhibition among families 
produced by the single-pair crosses.  Percentage mortality and moult inhibited data 
were arcsine transformed prior to ANOVA. 
 
The backcross data was used as a direct test of a monogenic model of resistance 
(Tabashnik, 1991).  The null hypothesis is that resistance is controlled by one locus 
with two alleles (monogenic resistance), S (susceptible) and R (resistant), with the 
parental resistant population RR, and the F1 offspring RS.  If so, then a backcross of 
F1 (WF06-Vip3ASEL x WF06-UNSEL) RS x WF06-Vip3ASEL RR will produce 
progeny that are 50 % RR and 50 % RS.  This hypothesis is tested through calculation 
of the expected mortality, followed by a χ2 test for goodness of fit between the 
expected and observed mortality and moult inhibition of the backcross data at each 
concentration.  The expected mortality or moult inhibition, Y(x), for the backcross 
progeny at concentration (x) is calculated as: 
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Y(x) = 0.50(WRS + WRR), 
 
where WRS and WRR are the mortality or moult inhibition values of the presumed RS 
(F1) and RR (resistant parental line: WF06-Vip3ASEL) geneotypes at concentration 
(x), respectively (Tabashnik, 1991; Wyss et al., 2003).  The χ2 test for goodness of fit 
between the backcross and expected mortality or moult inhibition is calculated, as 
described by Sokal and Rohlf (1995), as: 
 
χ2 = (F1 – pn)2 / pqn, 
 
where F1 is the observed number dead in the backcross generation at concentration 
(x), p is the expected proportion dead calculated as Y(x), n is the number of backcross 
progeny exposed to concentration (x) and q = 1 – p.  The χ2 value is compared with 
the χ2 distribution with one degree of freedom, and if P<0.05 the null hypothesis of 
monogenic resistance is rejected (Tabashnik, 1991; Wyss et al., 2003). 
 
 
5.3 Results 
 
5.3.1 Selection with Vip3A 
 
The average survival rate to pupation of Vip3A selected larvae was 42 % (Table 5.2).  
The Vip3A concentrations remained constant at 2 µg ml-1 from the 3rd generation
 
to 
the 9th generation, but were increased from the 10th generation (selection nine) 
onwards as resistance increased dramatically.  No selection took place at generation 
15 and 16, as bioassay results indicated that LC50 values were unattainable as even 
high concentrations failed to kill sufficient larvae.  A relaxation in selection aimed to 
reduce the level of resistance to allow the calculation of the LC50. 
 
5.3.2 Response to selection with Vip3A in the WF06 population 
 
The LC50 values (Table 5.3) for the WF06 unselected population (WF06-UNSEL) 
remained relatively unchanged.  The only exception being at generation seven where 
 78
there was around a 2- to 3-fold decrease in the LC50, however, there was also a 
decrease in the LC50 for the WF06 selected population (WF06-Vip3ASEL) at the 
same generation (time).  The LC50 values for WF06-Vip3ASEL indicated a large 
increase in the resistance ratio after 13 selection episodes.  There were reversing 
fluctuations in the LC50 estimates with the LC50 at selection nine (516 µg ml-1) 
approximately 2-fold greater than at selection 10 (246 µg ml-1).  After 12 selections 
the LC50 was undetermined as the mortality at the highest bioassay concentration, 
4000 µg ml-1, was only 21 %.  Therefore, the LC50 could only be assumed to be 
greater than 4000 µg ml-1.  No Vip3A selection occurred at generations 15 and 16 in 
an attempt to lower the LC50 so that it could be determined.  This proved successful as 
at generation 17, after 13 selection episodes, the LC50 was 2300 µg ml-1 with a 
resistance ratio of 2040. 
 
The MIC50 values for WF06-UNSEL ranged from 0.1 to 1.07 µg ml-1, with CI’s 
overlapping for the majority of values (Table 5.4).  The MIC50 values for WF06-
Vip3ASEL determined a 6-fold increase in resistance after 13 selection episodes.  
There were fluctuations in the MIC50 values during the selection process.  The 
resistance ratio increased 7-fold after nine selection episodes before rising to 809 fold 
after 12 selections.  The resistance ratio then decreased to 6-fold after 13 selection 
episodes, as Vip3A selection was relaxed to allow determination of the LC50 as 
previously mentioned (Table 5.4). 
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Table 5.2: Summary of selection experiment for Vip3A against WF06 population of 
Heliothis virescens. 
 
Generation Selection 
No. of 
larvae 
selected 
Vip3A 
concentration 
(µg ml-1) 
No. of larvae 
transferred to 
normal diet1  
No. of 
healthy 
pupae 
Survival 
(%)3 
2 1 330 1.5 1402 95 29 
3 2 768 2 362 276 36 
4 3 768 2 244 214 28 
5 4 864 2 414 345 40 
6 5 1120 2 4302 241 22 
7 6 1184 2 3682 252 21 
8 7 821 2 440 350 43 
9 8 1161 2 624 532 46 
10 9 1232 2.5 600 482 39 
11 10 1152 3 745 542 47 
12 11 663 4 534 422 64 
13 12 800 20 395 305 38 
14 13 768 20 594 478 54 
15 - - - 403 307 76 
16 - - - 576 386 67 
17 14 715 20 480 380 53 
 
1
 Only larvae that had developed to 2nd Instar or higher were transferred. 
2
 Number of larvae included 1st instars as there was poor larval development. 
3
 Survival rate of larvae setup to pupation. 
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Table 5.3: Toxicity of Vip3A against a field population of Heliothis virescens 
unselected (WF06-UNSEL) and selected (WF06-Vip3ASEL) in the laboratory. 
 
Population Gen 1 Sel 2 LC50 (µg ml-1) 95% CI Slope (± se) n 3 RR 4 
        
WF06- 1 -         2.06 1.46 - 2.90 1.00 (±0.11) 384 - 
UNSEL 7 -         0.73 0.43 - 1.24 0.80 (±0.17) 288 - 
 11 -         2.47 1.65 - 3.69 0.81 (±0.16) 288 - 
 12 -         2.63 1.87 - 3.70 0.82 (±0.10) 384 - 
 15 -         1.76 1.14 – 2.72 0.56 (±0.07) 384 - 
 18 -         1.13 0.72 - 1.75 0.66 (±0.08) 336 - 
        
WF06-Vip3A 5 3         2.44 0.92 - 6.48 0.26 (±0.08) 336 1 
SEL 7 5         2.02 1.19 - 3.43 0.47 (±0.11) 336 3 
 9 7       38.1 7.39 - 197 0.48 (±0.14) 336 19 
 11 9     516 111 - 2400 0.33 (±0.07) 384 209 
 12 10     246 102 - 595 0.29 (±0.05) 480 94 
 14 12 >40005    >2000 
  17 13   2300 1010 - 5260 0.24 (±0.05) 432 2040 
 
1
 Number of laboratory generations.  WF06-UNSEL generations 15 and 18 were synchronised 
with WF06-Vip3ASEL generations 14 and 17. 
2
 Number of selections with Vip3A. 
3 Number of larvae tested, including control. 
4
 Resistance ratio (WF06-Vip3ASEL / WF06-UNSEL).  RR for selections 3 and 7 were 
compared to WF06-UNSEL generation 1. 
5
 LC50 undetermined as mortality at highest concentration of 4000 µg ml-1 was only 21 %.   
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Table 5.4: Moult inhibiting toxicity of Vip3A against a field population of Heliothis 
virescens unselected (WF06-UNSEL) and selected (WF06-Vip3ASEL) in the 
laboratory. 
 
Population Gen 1 Sel 2 MIC50 (µg ml-1) 95% CI Slope (± se) n 3 RR 4 
        
WF06 1 - 1.07 0.84 - 1.35 1.72 (±0.21) 384 - 
UNSEL 7 - 0.10 0.01 - 0.90 0.76 (±0.32) 240 - 
 11 - 0.63 0.48 - 0.82 1.09 (±0.14) 336 - 
 12 - 0.90 0.69 - 1.18 0.82 (±0.10) 336 - 
 15 - 0.46 0.33 - 0.65 0.96 (±0.11) 384 - 
 18 - 0.36 0.25 - 0.50 1.08 (±0.15) 336 - 
        
WF06-Vip3A 5 3 0.67 0.39 - 1.16 0.76 (±0.14) 336 0.6 
SEL 7 5 0.20 0.07 - 0.64 0.46 (±0.12) 336 2.0 
 9 7 4.59 2.51 - 8.41 0.52 (±0.11) 336 4.3 
 11 9 4.63 2.52 - 8.49 0.43 (±0.06) 384 7.4 
 12 10 2.41 1.20 - 4.85 0.38 (±0.04) 480 2.7 
 14 12      372 137 - 1012 0.22 (±0.04) 432   810 
  17 13 2.02 0.39 - 10.6 0.21 (±0.05) 432 5.6 
 
1
 Number of laboratory generations.  WF06-UNSEL generations 15 and 18 were synchronised 
with WF06-Vip3ASEL generations 14 and 17. 
2
 Number of selections with Vip3A. 
3 Number of larvae tested, including control. 
4
 Resistance ratio (WF06-Vip3ASEL / WF06-UNSEL).  RR for selections 3 and 7 were 
compared to WF06-UNSEL generation 1. 
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5.3.3 Stability of resistance in the Vip3A selected (WF06-Vip3ASEL) population 
 
After five generations without exposure to Vip3A, the Vip3A LC50 for WF06-
Vip3AREV, 709 µg ml-1, was approximately 630-fold greater than and significantly 
different from WF06-UNSEL, 1.13 µg ml-1 (P<0.01) (Table 5.5).  The MIC50 for 
WF06-Vip3AREV, 39.8 µg ml-1, was also significantly greater (110-fold) than that 
for WF06-UNSEL, 0.36 µg ml-1 (P<0.01). 
 
The Cry1Ab LC50 for WF06-Vip3AREV was not significantly different to that of 
WF06-UNSEL (P>0.01), but the MIC50 was significantly lower than WF06-UNSEL 
(P<0.01) (Tables 5.5 and 5.6). 
 
There were no significant differences in either the Cry1Ac LC50 or MIC50 values 
when comparing WF06-Vip3AREV with WF06-UNSEL (P>0.01). 
 
 
5.3.4 Cross-resistance to Cry1Ab and Cry1Ac in the Vip3A selected (WF06-
Vip3ASEL) population 
 
Cry1Ab LC50 values for WF06-Vip3ASEL after both 11 and 13 Vip3A selections, 
although respectively 2- and 3-fold greater, were not significantly different from the 
LC50 values of WF06-UNSEL (P>0.01).  However, after 14 selections the Cry1Ab 
LC50 value for WF06-Vip3ASEL was 7-fold greater than that of WF06-UNSEL, a 
significant increase (P<0.01) (Table 5.5).  The Cry1Ab MIC50 values for WF06-
Vip3ASEL after 11, 13 and 14 Vip3A selections were all significantly lower than the 
respective WF06-UNSEL values (P<0.01) (Table 5.6). 
 
There was a significant increase in the Cry1Ac LC50 value for WF06-Vip3ASEL after 
13 selections with Vip3A, approximately 7-fold greater than that of WF06-UNSEL 
(P<0.01).  However, the respective MIC50 values were similar with CIs determining 
no significant difference (P>0.01).  After 14 selections there were no significant 
differences in either the LC50 or MIC50 values (P>0.01) (Tables 5.5 and 5.6). 
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Table 5.5: LC50 values of Heliothis virescens 1st instar larvae determining resistance and cross-resistance of Vip3A and Cry1Ab / Ac in the 
WF06-Vip3ASEL and WF06-Vip3A-REV. 
Population No. of generations 1 
Vip3A 
selections Toxin LC50 (µg ml-1) 95% CI Slope (± se)  n 3 RR 4 
WF06-UNSEL 14 - Cry1Ab  1.20 0.74 - 1.94 0.68 (± 0.08) 384 - 
WF06-Vip3ASEL 13 11 Cry1Ab  2.89 1.50 - 5.62 0.62 (± 0.10) 336 2.4 
         
WF06-UNSEL 16 - Cry1Ab  1.46 0.92 - 2.31 0.76 (± 0.10) 288 - 
WF06-Vip3ASEL 15 13 Cry1Ab  4.63 1.89 - 11.3 0.40 (± 0.22) 288 3.2 
         
WF06-UNSEL 19 - Cry1Ab  2.49 1.84 - 3.38 1.17 (± 0.15) 288 - 
WF06-Vip3ASEL 18 14 Cry1Ab          16.7 4.06 - 68.5 0.37 (± 0.09) 288 6.7 
WF06-Vip3AREV   18 2 11 Cry1Ab  2.03 1.36 - 3.02 0.79 (± 0.10)  384 0.8 
         
WF06-UNSEL 16 - Cry1Ac  0.41 0.27 - 0.61 1.16 (± 0.16) 240 - 
WF06-Vip3ASEL 15 13 Cry1Ac  2.95 0.91 - 9.58 0.59 (± 0.17) 336 7.1 
         
WF06-UNSEL 19 - Cry1Ac  1.67 1.06 - 2.63 0.87 (± 0.14) 288 - 
WF06-Vip3ASEL 18 14 Cry1Ac  1.67 1.14 - 2.43 0.85 (± 0.10) 384 1 
WF06-Vip3AREV   18 2 11 Cry1Ac  0.93 0.68 - 1.29 1.00 (± 0.11)  336 0.6 
         
WF06-UNSEL 19 - Vip3A  1.13 0.72 - 1.75 0.66 (± 0.08) 336 - 
WF06-Vip3AREV   18 2 11 Vip3A        709  246 - 2040 0.27 (± 0.04)  480 627 
 
1 WF06-UNSEL generations 14, 16, 19 were respectively synchronised with WF06-Vip3ASEL generations 13, 15 and 18 and WF06-Vip3AREV gen 18. 
2
 Absence of selection with Vip3A from generation 13 to 17 (5 continuous generations). 
3 Number of larvae tested, including control. 
4
 Resistance ratio: WF06-Vip3ASEL LC50 / WF06-UNSEL LC50; or WF06-Vip3AREV LC50 / WF06-UNSEL LC50.
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Table 5.6: MIC50 values of Heliothis virescens 1st instar larvae determining resistance and cross-resistance of Vip3A and Cry1Ab / Ac in the 
WF06-Vip3ASEL and WF06-Vip3A-REV. 
Population No. of generations 1 
Vip3A 
selections Toxin MIC50 (µg ml-1) 95% CI Slope (± se) n 3 RR 4 
WF06-UNSEL 14 - Cry1Ab 0.35 0.25 - 0.48 1.54 (± 0.33) 384 - 
WF06-Vip3ASEL 13 11 Cry1Ab 0.15 0.11 - 0.20 1.35 (± 0.16) 288 0.4 
         
WF06-UNSEL 16 - Cry1Ab 0.49 0.36 - 0.66 1.19 (± 0.16) 288 - 
WF06-Vip3ASEL 15 13 Cry1Ab 0.19 0.14 - 0.26 1.66 (± 0.36) 192 0.4 
         
WF06-UNSEL 19 - Cry1Ab 0.86 0.66 - 1.12 1.44 (± 0.20) 240 - 
WF06-Vip3ASEL 18 14 Cry1Ab 0.36 0.25 - 0.45 1.13 (± 0.13) 336 0.4 
WF06-Vip3AREV   18 2 11 Cry1Ab 0.20 0.15 - 0.25 1.44 (± 0.18)  288 0.2 
         
WF06-UNSEL 16 - Cry1Ac 0.25 0.17 - 0.35 1.29 (± 0.17) 240 - 
WF06-Vip3ASEL 15 13 Cry1Ac 0.31 0.22 - 0.44 1.05 (± 0.25) 336 1.2 
         
WF06-UNSEL 19 - Cry1Ac 0.50 0.37 - 0.67 1.18 (± 0.15) 288 - 
WF06-Vip3ASEL 18 14 Cry1Ac 0.43 0.32 - 0.59 1.07 (± 0.12) 336 0.9 
WF06-Vip3AREV   18 2 11 Cry1Ac 0.30 0.23 - 0.38 1.71 (± 0.24)  240 0.6 
         
WF06-UNSEL 19 - Vip3A 0.36 0.25 - 0.50 1.08 (± 0.15) 336 - 
WF06-Vip3AREV   18 2 11 Vip3A          39.8 19.0 - 83.4 0.28 (± 0.04)  480     110 
 
1 WF06-UNSEL generations 14, 16, 19 were respectively synchronised with WF06-Vip3ASEL generations 13, 15 and 18 and WF06-Vip3AREV gen 18. 
2
 Absence of selection with Vip3A from generation 13 to 17 (5 continuous generations). 
3 Number of larvae tested, including control. 
4
 Resistance ratio: WF06-Vip3ASEL LC50 / WF06-UNSEL LC50; or WF06-Vip3AREV LC50 / WF06-UNSEL LC50. 
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5.3.5 Degree of dominance 
 
Bioassays of F1 progeny from single-pair crosses with two concentrations of Vip3A 
showed that dominance of resistance depended upon the F1 reciprocal cross, the 
analysis of mortality or moult inhibition data and the concentration of Vip3A (Tables 
5.7 and 5.8).  The mean dominance values of F1 progeny from WF06-Vip3ASEL 
males x WF06-UNSEL females showed that the degree of dominance increased with 
an increase in Vip3A concentration.  Resistance was incompletely recessive (mean h 
= 0.47) and incompletely dominant (mean h = 0.58) at 100 and 500 µg ml-1 
respectively, based on larval mortality and resistance based on larval moult inhibition 
at 100 and 500 µg ml-1 was incompletely recessive (h = 0.22 and 0.37, respectively).  
In comparison, the mean dominance values of F1 progeny from WF06-Vip3ASEL 
females x WF06-UNSEL males showed that resistance was incompletely recessive at 
100 and 500 µg ml-1 for both mortality and moult inhibition data (Tables 5.7 and 5.8). 
 
5.3.6 Evaluation of genetic variation within the populations by single-pair crosses 
 
The mortality and moult inhibition with Vip3A of the progeny of F1 families from 
crosses between WF06-Vip3ASEL and WF06-UNSEL (Tables 5.7 and 5.8) indicated 
that there were significant differences at three levels.   
 
There were significant differences within the seven single-pair families at 100 µg ml-1 
(mortality: F6,17 = 44.51, P<0.001; moult inhibition: F6, 17 = 9.11, P<0.001) and within 
the 11 single-pair families at 500 µg ml-1 (mortality: F11, 32 = 5.98, P<0.001; moult 
inhibition: F11, 32 = 9.43, P<0.001).  There was a significant difference between the 
reciprocal crosses (WF06-Vip3ASEL female x WF06-UNSEL male and WF06-
Vip3ASEL male x WF06-UNSEL female) at 100 µg ml-1 (mortality: F1, 22 = 13.55, 
P<0.01; moult inhibition: F1, 22 = 4.63, P<0.05) and 500 µg ml-1 (mortality: F1, 42 = 
24.67, P<0.001; moult inhibition: F1, 42 = 25.44, P<0.001).  There were significant 
differences within the WF06-Vip3ASEL female x WF06-UNSEL male cross at 100 
µg ml-1 for the four single-pair crosses (mortality: F3, 10 = 52.67, P<0.001; moult 
inhibition: F3, 10 = 8.23, P<0.01) and at 500 µg ml-1 for the seven single-pair crosses 
(mortality: F6, 19 = 4.58, P<0.05; moult inhibition: F6, 19 = 12.70, P<0.001).  Likewise, 
there were significant differences within the WF06-Vip3ASEL male x WF06-UNSEL 
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female cross at 100 µg ml-1 for the three single-pair crosses (mortality: F2, 7 = 8.19, 
P<0.05; moult inhibition: F2, 7 = 8.90, P<0.05).  However, at 500 µg ml-1 there was no 
significant difference in the mortality or moult inhibition within the five single-pair 
crosses (mortality: F4, 13 = 1.85, P>0.05; moult inhibition: F4, 13 = 2.53, P>0.05). 
 
There were significant differences in the mortality and moult inhibition with Vip3A of 
the progeny of F2 families of F1 (WF06-Vip3ASEL x WF06-UNSEL) x WF06-
Vip3ASEL backcrosses and F1 (WF06-Vip3ASEL x WF06-UNSEL) female x male 
crosses (Tables 5.9 and 5.10).  There were significant differences within the 19 single-
pair families at 100 µg ml-1 (mortality: F18, 54 = 4.99, P<0.001; moult inhibition: F18, 54 
= 3.76, P<0.001) and at 500 µg ml-1 (mortality: F18, 54 = 4.35, P<0.001; moult 
inhibition: F18, 54 = 2.4, P<0.01).  There were significant differences between the F2 
cross types, with the mean mortality at 100 µg ml-1 of F1 (WF06-UNSEL female x 
WF06-Vip3ASEL male) female x F1 (WF06-UNSEL female x WF06-Vip3ASEL 
male) male, and the WF06-Vip3ASEL female x F1 (WF06-UNSEL female x WF06-
Vip3ASEL male) male, 51 and 64 % respectively, significantly lower than the 
remaining F2 cross types (F5, 67 = 5.2, P<0.001).  The same trend was present with the 
mean mortality at 500 µg ml-1 for F1 (WF06-UNSEL female x WF06-Vip3ASEL 
male) female x F1 (WF06-UNSEL female x WF06-Vip3ASEL male) male, and the 
WF06-Vip3ASEL female x F1 (WF06-UNSEL female x WF06-Vip3ASEL male) 
male, 49 and 60 % respectively, significantly lower than the remaining F2 cross types 
(F5, 67 = 6.97, P<0.001).  There were no significant differences in mean moult 
inhibition between the F2 cross types at 100 µg ml-1 (F5, 67 = 0.83, P>0.05) and at 500 
µg ml-1 (F5, 67 = 1.52, P>0.05). 
 
5.3.7 Mode of inheritance in the Vip3A selected (WF06-Vip3ASEL) population 
 
The direct test for a monogenic mode (single gene) of inheritance of Vip3A resistance 
showed significantly greater (P<0.001) observed mortality and moult inhibition than 
expected values at 100 µg ml-1 and 500 µg ml-1 of Vip3A for the backcross progeny 
F1 (WF06-Vip3ASEL x WF06-UNSEL) and the WF06-Vip3ASEL (Tables 5.11, 
5.12, 5.13 and 5.14).  This indicated that the null hypothesis was rejected, thus a 
monogenic model was not an acceptable fit of the data at the concentrations tested. 
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Table 5.7: Dominance (h) of resistance to Vip3A in the WF06-Vip3ASEL Heliothis 
virescens population using mortality values as a function of the concentration of Vip3A for 
single-pair hybrid F1families. 
 
Population/families Characteristics of larvae at Vip3A concentration 
 100 µg ml-1  500 µg ml-1 
 
Mortality 
(%) 1 Fitness 2 h 3  
Mortality 
(%) Fitness h 
Vip3ASEL 38 1.00   27 1.00  
UNSEL 90 0.16   89 0.16  
        
Single-pair F1 families        
        
(Vip3ASEL ♀ x UNSEL ♂) A 100 0.00 0.00  81 0.26 0.12 
(Vip3ASEL ♀ x UNSEL ♂) B 65 0.56 0.48  65 0.48 0.38 
(Vip3ASEL ♀ x UNSEL ♂) C - - -  94 0.08 0.00 
(Vip3ASEL ♀ x UNSEL ♂) D - - -  91 0.13 0.00 
(Vip3ASEL ♀ x UNSEL ♂) E 100 0.00 0.00  96 0.06 0.00 
(Vip3ASEL ♀ x UNSEL ♂) F - - -  98 0.20 0.05 
(Vip3ASEL ♀ x UNSEL ♂) G 77 0.37 0.25  67 0.46 0.36 
        
(Vip3ASEL ♀ x UNSEL ♂) mean 88 0.19 0.03  86 0.20 0.05 
        
(UNSEL ♀ x Vip3ASEL ♂) H -  -  68 0.45 0.34 
(UNSEL ♀ x Vip3ASEL ♂) I 65 0.56 0.47  28 0.99 0.98 
(UNSEL ♀ x Vip3ASEL ♂) J 60 0.63 0.56  47 0.73 0.69 
(UNSEL ♀ x Vip3ASEL ♂) K - - -  67 0.46 0.36 
(UNSEL ♀ x Vip3ASEL ♂) L 87 0.21 0.06  65 0.48 0.38 
        
(UNSEL ♀ x Vip3ASEL ♂) mean 66 0.55 0.47  53 0.65 0.58 
 
1
 Adjusted for control mortality by Abbott’s (1925) method. 
2
 Fitness is the survival rate of the larvae divided by the survival rate of the Vip3ASEL larvae 
(survival rate is estimated as 100 - % mortality) (section 5.2.8). 
3
 Estimates of dominance range from 0 (completely recessive resistance) to 1 (completely 
dominant) (section 5.2.8). 
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Table 5.8: Dominance (h) of resistance to Vip3A in the WF06-Vip3ASEL Heliothis 
virescens population using moult inhibition (MI) values as a function of the 
concentration of Vip3A for single-pair hybrid F1families with WF06-UNSEL. 
 
Population/families Characteristics of larvae at Vip3A concentration 
 100 µg ml-1  500 µg ml-1 
 MI (%) 1 Fitness 2 h 3  MI (%) Fitness h 
WF06-Vip3ASEL 42 1.00   31 1.00  
WF06-UNSEL 97 0.06   100 0.00  
        
Single-pair F1 families        
        
(Vip3ASEL ♀ x UNSEL ♂) A 100 0.00 0.00  98 0.03 0.03 
(Vip3ASEL ♀ x UNSEL ♂) B 79 0.36 0.32  79 0.30 0.30 
(Vip3ASEL ♀ x UNSEL ♂) C - - -  100 0.00 0.00 
(Vip3ASEL ♀ x UNSEL ♂) D - - -  98 0.03 0.03 
(Vip3ASEL ♀ x UNSEL ♂) E 100 0.00 0.00  100 0.00 0.00 
(Vip3ASEL ♀ x UNSEL ♂) F - - -  100 0.00 0.00 
(Vip3ASEL ♀ x UNSEL ♂) G 83 0.29 0.24  79 0.30 0.30 
        
(Vip3ASEL ♀ x UNSEL ♂) mean 92 0.14 0.08  94 0.08 0.08 
        
(UNSEL ♀ x Vip3ASEL ♂) H - - -  78 0.32 0.32 
(UNSEL ♀ x Vip3ASEL ♂) I 78 0.38 0.34  52 0.69 0.69 
(UNSEL ♀ x Vip3ASEL ♂) J 88 0.20 0.15  88 0.17 0.16 
(UNSEL ♀ x Vip3ASEL ♂) K - - -  81 0.28 0.28 
(UNSEL ♀ x Vip3ASEL ♂) L 96 0.08 0.02  78 0.31 0.31 
        
(UNSEL ♀ x Vip3ASEL ♂) mean 85 0.27 0.22  74 0.37 0.37 
 
1
 Adjusted for control moult inhibition by Abbott’s (1925) method. 
2
 Fitness is the survival rate of the larvae divided by the survival rate of the Vip3ASEL larvae 
(survival rate is estimated as 100 - % moult inhibition) (section 5.2.8). 
3
 Estimates of dominance range from 0 (completely recessive resistance) to 1 (completely 
dominant) (section 5.2.8). 
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Table 5.9: Mortality and moult inhibition (MI) in WF06 population of Heliothis 
virescens larvae from single-pair F2 families to Vip3A. 
 
Vip3A concentration 
Backcross and F2 family2 100 µg ml-1  500 µg ml-1 
 Mortality (%)1 MI (%)1  Mortality (%) MI (%) 
 
F1 progeny (Vip3ASEL ♀ x UNSEL ♂) backcrossed with Vip3ASEL population 
      
F1 progeny ♀ (G) (n = 4) 89 94  90 92 
F1 progeny ♀ (E) (n = 2) 93 99  83 94 
F1 progeny ♀ (A) (n = 4) 75 91  73 90 
F1 progeny ♀ (F) (n = 4) 60 60  63 63 
      
F1 progeny ♀ mean 79 85  78 84 
      
F1 progeny ♂ (G) (n = 3) 79 97  80 97 
F1 progeny ♂ (E) (n = 4) 85 94  85 93 
F1 progeny ♂ (A) (n = 5) 75 84  77 88 
F1 progeny ♂ (F) (n = 4) 70 72  66 69 
      
F1 progeny ♂ mean 78 90  78 90 
      
F1 progeny (Vip3ASEL ♀ x UNSEL ♂) ♀ x ♂ 
      
(G) (n = 4) 92 98  89 97 
(E) (n = 4) 85 97  92 97 
(A) (n = 4) 75 92  79 93 
(F) (n = 4) 76 78  76 76 
      
mean 82 90  83 90 
 
1
 Adjusted for control mortality and moult inhibition by Abbott’s (1925) method. 
2
 Capital letters in brackets refer to the family connection in the F1 crosses in Tables 5.7 and 
5.8; n is the number of successful pairs setup for that family. 
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Table 5.10: Mortality and moult inhibition (MI) in WF06 population of Heliothis 
virescens larvae from single-pair F2 families to Vip3A. 
 
Vip3A concentration 
Backcross and F2 family 100 µg ml-1  500 µg ml-1 
 Mortality (%)1 MI (%)1  Mortality (%) MI (%) 
 
F1 progeny (UNSEL ♀ x Vip3ASEL ♂) backcrossed with Vip3ASEL population 
      
F1 progeny ♀ (J) (n = 5) 84 94  78 95 
F1 progeny ♀ (I) (n = 4) 90 98  81 96 
F1 progeny ♀ (H) (n = 2) 68 78  79 84 
      
F1 progeny ♀ mean 83 93  79 93 
      
F1 progeny ♂ (J) (n = 4) 78 93  67 93 
F1 progeny ♂ (I) (n = 4) 40 76  46 86 
      
F1 progeny ♂ mean 64 86  60 91 
      
F1 progeny (UNSEL ♀ x Vip3ASEL ♂) ♀ x ♂ 
      
(J) (n = 4) 64 94  61 89 
(I) (n = 4) 38 71  36 71 
      
mean 51 83  49 80 
 
1
 Adjusted for control mortality and moult inhibition by Abbott’s (1925) method. 
2
 Capital letters in brackets refer to the family connection in the F1 crosses in Tables 5.7 and 
5.8; n is the number of successful pairs setup for that family. 
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Table 5.11: Direct test of monogenic inheritance for resistance to Vip3A by 
comparing expected and observed mortality of the backcross of F1 (Vip3ASEL x 
UNSEL) and Vip3ASEL population of Heliothis virescens at a Vip3A concentration 
of 100 µg ml-1. 
 
Single-pair matings n1 
Observed 
mortality 
(%) 
Expected 
mortality 
(%)2 
χ2 
(df=1)3 P 
Vip3ASEL ♀ x ♂ 96 44    
UNSEL ♀ x ♂ 240 90    
Vip3ASEL ♀ x UNSEL ♂ 168 89    
UNSEL ♀ x Vip3ASEL ♂ 120 70    
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♀ x 
Vip3ASEL ♂ 733 80 67 64.41 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♀ x 
Vip3ASEL ♂ 635 86 57 210.61 <0.001 
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♂ x 
Vip3ASEL ♀ 834 79 67 62.07 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♂ x 
Vip3ASEL ♀ 507 69 57 31.95 <0.001 
 
1
 Number of larvae tested. 
2
 Expected number of larvae dead at a given dose = 0.5 (observed mortality of F1 larvae + 
observed mortality of Vip3ASEL) (section 5.2.8). 
3
 df = degrees of freedom. 
 
  92
Table 5.12: Direct test of monogenic inheritance for resistance to Vip3A by comparing 
expected and observed moult inhibition (MI) of the backcross of F1 (Vip3ASEL x UNSEL) 
and Vip3ASEL population of Heliothis virescens at a Vip3A concentration of 100 µg ml-1. 
 
Single-pair matings n 
Observed 
MI (%) 
Expected 
MI (%) 
χ2 
(df=1) P 
Vip3ASEL ♀ x ♂ 96 48    
UNSEL ♀ x ♂ 240 97    
Vip3ASEL ♀ x UNSEL ♂ 168 93    
UNSEL ♀ x Vip3ASEL ♂ 120 87    
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♀ x 
Vip3ASEL ♂ 733 86 71 88.63 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♀ x 
Vip3ASEL ♂ 635 94 68 198.71 <0.001 
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♂ x 
Vip3ASEL ♀ 834 91 71 160.85 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♂ x 
Vip3ASEL ♀ 507 88 68 100.59 <0.001 
 
1
 Number of larvae tested. 
2
 Expected number of larvae moult inhibited at a given dose = 0.5 (observed MI of F1 larvae + 
observed MI of Vip3ASEL) (section 5.2.8). 
3
 df = degrees of freedom. 
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Table 5.13: Direct test of monogenic inheritance for resistance to Vip3A by comparing 
expected and observed mortality of the backcross of F1 (Vip3ASEL x UNSEL) and 
Vip3ASEL population of Heliothis virescens at a Vip3A concentration of 500 µg ml-1. 
 
Single-pair matings n 
Observed 
mortality 
(%) 
Expected 
mortality 
(%) 
χ2 
(df=1) P 
Vip3ASEL ♀ x ♂ 96 34    
UNSEL ♀ x ♂ 336 89    
Vip3ASEL ♀ x UNSEL ♂ 312 87    
UNSEL ♀ x Vip3ASEL ♂ 216 59    
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♀ x 
Vip3ASEL ♂ 742 80 61 118.72 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♀ x 
Vip3ASEL ♂ 636 82 47 317.86 <0.001 
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♂ x 
Vip3ASEL ♀ 830 80 61 130.44 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♂ x 
Vip3ASEL ♀ 502 66 47 73.14 <0.001 
 
1
 Number of larvae tested. 
2
 Expected number of larvae dead at a given dose = 0.5 (observed mortality of F1 larvae + 
observed mortality of Vip3ASEL) (section 5.2.8). 
3
 df = degrees of freedom. 
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Table 5.14: Direct test of monogenic inheritance for resistance to Vip3A by comparing 
expected and observed moult inhibition (MI) of the backcross of F1 (Vip3ASEL x UNSEL) 
and Vip3ASEL population of Heliothis virescens at a Vip3A concentration of 500 µg ml-1. 
 
Single-pair matings n 
Observed 
MI (%) 
Expected 
MI (%) 
χ2 
(df=1) P 
Vip3ASEL ♀ x ♂ 96 39    
UNSEL ♀ x ♂ 336 100    
Vip3ASEL ♀ x UNSEL ♂ 312 95    
UNSEL ♀ x Vip3ASEL ♂ 216 78    
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♀ x 
Vip3ASEL ♂ 742 86 67 121.25 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♀ x 
Vip3ASEL ♂ 636 94 58 341.80 <0.001 
      
F1 (Vip3ASEL ♀ x UNSEL ♂) ♂ x 
Vip3ASEL ♀ 830 91 67 216.44 <0.001 
F1 (UNSEL ♀ x Vip3ASEL ♂) ♂ x 
Vip3ASEL ♀ 502 92 58 241.47 <0.001 
 
1
 Number of larvae tested. 
2
 Expected number of larvae moult inhibited at a given dose = 0.5 (observed MI of F1 larvae + 
observed MI of Vip3ASEL) (section 5.2.8). 
3
 df = degrees of freedom. 
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5.4 Discussion 
 
The present study reports the first known laboratory selection of an insect population 
for resistance to Vip3A.  The development of Vip3A resistance in the H. virescens 
selected population was rapid with 200-fold resistance after nine selection episodes 
and over 2000-fold resistance after 13 selection episodes based on mortality data 
(Table 5.3).  No direct comparison of Vip3A resistance in other populations can be 
made, but in comparison to selection with Cry toxins other H. virescens populations 
appear to have developed resistance to Cry1Ac more slowly (Gould et al., 1992; 
Gould et al., 1995).  In a H. zea population fast development of Cry1Ac resistance 
was observed with 123-fold resistance after 11 selection episodes (Anilkumar et al., 
2008).  In P. xylostella populations, the speed and intensity of selection for resistance 
appears to vary with the Cry1 toxin being selected (Liu and Tabashnik, 1997; Sayyed 
et al., 2000b; Sayyed and Wright, 2001a) although other factors such as initial 
frequency of resistance alleles and the selection pressure would also be involved.  In 
the present study, the relatively fast development of resistance may have also been 
helped by the procedure of only selecting larvae that had moulted to at least 2nd instar 
after the 7 day bioassay period (three exceptions; Table 5.2), thus removing more 
susceptible individuals, a procedure also carried out by Anilkumar et al. (2008). 
Moult inhibition data indicated that larval development of some individuals was 
inhibited by the presence of Vip3A toxin in the diet, also demonstrating resistance to 
Vip3A. 
 
In the absence of exposure to Vip3A for 5 generations, resistance to Vip3A in WF06-
Vip3AREV was still 627-fold greater than the WF06-UNSEL.  Although no direct 
comparison could be made to assess the change in resistance over the five unselected 
generations, the high LC50 and MIC50 values relative to the WF06-Vip3ASEL after 10 
selections suggests that resistance to Vip3A was relatively stable over this period.  A 
study on the stability of Cry resistance in many other populations of insects of various 
species found that, on average, resistance ratios decreased by a factor of 10 in seven 
generations without exposure to Cry toxins (Gassmann et al., 2009).  Fitness costs 
associated with Cry resistance are thought to cause instability in resistance (Ferré and 
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Van Rie, 2002).  In the present study, this association appears to be absent (Chapter 
6). 
 
Little or no cross-resistance was apparent between Vip3A and Cry1Ab or Cry1Ac 
based on mortality of the resistant Vip3A population. There was 7-fold resistance to 
Cry1Ab and Cry1Ac based on mortality data.  However, only resistance ratios that are 
more than 10-fold will generally reflect heritable decreases in susceptibility 
(Tabashnik, 1994; Tabashnik et al., 2008a), thus no significant cross-resistance can be 
assumed.  The moult inhibition data indicated no cross-resistance between Vip3A and 
Cry1Ab or Cry1Ac.  These findings are supported indirectly by previous work 
demonstrating the lack of sequence homology and differing modes of action between 
Vip3A and Cry toxins (Estruch et al., 1996; Yu et al., 1997; Lee et al., 2003; Lee et 
al., 2006) thus reducing the likelihood of cross-resistance mechanisms based on 
altered target site, the most commonly observed resistance mechanism (Ferré and Van 
Rie, 2002).  The lack of observed cross-resistance is also consistent with the results of 
Jackson et al. (2007) that found no cross-resistance to Vip3A in three H. virescens 
populations that had been selected for resistance to Cry1 toxins and Cry2A.  A 
Cry1Ac resistant H. zea population also demonstrated a lack of cross-resistance to 
Vip3A (Anilkumar et al., 2008). 
 
The significantly lower mortality and moult inhibition of larvae (Tables 5.7 and 5.8) 
from the WF06-Vip3ASEL male x WF06-UNSEL female cross compared to the 
WF06-Vip3ASEL female x WF06-UNSEL male cross, suggested a paternal influence 
on Vip3A resistance.  While paternal influences have not been noted in other studies, 
maternal influences have been suggested in Cry1Ac and Cry1Ab resistant P. 
xylostella populations (Martinez-Ramirez et al., 1995; Sayyed and Wright, 2001a; 
Sayyed et al., 2005), although sex linkage was rejected in one study as no significant 
difference in the number of male and female survivors was found (Martinez-Ramirez 
et al., 1995).  In the present study, male and female survival was not recorded but a 
paternal influence would have resulted in greater female survival as males are the 
heterogametic sex in Lepidoptera (Hartl and Jones, 1999).  It is important to highlight 
that paternal and maternal effects may also be caused by epigenetic effects or 
genomic imprinting and not by sex linkage (Reik and Walter, 2001).  Therefore data 
in the present study cannot indicate the mechanism for a potential paternal influence 
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of Vip3A resistance.  The majority of other studies have found no influence of sex, 
maternal or paternal,  and have assumed an autosomal mode of inheritance, for 
example, with Cry1Ac resistant H. virescens populations (Sims and Stone, 1991; 
Gould et al., 1992; Gould et al., 1995), Cry1Ac and Cry2Ab resistant H. armigera 
populations (Akhurst et al., 2003; Xu et al., 2005; Mahon et al., 2007), and Cry1 
toxin resistant P. xylostella populations (Liu and Tabashnik, 1997; Tabashnik et al., 
1997b; Sayyed et al., 2000a; Sayyed et al., 2000b; Sayyed et al., 2004). 
 
The degree of dominance of Vip3A depended on the F1 reciprocal cross, the Vip3A 
concentration and the use of mortality or moult inhibition data.  Inheritance of 
resistance in WF06-Vip3ASEL female x WF06-UNSEL male cross was almost 
completely recessive using mortality and moult inhibition data at two toxin 
concentrations (100 and 500 µg ml-1).  Whereas the dominance of resistance for the 
WF06-Vip3ASEL male x WF06-UNSEL female cross increased from incompletely 
recessive to incompletely dominant with an increase in toxin concentration using the 
mortality data, while dominance remained incompletely recessive using moult 
inhibition data, although greater at 500 µg ml-1.  This apparent split mode of 
dominance gives further evidence of a possible paternal influence on Vip3A 
resistance.  A similar split, but reversed, was found in a P. xylostella population with 
incomplete dominance in resistant females crossed with susceptible males, but 
incomplete recessivity in resistant males crossed with susceptible females (Sayyed 
and Wright, 2001a).  Dominance of resistance in other H. virescens populations 
against Cry1Ac and Cry1Ab were either incompletely recessive or incompletely 
dominant (Sims and Stone, 1991; Gould et al., 1992; Gould et al., 1995).  This 
variation in degree of dominance has also been found in P. xylostella (Sayyed et al., 
2000a; Sayyed et al., 2000b), H. armigera (Xu et al., 2005; Mahon et al., 2007) and 
P. gossypiella populations (Tabashnik et al., 2004; Carrière et al., 2006).  Dominance 
of resistance in other selected populations against Cry toxins has revealed both 
recessive and incompletely dominant resistance that can vary depending on the 
concentration of the toxin used.  However, the general pattern frequently found shows 
that the degree of dominance decreases with increasing toxin concentration (Liu and 
Tabashnik, 1997; Sayyed and Wright, 2001a; Tabashnik et al., 2002), the opposite 
trend to that found in the present study. 
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The estimation of dominance was based on the assumption that the resistant 
population and susceptible population were completely homozygous when F1 progeny 
were produced.  The presence of heterozygotes in a selected population would tend to 
lower the survival rate of F1 progeny and underestimate the degree of dominance, 
with heterozygotes in the susceptible population having the opposite effect (Liu and 
Tabashnik, 1997; Tabashnik et al., 1997b; Sayyed et al., 2005).  There was significant 
variation in mortality and moult inhibition for single-pair F1 families, suggesting that 
the resistant population was not homozygous for resistance at the time of the crosses 
and so that the estimates of dominance may be lower than the true values.  The 
significant variation within the single pair F2 families suggests that differences in 
resistance between single-pairs was due to different combinations of resistance alleles 
being carried by individuals (Tabashnik et al., 1997; Sayyed et al., 2005), which 
would indicate that more than one locus was involved in Vip3A resistance.  However, 
the potential for underestimation of dominance indicated by the heterozygous resistant 
line may compromise the suggestion of more than one locus involved in Vip3A 
resistance (Liu and Tabashnik, 1997). 
 
In the present study, further analysis involving the backcross experiments suggested 
that resistance to Vip3A in WF06-Vip3ASEL was due to more than one locus 
(polygenic) at both concentrations tested for mortality and moult inhibition data.  
Other populations resistant to Cry toxins have also been shown to exhibit polygenic 
resistance, for example, a Cry2Aa resistant H. virescens population (Gahan et al., 
2005) and Cry1Ac resistant P. xylostella (Sayyed et al., 2000b; Sayyed and Wright, 
2001a; Sayyed et al., 2005) and P. gossypiella populations (Tabashnik et al., 2006).  
In contrast monogenic resistance has been found in other populations of H. virescens 
(Gould et al., 1995), H. armigera (Xu et al., 2005; Mahon et al., 2007), P. xylostella 
(Tabashnik et al., 1992; Sayyed et al., 2000a; Sayyed et al., 2004) and O. nubilalis 
(Alves et al., 2006) and is generally regarded as the most common form of Cry 
resistance (Ferré and Van Rie, 2002). 
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Chapter 6 
 
Fitness studies on a Vip3A resistant population  
of Heliothis virescens 
 
 
6.1 Introduction 
 
Evaluation of the fitness of resistant populations in comparison to susceptible 
populations can reveal whether resistant populations have associated fitness costs that 
may put them at a disadvantage for there continuing survival in the field, therefore 
delaying resistance.  Fitness costs of Cry resistance occur in the absence of Bt, with 
the fitness of resistant insects lower than that of susceptible insects.  Knowledge of 
fitness costs can aid the design of insect management strategies, such as improving 
the effectiveness of refuges through designs to increase the dominance or magnitude 
of fitness costs.  Greater expression of fitness costs of resistance in refuges will 
actively select against resistance (Carrière and Tabashnik, 2001; Gould et al., 2006; 
Raymond et al., 2007b; Gassmann et al., 2009).  However, estimating the total fitness 
of a population is often impossible, with only measurements of some of its 
components recorded.  Therefore, care must be taken when drawing conclusions 
about an individual’s or a population’s fitness based on only a few fitness components 
as there will be a lack of information on trade-offs amongst life history traits and how 
they may affect a field population (Reed and Bryant, 2004). 
 
Fitness costs linked to Cry resistance have been reported in studies on various insect 
species, (e.g. H. virescens, H. armigera, P. gossypiella, P. xylostella and T. ni) 
including effects on survival, development rate, larval and pupal weight, and 
fecundity (Sayyed and Wright, 2001b; Janmaat and Myers, 2003; Bird and Akhurst, 
2005; Carrière et al., 2005; Bird and Akhurst, 2007; Gassmann et al., 2009).  
However, not all studies have demonstrated fitness costs.  Studies on a Btk resistant 
population of H. virescens found no difference in larval weight, larval survival and 
egg viability compared with a susceptible population (Gould and Anderson, 1991), 
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while in a Cry1Ac resistant population of the same species (BRX8.8) there was no 
apparent effect on growth rate (Gahan et al., 2005). 
 
The present study compares the biology of the Vip3A resistant population (WF06-
Vip3ASEL) and unselected population (WF06-UNSEL) of H. virescens (Chapter 5) 
to investigate the effects of Vip3A resistance on fitness. The fitness effects studied 
were development time, pupal weight, survival to eclosion, adult sex ratio, mating 
success, fecundity and egg viability. 
 
 
6.2 Materials and Methods 
 
6.2.1 Heliothis virescens populations 
 
The populations used were the resistant WF06-Vip3ASEL population at generation 
15, which had undergone 12 selections with Vip3A, and the unselected WF06-
UNSEL population. 
 
6.2.2 Development time, pupal weight and sex ratio of WF06-UNSEL and WF06-
Vip3ASEL  
 
One hundred and fifty 1st instar larvae from WF06-UNSEL and WF06-Vip3ASEL, in 
15 replicates of 10 larvae each, were setup on artificial diet (six WF06-UNSEL and 
two WF06-Vip3ASEL individuals lost through handling error).  The artificial diet was 
prepared as described in section 3.1, except that the diet was setup in 1 oz. plastic 
cups (9051, Bio-Serv, NJ, USA) as opposed to the 32-cell rearing trays.  A single 1st 
instar larva (< 24 h old) was placed in each diet cup and sealed with a snap on lid 
(9053, Bio-Serv, NJ, USA) that had a single slit for aeration.  The development time 
from larva to pupa was recorded and two day old pupae were weighed.  The sex of the 
pupae was determined as described in section 5.2.7.  The pupae were placed 
individually in 250 ml round plastic containers covered with netting held in place by 
an elastic band.  Development times from pupae to adult and from egg to adult were 
recorded.  The number of larvae that survived to successful adult eclosion was 
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recorded, although adults with wing deformities were not classed as successful.  The 
populations were maintained in CE rooms at 25 ± 2 °C, 65 ± 10 % relative humidity 
(RH) with a 16:8 (light:dark) cycle. 
 
6.2.3 Mating success, fecundity and egg viability of WF06-UNSEL and WF06-
Vip3ASEL populations and their reciprocal crosses 
 
Newly emerged adult males and females from the development studies (section 6.2.2) 
were paired at random into WF06-UNSEL female and male (21 pairs), WF06-
Vip3ASEL female and male (19 pairs), WF06-Vip3ASEL female x WF06-UNSEL 
male (17 pairs) and WF06-UNSEL female x WF06-Vip3ASEL male (20 pairs) 
crosses.  Each pair was setup in a 250 ml round plastic container covered with netting 
held in place by an elastic band.  They were fed ad lib with 10 % (v/v) honey solution 
soaked into cotton wool pads that were placed on top of the netting allowing the 
adults to feed but preventing egg lay on the cotton pad.  Once the female had started 
laying eggs, the adult pair was transferred to a new 250 ml container setup every 2 
days, as eggs were laid on the container itself as well as the netting.  The eggs were 
counted and the netting (if eggs were present) was placed inside the container and 
sealed with a plastic lid.  Hatching usually occurred after 3 - 4 days, but the eggs were 
given up to seven days to hatch before the container was discarded.  Emerging larvae 
were counted and removed each day.  Mating pair success was recorded by the 
number of females that laid eggs and the number of pairs that had viable progeny.  
The populations were maintained in CE rooms at 25 ± 2 °C, 65 ± 10 % relative 
humidity (RH) with a 16:8 (light:dark) cycle. 
 
6.2.4 Statistical analysis 
 
Statistical analysis was carried out using R version 2.8.1 (R Development Core Team, 
2009).  Larval, pupal and egg to adult development times were modelled using 
analysis of variance (ANOVA).  The pupal development time data was log 
transformed to correct for non-normal distribution.  Pupal weight was modelled using 
ANOVA.  The sex ratio was analysed using the chi squared test for given 
probabilities (chisq.test), where the null hypothesis probability is equal to 0.5 (50:50 
sex ratio).  The proportion of larvae that survived to adult eclosion was analysed using 
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a generalised linear model with a binomial error structure.  Mating success for both 
proportion of pairs laying eggs and pairs producing viable progeny was analysed 
using the binomial proportions test (prop.test) to compare four proportions.  The mean 
number of eggs was modelled using a generalised linear model with a poisson error 
structure corrected for overdispersion.  The mean egg viability was modelled using a 
generalised linear model with binomial errors corrected for overdispersion.  For all 
analyses significance differences between treatments were accepted at the 5 % level 
(P<0.05). 
 
 
6.3 Results 
 
6.3.1 Development time, pupal weight and sex ratio of the WF06-UNSEL and 
WF06-Vip3ASEL populations 
 
There was a significant effect on mean larval development time (F3,157 = 7.97,  
P<0.01). The WF06-Vip3ASEL population had significantly lower larval 
development times compared with the WF06-UNSEL population (Table 6.1). There 
was no significant difference between male and female larval development times 
within each population (P>0.05). 
 
The mean pupal development time was significantly different (F3,157 = 12.51, P<0.01).  
The mean male pupal development time was significantly longer in both the WF06-
UNSEL and WF06-Vip3ASEL populations compared with the mean female pupal 
development time (Table 6.1).  There was no significant difference within either male 
or female pupal development times (P>0.05).  
 
There was a significant effect on mean development time from egg to adult eclosion 
(F3,157 = 5.59, P<0.01), with WF06-Vip3ASEL female development significantly 
faster compared with WF06-Vip3ASEL males, and WF06-UNSEL female and males  
(Table 6.1).  There were no further significant differences between WF06-Vip3ASEL 
males and WF06-UNSEL females and males (P>0.05). 
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The proportion of larvae that survived to adult eclosion was significantly different 
between WF06-Vip3ASEL (72 out of 148) and WF06-UNSEL (89 out of 144) (z1, 28 = 
-2.253, P<0.05; Table 6.1). 
 
There were significant effects on pupal weight between the populations (F3, 157 = 
15.37, P<0.01; Table 6.1).   Mean female and male pupal weights were significantly 
greater in the WF06-UNSEL population compared with the WF06-Vip3ASEL 
population (P<0.05).  There were no significant differences in mean pupal weight 
between females and males within each population (P>0.05). 
 
There were no significant differences in the sex ratio for both populations from the 
expected 50:50 split, with the WF06-UNSEL population having 41 females and 48 
males (χ2=0.55, 1 d.f., P>0.05), and the WF06-Vip3ASEL population having 35 
females and 37 males (χ2 = 0.056, 1 d.f., P>0.05) 
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Table 6.1:  Mean (± se) development parameters for WF06-UNSEL and WF06-
Vip3ASEL populations of Heliothis virescens. 
 
Life history trait Sex  WF06-UNSEL1 WF06-Vip3ASEL1 
Larval development time (days) female 19.3 ± 0.3 17.1 ± 0.5 
 male 18.9 ± 0.5 17.9 ± 0.5 
Pupal development time (days) female 14.0 ± 0.2 14.3 ± 0.3 
 male 15.2 ± 0.3 15.3 ± 0.3 
Egg to adult development time (days) female 36.3 ± 0.5 34.4 ± 0.7 
 male 37.1 ± 0.6 36.1 ± 0.7 
Pupal weight (mg) female       288 ± 4  264 ± 4  
 male       290 ± 4 259 ± 5 
Adult eclosion (%) - 62 ± 3 49 ± 2 
 
1
 Sample size: WF06-UNSEL n (females) = 41, n (males) = 48; WF06-Vip3ASEL n (females) 
= 35, n (males) = 37. 
 
 
6.3.2 Mating success, fecundity and egg viability of WF06-UNSEL and WF06-
Vip3ASEL populations and their reciprocal crosses 
 
There was no significant difference in the proportion of pairs that produced eggs 
between any of the four crosses (χ2=4.47, 3 d.f., P>0.05; Table 6.2). There were 
significant differences in the proportion of pairs that produced viable progeny.  In the 
WF06-Vip3ASEL and WF06-UNSEL female x WF06-Vip3ASEL male crosses fewer 
pairs produced viable progeny compared with WF06-UNSEL and WF06-Vip3ASEL 
female x WF06-UNSEL male crosses (χ2=8.26, 3 d.f., P<0.05; Table 6.2). 
 
There was no significant difference in the mean number of eggs laid excluding pairs 
that produced no viable offspring between any of the four crosses (P>0.05, 28 d.f., 
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n=31; Table 6.2).  There was also no significant difference in the mean number of 
eggs laid that included pairs which produced no viable offspring between any of the 
four crosses (P>0.05, 63 d.f., n=66). 
 
The mean egg viability of the WF06-Vip3ASEL cross was significantly lower 
compared with the WF06-UNSEL cross, or the WF06-UNSEL female x WF06-
Vip3ASEL male and WF06-Vip3ASEL female x WF06-UNSEL male crosses 
(P<0.05, 63 d.f., n=66; Table 6.2).  There were no other significant differences in 
mean egg viability (P>0.05, 63 d.f., n=66). 
 
 
Table 6.2:  Mean reproductive parameters for WF06-UNSEL, WF06-Vip3ASEL, 
WF06-Vip3ASEL female x WF06-UNSEL male and WF06-UNSEL female x WF06-
Vip3ASEL male populations of Heliothis virescens. 
 
Life history trait WF06-UNSEL 1 
WF06-
Vip3ASEL 1 
WF06-Vip3ASEL 
female x WF06-
UNSEL male 1 
WF06-UNSEL 
female x WF06-
Vip3ASEL male 1 
Mating pair success 2 
- eggs laid (%) 81 79 100 90 
Mating pair success 3 
- viable progeny (%) 57 26 59 25 
Mean egg no. per 
viable  pair 2 (± se) 802 ± 157 856 ± 297 939 ± 209 1020 ± 338 
Egg viability (%) 
(± se) 43 ± 4 10 ± 7 48 ± 6 43 ± 13 
 
1
 Number of pairs: WF06-UNSEL = 21; WF06-Vip3ASEL = 19; WF06-Vip3ASEL female x WF06-
UNSEL male = 17; WF06-UNSEL female x WF06-Vip3ASEL male = 20. 
2
 Number of egg laying pairs: WF06-UNSEL = 17; WF06-Vip3ASEL = 15; WF06-Vip3ASEL female x 
WF06-UNSEL male = 17; WF06-UNSEL female x WF06-Vip3ASEL male = 18. 
3
 Number of viable pairs: WF06-UNSEL = 12; WF06-Vip3ASEL = 5; WF06-Vip3ASEL female x 
WF06-UNSEL male = 10; WF06-UNSEL female x WF06-Vip3ASEL male = 5. 
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6.4 Discussion 
 
In the present study, the Vip3A resistant population of H. virescens showed faster 
larval development and faster female development to adult eclosion compared with an 
unselected population. A Cry1Ac resistant population of P. xylostella (SERD4) has 
also been reported to show faster larval development time (Sayyed et al., 2003) but 
other reports on Cry resistant populations have generally shown an increased 
development time or no effect (Gassmann et al., 2009; Table 6.3).  For example, a 
reduced growth rate was found in a H. virescens population resistant to Cry1Ac and 
Cry2Aa, although the authors suggested that this cost may have been a result of 
inbreeding (Gahan et al., 2005).  Differences in development time have the potential 
to lead to non-random mating with resistant adults mating with each other and not 
susceptible populations.  However, the relatively small differences in faster 
development time for resistant insects observed in the laboratory, in the present study, 
would probably be mitigated by overlapping generations in the field, particularly as 
the season progresses (Wu et al., 2002; Bird and Akhurst, 2004).  The bias of only 
using larvae that had moulted during selection to continue the population may also 
have had an impact on the observed faster development rates of the Vip3A resistant 
population in comparison to the susceptible population. 
 
The reduced pupal weight for the Vip3A resistant population observed in the present 
work was similar to findings in other studies (Table 6.3), although an increase in 
pupal weight was reported in the Cry1Ac resistant SERD4 population of P. xylostella 
(Sayyed and Wright, 2001b; Sayyed et al., 2003).  The decrease in survival to adult 
eclosion for the Vip3A resistant population in the present study has also been 
observed in other studies with Bt toxins (Table 6.3), and while survival in some 
resistant populations was not affected, there appears to have been no reported increase 
in survival.  Larval survival was also found to be reduced in populations of H. 
armigera and P. gossypiella (Table 6.3). 
 
Fitness studies that include F1 reciprocal crosses allow the dominance of fitness costs 
to be further classified.  Nonrecessive fitness costs, expressed in the F1 reciprocal 
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Table 6.3: A summary demonstrating the variety of fitness effects correlated with Cry resistance in some lepidopteran pest species. 
 
Species 
larval 
development larval survival 
pupal 
weight 
survival to 
adult fecundity 
egg 
viability 
mating 
success 
H. virescens 
(present study) +ve  -ve -ve NE -ve -ve 
H. virescens 1 NE / -ve NE    NE  
H. armigera 2 NE / -ve -ve -ve  -ve -ve -ve 
P. gossypiella 3 NE -ve   NE NE NE / -ve 
P. xylostella 4 NE / +ve  NE / +ve NE / -ve -ve NE / -ve -ve 
P. interpunctella 5 NE / -ve   NE / -ve    
T. ni 6 -ve  -ve     
 
+ve means positive effect on fitness of resistant population compared to susceptible population; -ve means negative effect on fitness of 
resistant population compared to susceptible population; NE means no effect on fitness of resistant population. 
 
1
 (Gould and Anderson, 1991; Gahan et al., 2005) 
2
 (Akhurst et al., 2003; Bird and Akhurst, 2004; Bird and Akhurst, 2005; Liang et al., 2008; Zhao et al., 2008)  
3
 (Carrière et al., 2001a; Higginson et al., 2005) 
4
 (Groeters et al., 1993; Groeters et al., 1994; Sayyed and Wright, 2001b; Sayyed et al., 2003) 
5
 (Oppert et al., 2000) 
6
 (Janmaat and Myers, 2003) 
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cross as well as in the resistant population, would be expected to be most effective for 
delaying resistance (Gassmann et al., 2009). 
 
In the present study, studies on mating success, fecundity and egg viability revealed 
variability between the resistant WF06-Vip3ASEL and susceptible WF06-UNSEL 
populations and their F1 reciprocal crosses.  The number of females that successfully 
laid eggs was not affected by the cross, indicating that the ability of females to 
produce eggs was not effected, and this was further demonstrated by no effect on 
fecundity among the crosses.  Successful mating with pairs involving WF06-
Vip3ASEL males was reduced as determined by the proportion of pairs producing 
viable progeny demonstrating a nonrecessive fitness cost.  This suggests that resistant 
males may have reduced virility. However, only the resistant population exhibited 
reduced egg viability in comparison to WF06-UNSEL and the F1 reciprocal crosses, 
indicating that expression of reduced egg viability requires mating between resistant 
males and females, a recessive fitness cost.  It may be more likely, therefore, that 
mating frequency was reduced or mating did not occur with some resistant males. 
 
Fitness costs on fecundity and egg viability have been found in other studies (Table 
6.3), for example, with Cry1Ac resistant H. armigera (Liang et al., 2008), and Btk 
resistant P. xylostella  (Groeters et al., 1994).  Fitness effects on resistant males have 
also been reported.  Male mating frequency was reduced in a Btk resistant population 
of P. xylostella population (Groeters et al., 1993).  While Zhao et al. (2008) found 
that the incidence of successful mating was reduced in a Cry1Ac resistant population 
of H. armigera, where differences between F1 crosses suggested that resistant males 
reduce the incidence of mating paternity (egg viability) rather than mating frequency.  
Reduced male fertility was also observed in another Cry1Ac resistant population of H. 
armigera and in F1 crosses (Bird and Akhurst, 2005).  Higginson et al. (2005) found 
no effect on mating frequency or egg viability in the absence of competition for 
several Cry1Ac resistant populations of P. gossypiella.  However, competition studies 
with susceptible males resulted in reduced egg viability with resistant males that had 
mated first, caused perhaps by reduced sperm precedence. 
 
Inbreeding within laboratory populations can be problematic for resistance studies 
(Groeters et al., 1994; Bird and Akhurst, 2004; Zhao et al., 2008), and care was taken 
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in the present study to maintain large populations of selected and unselected 
populations to ensure that differences in fitness of populations are a result of Vip3A 
resistance.  However, the nature of establishing a laboratory population will no doubt 
result in the genetic background of such a population differing over time with that of a 
wild population, therefore, measuring the fitness of a population is very difficult and 
it is important to understand the limitations of drawn conclusions (Reed and Bryant 
2004; section 6.1). 
 
Fitness studies on Vip3A resistant H. virescens could be extended to include other 
parameters investigated in Cry toxin resistant insect populations, such as emergence 
of overwintering populations (Carrière et al., 2001b; Bird and Akhurst, 2004; Carrière 
et al., 2007), the effect of host plants on larval development and survival (Raymond et 
al., 2005; Bird and Akhurst, 2007) and the effect of pathogens (Raymond et al., 
2007a).  
 
Fitness costs expressed in the present study revealed a variety of effects on the Vip3A 
resistant WF06-Vip3ASEL population.  The reduced mating success observed in 
resistant males may help to limit an increase in the frequency of the resistant allele 
(Zhao et al., 2008), and with the possible paternal influence on Vip3A resistance 
(Chapter 5), contribute to delays in the evolution of resistance in the field with the 
involvement of current management strategies involving the use of refuges 
(Gassmann et al., 2009).  
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Chapter 7 
 
The effect of antibiotics on Heliothis virescens larval susceptibility to 
Bacillus thuringiensis toxins 
 
 
7.1 Introduction 
 
The mechanisms responsible for the death of insect larvae exposed to Bt toxins are not 
fully understood (section 2.1.2.3).  Broderick et al. (2006) used broad spectrum 
antibiotics (gentamicin, penicillin, rifampicin, streptomycin in a combined cocktail) to 
eliminate the gut microbiota from larvae of the gypsy moth, Lymantria dispar L. 
(Lepidoptera: Lymantriidae).  They found that mortality caused by Btk (Dipel) was 
greatly reduced in antibiotic-treated larvae compared with untreated larvae, thus 
suggesting a novel mechanism of larval death involving the insect gut microbiota.  
Further research has suggested that this mechanism has an important role in a range of 
Lepidoptera taxa (Broderick et al., 2009). 
 
The present study, investigates Broderick et al.’s (2006) findings, using the same 
antibiotics, both singly and in combination, on the toxicity of Dipel, Cry1Ab, and 
Vip3A on 1st and 3rd instar larvae of H. virescens. 
 
The use of antibiotics in insect artificial diet is standard practice to help prevent 
disease establishing on the diet, e.g. ampicillin sodium salt for H. virescens artificial 
diet (section 3.1).  Previous research has found that antibiotics, such as aureomycin 
can have variable effects on insect susceptibility to Bt toxins in the artificial diet 
bioassays (Beegle et al., 1981; Beegle, 1990).  Antibiotics are therefore generally 
excluded from toxin bioassays to avoid misleading results (sections 3.4.1 and 3.4.2).  
The present experiments, in using single as well as mixtures of antibiotics, were also 
designed to investigate whether all antibiotics had similar interactions with a range of 
Bt toxins. 
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7.2 Materials and Methods 
 
7.2.1 Heliothis  virescens populations 
 
The established WF06 unselected population (WF06-UNSEL) was used as the test 
population for these experiments.  First instar larvae used in the experiments had 
hatched less than 24 h before experimental setup.  Third instar larvae used in the 
experiments were within 24 h of having moulted to 3rd instar larvae. 
 
7.2.2 Antibiotic preparation 
 
Gentamicin, penicillin, rifampicin and streptomycin were all used at a concentration 
of 500 µg ml-1 (Broderick et al., 2006).  For each 100 ml treatment combination, 50 
mg of the required antibiotic(s) were therefore needed: gentamicin sulphate salt 
(G3632, Sigma, UK; 600 µg ml-1 83.3 mg equivalent to 50 mg antibiotic); penicillin 
G potassium salt (P7794, Sigma; 1596 units mg-1); rifampicin (R8883, Sigma; 1010 
µg ml-1);  streptomycin sulphate salt (S6501, Sigma; 753 units mg-1).  
 
Ampicillin sodium salt was used at a concentration of 124 µg ml-1, as per the 
concentration used in the standard artificial diet (section 3.1).  Therefore, 12.4 mg was 
required for each 100 ml treatment combination. 
 
The single antibiotic treatments were then mixed with 10 ml distilled water.  For the 
antibiotic cocktail treatment, gentamicin, penicillin, rifampicin and streptomycin were 
added together and mixed in 10 ml distilled water.  For the treatments not containing 
any antibiotic, 10 ml of distilled water alone was prepared and used instead. 
 
Treatments using 3rd instar larvae required 200 ml of artificial diet solution. 
Therefore, the antibiotic cocktail treatments required 166.6 mg of gentamicin and 
100 mg for each of penicillin, rifampicin and streptomycin were required in 20 ml 
distilled water, or 20 ml distilled water alone for treatments not containing the 
antibiotic cocktail.  Some treatment combinations also required larvae reared from 
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emergence to 3rd instar on artificial diet containing the antibiotic cocktail at a 
concentration of 500 µg ml-1. 
 
7.2.3 Bacillus thuringiensis toxin preparation 
 
The toxin concentrations for Cry1Ab, Dipel and Vip3A treatments were based on 
their respective LC50 values for that particular instar.  The Cry1Ab concentration for 
1st instar larvae was 0.024 µg ml-1.   In earlier results the LC50 for 1st and 3rd instar 
larvae was similar, however, the toxicity of the Cry1Ab protoxin batch used for this 
experiment was reduced in comparison to earlier batches; the calculated 3rd instar 
larvae concentration was 0.3 µg ml-1.  The Vip3A concentration for 1st instar larvae 
was 2 µg ml-1.  Two concentrations were setup for 1st instar larvae with Dipel, 0.047 
µg ml-1 and 0.0047 µg ml-1 as an accurate LC50 value was not successfully 
established.  The Dipel concentration for 3rd instar larvae was 5 µg ml-1.  The 
required toxin volume was calculated for 100 ml treatments for 1st instar larvae, and 
200 ml treatments for 3rd instar larvae and added to either 10 ml or 20 ml 
respectively, of distilled water. 
 
Control treatments did not contain toxin, instead 10 ml (for 1st instar treatments) or 
20 ml (for 3rd instar treatments) of distilled water alone was prepared. 
 
7.2.4 1st instar larvae antibiotic bioassay method 
 
Each treatment combination used 100 ml of artificial diet solution that included the 
toxin solution and antibiotic solution.  The bioassay procedure was similar to that 
described in section 3.4.1 with the exception of a requirement of 20 % reduction in 
distilled water content in the diet preparation (section 3.1) to allow the addition of the 
antibiotic and toxin solutions to the diet preparation at a ratio of 1:1:8 
(antibiotic:toxin:diet).  For each treatment the required 10 ml antibiotic solution (or 
control alternative), 10 ml toxin solution (or control alternative) and 80 ml artificial 
diet solution were mixed together vigorously using a glass stirring rod in a 250 ml 
beaker and setup as previously described in section 3.4.1, with 48 larvae per treatment 
split into four replicates of 12 larvae.  Mortality and moult inhibition were both 
determined after seven days.   
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7.2.5 3rd instar larvae antibiotic bioassay method  
 
The method was similar to that for the 1st instar larvae antibiotic bioassay method 
with these following few exceptions.  The artificial diet solution for each treatment 
was increased from 100 ml to 200 ml (20 ml antibiotic solution, 20 ml toxin solution 
and 160 ml diet solution), with approximately 3 – 4 ml per well.  The bioassay plates 
were replaced by 32-well rearing trays (24 wells used) sealed with breathable 
polyester film.  Depending on the treatment combination, larvae had been reared from 
emergence to 3rd instar on either artificial diet prepared without any antibiotics or 
with the antibiotic cocktail (500 µg ml-1 for each antibiotic).  3rd instar larvae were 
transferred to the wells using soft forceps.  Some of these changes were made to 
accommodate larger larval size and increased food consumption of later instar larvae.  
Mortality and moult inhibition were both determined after seven and 14 days. 
 
7.2.6 Treatments 
 
1) To investigate the effect of the antibiotic cocktail and ampicillin alone on larval 
mortality and moult inhibition (MI) of Cry1Ab and Vip3A the following treatments 
were used: 
 
Treatment Antibiotic Bt toxin 
1 none none 
2 cocktail none 
3 ampicillin none 
4 none Cry1Ab 
5 cocktail Cry1Ab 
6 ampicillin Cry1Ab 
7 none Vip3A 
8 cocktail Vip3A 
9 ampicillin Vip3A 
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2) To investigate the effect of individual antibiotics on larval mortality and moult 
inhibition (MI) of Cry1Ab and Vip3A the following treatments were used: 
 
Treatment Antibiotic Bt toxin 
1 none none 
2 gentamicin none 
3 penicillin none 
4 rifampicin none 
5 streptomycin none 
6 none Cry1Ab 
7 gentamicin Cry1Ab 
8 penicillin Cry1Ab 
9 rifampicin Cry1Ab 
10 streptomycin Cry1Ab 
11 none Vip3A 
12 gentamicin Vip3A 
13 penicillin Vip3A 
14 rifampicin Vip3A 
15 streptomycin Vip3A 
 
 
3) To investigate the effect of the antibiotic cocktail on larval mortality and moult 
inhibition (MI) of Dipel the following treatments were used: 
 
Treatment Antibiotic Bt toxin 
1 none none 
2 cocktail none 
3 none Dipel (0.047 µg ml-1) 
4 cocktail Dipel (0.047 µg ml-1)  
5 none Dipel (0.0047 µg ml-1) 
6 cocktail Dipel (0.0047 µg ml-1) 
7 none Cry1Ab 
8 cocktail Cry1Ab 
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4) To investigate the effect of individual antibiotics on larval mortality and moult 
inhibition (MI) of Dipel (0.0047 µg ml-1) the following treatments were used: 
 
Treatment Antibiotic Bt toxin 
1 none none 
2 cocktail none 
3 gentamicin none 
4 penicillin none 
5 rifampicin none 
6 streptomycin none 
7 none Dipel  
8 cocktail Dipel 
9 gentamicin Dipel 
10 penicillin Dipel 
11 rifampicin Dipel 
12 streptomycin Dipel 
 
 
5) To investigate the effect of an antibiotic cocktail on the larval mortality and moult 
inhibition (MI) of Dipel (0.0047 µg ml-1) and Cry1Ab on 3rd instar larvae reared in 
the presence or absence of antibiotics the following treatments were used: 
 
Treatment Antibiotic pre treatment Antibiotic Bt toxin 
1 Yes none none 
2 Yes cocktail none 
3 Yes none Dipel 
4 Yes cocktail Dipel 
5 Yes none Cry1Ab 
6 Yes cocktail Cry1Ab 
7 No none none 
8 No cocktail none 
9 No none Dipel 
10 No cocktail Dipel 
11 No none Cry1Ab 
12 No cocktail Cry1Ab 
 
 
  116
7.2.7 Statistical analysis 
 
Statistical analysis was carried out using R version 2.8.1 (R Development Core Team, 
2009).  Percentage mortality and moult inhibition data were arcsine transformed and 
modelled using analysis of variance (ANOVA) to determine the effects of antibiotic 
treatment and Bt toxin.   Significance differences between treatments were tested at 
the 5 % level (P<0.05) through comparison of standard errors as calculated in the 
ANOVA. 
 
 
7.3 Results 
 
7.3.1 Effect of an antibiotic cocktail and ampicillin alone on larval mortality and 
moult inhibition (MI) of Cry1Ab and Vip3A 
 
Larval mortality was unaffected (F2, 9 = 0.41, P>0.05; Figure 7.1A) by the antibiotics 
tested alone (mortality ≤ 5 %).  There were significant effects on larval mortality with 
treatments involving Cry1Ab (F5, 18 = 50.7, P<0.001) and Vip3A (F1, 22 = 100.2, 
P<0.001). 
 
A significant effect on larval mortality within Cry1Ab treatments was found (F2, 9 = 
79.1, P<0.001).  Larval mortality was significantly greater in the treatment combining 
Cry1Ab and the antibiotic cocktail when compared to Cry1Ab alone (89 and 35 % 
mortality respectively; P<0.001).  When Cry1Ab was combined with ampicillin, 
larval mortality (18 %) was significantly lower compared with Cry1Ab alone 
(P<0.05). 
 
There were no significant differences in larval mortality between Vip3A alone and 
Vip3A combined with the antibiotic cocktail or ampicillin (47, 57 and 60 % mortality 
respectively; F2, 9 = 0.7, P>0.05). 
 
The moult inhibition (MI) of larvae was unaffected (F2, 9 = 0.21, P>0.05; Figure 7.1B) 
by the antibiotics tested alone (MI ≤ 8 %).  There were significant effects on MI with 
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treatments involving Cry1Ab (F5, 18 = 74.53, P<0.001) and Vip3A (F1, 24 = 274.2, 
P<0.001). 
 
A significant effect on MI within Cry1Ab treatments was found (F2, 9 = 83.9, 
P<0.001).  There was no significant difference (P>0.05) in larval MI between Cry1Ab 
alone and Cry1Ab combined with ampicillin (48 and 36 % MI respectively).  The MI 
of Cry1Ab combined with the antibiotic cocktail (100 %) was significantly greater 
(P<0.001) than the other Cry1Ab treatments. 
 
There were no significant differences in larval MI between Vip3A alone and Vip3A 
combined with the antibiotic cocktail or ampicillin (72, 76 and 77 % MI respectively; 
F2, 9 = 0.27, P>0.05). 
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Figure 7.1: The effect of an antibiotic cocktail (gentamicin, penicillin, rifampicin and 
streptomycin) or ampicillin on toxicity of Cry1Ab and Vip3A to 1st instar Heliothis 
virescens in a diet incorporation assay after 7 days: (A) mean percent mortality (± se); 
(B) mean percent moult inhibition (± se);  * indicates a within treatment significant 
difference (P<0.05) to the toxin alone. 
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7.3.2 Effect of individual antibiotics on larval mortality and moult inhibition 
(MI) of Cry1Ab and Vip3A  
 
Larval mortality was unaffected (F4, 15 = 1.65, P>0.05; Figure 7.2A) by the antibiotics 
tested alone (mortality ≤15 %).  There were significant effects on larval mortality with 
treatments involving Cry1Ab (F5, 34 = 8.995, P<0.001) and Vip3A (F5, 34 = 15.04, 
P<0.001). 
 
There were no significant differences in larval mortality between Cry1Ab alone and 
combined with either gentamicin, penicillin, rifampicin, or streptomycin (25, 42, 13 
19 and 46 % mortality respectively; (F4, 15 = 4.963, P>0.05), despite greater mortality 
with either gentamicin or streptomycin. 
 
A significant effect on larval mortality within Vip3A treatments was found (F4, 15 = 
5.601, P<0.01).  There were no significant differences in larval mortality between 
Vip3A alone and combined with rifampicin or streptomycin (54, 54 and 42 % 
mortality respectively; P>0.05).  Vip3A combined with gentamicin or penicillin had 
significantly lower mortality than the other treatments (19 and 25 % mortality 
respectively; P<0.05), but were not significantly different from each other (P>0.05). 
 
Larval MI was unaffected (F4, 15 = 0.4, P>0.05; Figure 7.2B) by the antibiotics tested 
alone (MI ≤ 17%).  There were significant effects on MI with treatments involving 
Cry1Ab (F9, 30 = 18.17, P<0.001) and Vip3A (F5, 34 = 26.38, P<0.001). 
 
A significant effect of larval MI within Cry1Ab treatments was found (F4, 15 = 23.51, 
P<0.001).  There were no significant differences in larval MI between Cry1Ab alone 
and combined with penicillin or rifampicin (25, 21 and 38 % MI respectively; 
P>0.05).  The MI of Cry1Ab combined with gentamicin (83 %) or streptomycin (92 
%) were significantly greater than the other treatments (P<0.001), although they were 
not significantly different from each other (P>0.05). 
 
A significant effect of larval MI within Vip3A treatments was found (F4, 15 = 5.957, 
P<0.01).  There were no significant differences in larval MI between Vip3A alone and 
combined with rifampicin or streptomycin (81, 81 and 65 % MI respectively; P>0.05).  
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Vip3A combined with gentamicin or penicillin both had significantly lower MI than 
Vip3A alone and combined with rifampicin (P<0.05), but they were not significantly 
different from each other or streptomycin (P>0.05). 
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Figure 7.2: The effect of gentamicin, penicillin, rifampicin and streptomycin on 
toxicity of Cry1Ab and Vip3A to 1st instar Heliothis virescens in a diet incorporation 
assay after 7 days: (A) mean percent mortality (± se); (B) mean percent moult 
inhibition (± se);  * indicates a within treatment significant difference (P<0.05) to the 
toxin alone. 
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7.3.3 Effect of the antibiotic cocktail on larval mortality and moult inhibition 
(MI) of Dipel 
 
Larval mortality was unaffected (F1, 6 = 0.45, P>0.05; Figure 7.3A) by the antibiotics 
alone (mortality ≤ 15 %).  There were significant effects on larval mortality with 
treatments involving Dipel at 0.047 µg ml-1 (F1, 14 = 88.19, P<0.001), Dipel at 0.0047 
µg ml-1 (F1, 14 = 45.88, P<0.001) and Cry1Ab (F1, 14 = 9.304, P<0.01).  
 
There was no significant difference in larval mortality between Dipel at 0.047 µg ml-1 
with no antibiotic and the antibiotic cocktail (83 and 94 % mortality respectively; F1, 6 
= 4.15, P>0.05), between Dipel alone at 0.0047 µg ml-1 and combined with the 
antibiotic cocktail (54 and 69 % mortality respectively; F1, 6 = 1.869, P>0.05) and 
between Cry1Ab alone and combined with the antibiotic cocktail (25 and 48 % 
mortality respectively; F1, 6 = 4.47, P>0.05). 
 
Larval MI was unaffected (F1, 6 = 0.08, P>0.05; Figure 7.3B) by the antibiotics alone 
(MI ≤ 19 %).  There were significant effects on larval MI with treatments involving 
Dipel at 0.047 µg ml-1 (F1, 14 = 192.1, P<0.001), Dipel at 0.0047 µg ml-1 (F3, 12 = 51.3, 
P<0.001) and Cry1Ab (F3, 12 = 29.38, P<0.001). 
 
Larval MI was significantly greater in the treatment combining Dipel at 0.047 µg ml-1 
and the antibiotic cocktail compared to Dipel alone (100 and 92 % MI respectively; 
F1, 6 = 7.97, P<0.05).  Significant increases in MI were also confirmed with Dipel at 
0.0047 µg ml-1 and the antibiotic cocktail compared to Dipel alone (98 and 65 % MI 
respectively; F1, 6 = 22.45, P<0.01) and with Cry1Ab combined with the antibiotic 
cocktail compared to Cry1Ab alone and (92 and 29 % MI respectively; F1, 6 = 31.67, 
P<0.01). 
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Figure 7.3: A comparison of the effect of an antibiotic cocktail (gentamicin, 
penicillin, rifampicin and streptomycin) on the toxicity of Dipel (at two 
concentrations) and Cry1Ab to 1st instar Heliothis virescens in a diet incorporation 
assay after 7 days: (A) mean percent mortality (± se); (B) mean percent moult 
inhibition (± se);  * indicates a within treatment significant difference (P<0.05) to the 
toxin alone. 
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7.3.4 Effect of individual antibiotics on larval mortality and moult inhibition 
(MI) of Dipel (0.0047 µg ml-1) 
 
Larval mortality was unaffected (F5, 18 = 0.1795, P>0.05; Figure 7.4A) by the 
antibiotics alone (mortality ≤ 6 %).  There were significant effects on larval mortality 
with treatments involving Dipel at 0.0047 µg ml-1 (F11, 36 = 10.98, P<0.001). 
 
A significant effect on larval mortality within Dipel treatments was found (F5, 18 = 
11.1, P<0.001).  There were no significant differences in larval mortality between 
Dipel alone at 0.0047 µg ml-1 and combined with gentamicin, or penicillin or 
rifampicin (29, 42, 23 and 13 % mortality respectively; P>0.05).  There was a 
significant increase in larval mortality in Dipel at 0.0047 µg ml-1 combined with the 
antibiotic cocktail (73 % mortality; P<0.001) and a significant decrease in larval 
mortality in Dipel at 0.0047 µg ml-1 combined with streptomycin (10 % mortality; 
P<0.05). 
 
Larval MI was unaffected (F5, 18 = 0.2041, P>0.05; Figure 7.4B) by the antibiotics 
alone (mortality ≤ 10 %).  There were significant effects on larval MI with treatments 
involving Dipel at 0.0047 µg ml-1 (F11, 36 = 19.33, P<0.001). 
 
A significant effect on MI within Dipel treatments was found (F5, 18 = 13.11, 
P<0.001).  There were no significant differences (P>0.05) in larval MI between Dipel 
alone at 0.0047 µg ml-1 and combined with penicillin, or rifampicin (31, 58 and 23 % 
MI respectively; P>0.05).  Larval MI was significantly greater in the treatments 
combining Dipel at 0.0047 µg ml-1 with either the antibiotic cocktail, gentamicin, or 
streptomycin (94, 88 and 73 % MI respectively; P<0.01). 
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Figure 7.4: A comparison of the effect of an antibiotic cocktail (gentamicin, 
penicillin, rifampicin and streptomycin) and individual doses of those antibiotics on 
the toxicity of Dipel to 1st instar Heliothis virescens in a diet incorporation assay after 
7 days: (A) mean percent mortality (± se); (B) mean percent moult inhibition (± se);  * 
indicates a within treatment significant difference (P<0.05) to the toxin alone. 
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7.3.5 Effect of an antibiotic cocktail on the larval mortality and moult inhibition 
(MI) of Dipel and Cry1Ab on 3rd instar larvae reared in the presence or absence 
of antibiotics 
 
There was no larval mortality without the presence of Bt toxins, or with the antibiotic 
cocktail alone after either 7 days or 14 days with larvae reared in the presence of the 
antibiotic cocktail (Figure 7.5).  There was a significant increase in mortality with 
treatments involving Dipel and Cry1Ab after both 7 days (F3, 20 = 3.823, P<0.05) and 
14 days (F5, 18 = 41.41, P<0.001). 
 
The mortality within Dipel treatments after 7 days, with larvae reared in the presence 
of the antibiotic cocktail, was significantly greater with Dipel alone than combined 
with the antibiotic cocktail (13 and 3 % mortality respectively; F1, 6 = 9, P<0.05).  The 
same pattern was found after 14 days, with mortality greater in Dipel alone than 
combined with the antibiotic cocktail (34 and 3 % mortality respectively; F1, 6 = 
30.73, P<0.01). 
 
There were no significant differences in mortality associated with Cry1Ab treatments 
with larvae reared in the presence of the antibiotic cocktail.  After 7 days mortality 
with Cry1Ab alone was 6 % and combined with antibiotic cocktail was 12 % (F1, 6 = 
0.74, P>0.05).  After 14 days, mortality with Cry1Ab alone was 34 %, and combined 
with antibiotic cocktail was 44 % (F1, 6 = 1.11, P>0.05).  
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Figure 7.5: A comparison of the effect of an antibiotic cocktail (gentamicin, 
penicillin, rifampicin and streptomycin) on the mortality of Dipel and Cry1Ab to 3rd 
instar Heliothis virescens larvae that had been reared from 1st instar on artificial diet 
containing the antibiotic cocktail: (A) mean percent mortality after 7 days (± se); (B) 
mean percent mortality after 14 days (± se);  * indicates a within treatment significant 
difference (P<0.05) to the toxin alone. 
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There was no MI without the presence of Bt toxins, or with the antibiotic cocktail 
alone, after either 7 days or 14 days with larvae reared in the presence of the antibiotic 
cocktail (Figure 7.6).  There is a significant increase in MI with treatments involving 
Dipel and Cry1Ab after both 7 days (F5, 18 = 57.56, P<0.001) and 14 days (F5, 18 = 
31.09, P<0.001).   
 
The MI after 7 days, with larvae reared in the presence of the antibiotic cocktail, was 
significantly greater in the treatment combining Dipel and the antibiotic cocktail when 
compared to Dipel alone (63 and 16 % MI respectively; F1, 6 = 26.41, P<0.01).  The 
reverse pattern was demonstrated after 14 days, with significantly greater MI with 
Dipel alone than combined with the antibiotic cocktail (34 and 9 % MI respectively; 
F1, 6 = 13.48, P<0.05). 
 
There were no significant differences in larval MI between Cry1Ab alone and 
combined with the antibiotic cocktail after both 7 days (75 and 69 % mortality 
respectively; F1, 6 = 0.0004, P>0.05) and 14 days (53 and 75 % mortality respectively; 
F1, 6 = 2.84, P>0.05), with larvae reared in the presence of the antibiotic cocktail. 
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Figure 7.6: A comparison of the effect of an antibiotic cocktail (gentamicin, 
penicillin, rifampicin and streptomycin) on the moult inhibition of Dipel and Cry1Ab 
to 3rd instar Heliothis virescens larvae that had been reared from 1st instar on 
artificial diet containing the antibiotic cocktail: (A) mean percent moult inhibition 
after 7 days (± se); (B) mean percent moult inhibition after 14 days (± se);  * indicates 
a within treatment significant difference (P<0.05) to the toxin alone. 
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There was no larval mortality without the presence of Bt toxins, or with the antibiotic 
alone, after both 7 days and 14 days with larvae reared in the absence of the antibiotic 
cocktail (Figure 7.7).  There was a significant increase in mortality with treatments 
involving Dipel and Cry1Ab after both 7 days (F5, 18 = 4.69, P<0.01) and 14 days (F5, 
18 = 21.39, P<0.001).  
 
The mortality within Dipel treatments after 7 days, with larvae reared in the absence 
of the antibiotic cocktail, was significantly greater with Dipel alone than combined 
with the antibiotic cocktail (34 and 0 % mortality respectively; F1, 6 = 6.64, P<0.05).  
There was no significant difference in mortality after 14 days between Dipel alone 
combined with the antibiotic cocktail (41 and 16 % mortality respectively; F1, 6 = 
3.655, P>0.05) despite the trend of greater mortality with Dipel alone. 
 
There were no significant differences in mortality between Cry1Ab alone and 
combined with the antibiotic cocktail after both 7 days (3 and 13 % mortality 
respectively; F1, 6 = 2.4, P>0.05) and 14 days (34 and 44 % mortality respectively; F1, 6 
= 1.191, P>0.05), with larvae reared in the absence of the antibiotic cocktail. 
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Figure 7.7: A comparison of the effect of an antibiotic cocktail (gentamicin, 
penicillin, rifampicin and streptomycin) on the mortality of Dipel and Cry1Ab to 3rd 
instar Heliothis virescens larvae that had been reared from 1st instar on artificial diet 
without containing the antibiotic cocktail: (A) mean percent mortality after 7 days (± 
se); (B) mean percent mortality after 14 days (± se);  * indicates a within treatment 
significant difference (P<0.05) to the toxin alone. 
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There was no MI without the presence of Bt toxins, or the antibiotic cocktail alone, 
after both 7 days and 14 days, with larvae reared in the absence of the antibiotic 
cocktail (Figure 7.8).  There was a significant increase in MI with treatments 
involving Dipel and Cry1Ab after both 7 days (F5, 18 = 12.40, P<0.01) and 14 days (F5, 
18 = 17.86, P<0.001).   
 
There were no significant differences in MI between Dipel alone and combined with 
the antibiotic cocktail after both 7 days (34 and 13 % MI respectively; F1, 6 = 1.27, 
P>0.05) and 14 days (41 and 16 % MI respectively; F1, 6 = 3.66, P>0.05), with larvae 
reared in the absence of the antibiotic cocktail, despite the trend of greater MI with 
Dipel alone.  
 
The MI within Cry1Ab treatments after 7 days, with larvae reared in the presence of 
the antibiotic cocktail, was significantly greater with Cry1Ab and the antibiotic 
combined than with Cry1Ab alone (78 and 38 % MI respectively; F1, 6 = 13.15, 
P<0.05).  After 14 days the trend was similar although there was no significant 
difference between Cry1Ab alone and when combined with the antibiotic cocktail (47 
and 75 % MI respectively; F1, 6 = 3.10, P>0.05).  
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Figure 7.8: A comparison of the effect of an antibiotic cocktail (gentamicin, 
penicillin, rifampicin and streptomycin) on the moult inhibition of Dipel and Cry1Ab 
to 3rd instar Heliothis virescens larvae that had been reared from 1st instar on 
artificial diet without containing the antibiotic cocktail: (A) mean percent moult 
inhibition after 7 days (± se); (B) mean percent moult inhibition after 14 days (± se);  
* indicates a within treatment significant difference (P<0.05) to the toxin alone. 
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There was no significant difference in larval mortality of 3rd instar larvae reared in 
the presence or absence of the antibiotic cocktail with Dipel treatments after 7 days 
(F3, 12 = 4.73, P>0.05; Figures 7.5A and 7.7A) or 14 days (F3, 12 = 9.38, P>0.05; 
Figures 7.5B and 7.7B).  The same pattern was found with MI after 14 days (F3, 12 = 
4.80, P>0.05; Figures 7.6B and 7.8B).  
 
The MI of larvae reared in the presence of the antibiotic cocktail after 7 days on the  
Dipel and antibiotic cocktail treatment was significantly greater than the MI of larvae 
reared in the absence of the antibiotic cocktail (69 and 13 % MI respectively; F3, 12 = 
3.90, P<0.05; Figures 7.6A and 7.8A).  There was no significant difference in MI of 
larvae reared in the presence or absence of the antibiotic cocktail with Dipel alone 
(P>0.05). 
 
There was no significant difference in the larval mortality of 3rd instar larvae reared 
in the presence or absence of the antibiotic cocktail with Cry1Ab treatments after 7 
days (F3, 12 = 1.07, P>0.05; Figures 7.5A and 7.7A).  The same pattern was found with 
larval mortality after 14 days (F3, 12 = 0.77, P>0.05; Figures 7.5B and 7.7B) and MI 
after 14 days (F3, 12 = 2.02, P>0.05; Figures 7.6B and 7.8B).   
 
The MI of larvae reared in the presence of the antibiotic cocktail after 7 days on 
Cry1Ab alone was significantly greater than the MI of larvae reared in the absence of 
the antibiotic cocktail (75 and 38 % MI respectively; F3, 12 = 5.21, P<0.05; Figures 
7.6A and 7.8A).  There was no significant difference in MI of larvae reared in the 
presence or absence of the antibiotic cocktail with Cry1Ab combined with the 
antibiotic cocktail (F3, 12 = 5.21, P>0.05). 
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7.4 Discussion 
 
In the present study the effect of antibiotics on H. virescens larval susceptibility to Bt 
toxins varied depending on the antibiotic treatment, the Bt toxin used and the larval 
instar tested (Tables 7.1, 7.2).  
 
The antibiotic cocktail had a generally antagonistic effect on mortality due to Dipel 
against 3rd instar H. virescens larvae when they had been reared in the presence or 
absence of the antibiotic cocktail, although for some treatments the effect was not 
significant (Table 7.1).  The trend was less clear for moult inhibition, where the 
antibiotic cocktail had no significant effect when insects were not reared with the 
antibiotic and a synergistic effect on the moult inhibition was found after 7 days with 
the antibiotic pre-treatment, although after 14 days this effect was reversed. This 
apparent anomaly may have been due to environmental variation or to variability in 
susceptibility within the population. 
 
Broderick et al. (2006) found a similar antagonistic trend for mortality due to Dipel in 
3rd instar L. dispar larvae reared in the presence of the same antibiotic cocktail.  
Further studies (Broderick et al., 2009) with 3rd instar larvae of the painted lady, 
Vanessa cardui L. (Lepidoptera: Nymphalidae), the small white, Pieris rapae L. 
(Lepidoptera: Pieridae), M. sexta and H. virescens also showed that mortality caused 
by Dipel was reduced when the larvae were reared in the presence of antibiotics.  The 
toxicity of Cry1Ac (MVPII), the primary Cry toxin in Dipel, was also antagonised by 
the antibiotic cocktail against 3rd instar larvae of L. dispar.  However, these authors 
found the opposite effect for antibiotics with Cry1Ac against 3rd instar larvae of P. 
gossypiella.  
 
The present study suggested that the antibiotic cocktail had a different effect on the 
toxicity of Cry1Ab compared to Dipel against 3rd instar larvae (Table 7.1).  In all but 
one treatment antibiotics had no significant effect on mortality or moult inhibition due 
to Cry1Ab, however, the trend was for increased toxicity or moult inhibition. 
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Table 7.1: Summary of the effects on mortality and moult inhibition (MI) of Dipel or 
Cry1Ab combined with the antibiotic cocktail in comparison to the toxicity of toxins 
alone using 3rd instar larvae of Heliothis virescens that had been reared from 1st 
instars in the presence or absence of the antibiotic pre-treatment. 
 
Antibiotic 
pre-treatment Toxin 
Mortality  
(7 days)1 
Mortality  
(14 days)1 
MI  
(7 days)1 
MI  
(14 days)1 
Yes Dipel -ve -ve +ve -ve 
No Dipel -ve ne2 ne2 ne2 
Yes Cry1Ab ne ne ne ne3 
No Cry1Ab ne ne +ve ne3 
 
1
 Significantly increased toxicity with antibiotic cocktail (+ve); significantly decreased 
toxicity with antibiotic cocktail (-ve); no significant effect of antibiotic cocktail (ne). 
2
 No significant effect but a negative trend. 
3 No significant effect but a positive trend. 
 
The effect of Vip3A on the mortality and moult inhibition of 1st instar larvae was 
unaffected by the antibiotic cocktail, whereas the cocktail had a synergistic effect with 
Dipel and Cry1Ab (Table 7.2).  The synergistic effect with Dipel is in contrast to the 
antagonistic effect/trend observed with 3rd instar larvae of H. virescens (Table 7.1) 
and by Broderick et al. (2006, 2009) with other insect species, with the exception of 
P. gossypiella. 
 
The effects of individual antibiotics on mortality and moult inhibition due to Vip3A 
for 1st instar larvae of H. virescens indicated that gentamicin and penicillin 
significantly antagonised Vip3A toxicity but that these decreases in susceptibility 
were masked when the antibiotics were incorporated into the cocktail mixture (Table 
7.2).  Individual antibiotic treatments had either no significant effect or the opposite 
(antagonistic) effect on mortality due to Cry1Ab or Dipel in contrast to the antibiotic 
cocktail.  While gentamicin and, in this case, streptomycin had the same synergistic 
effects on moult inhibition due to Cry1Ab and Dipel as the antibiotic cocktail. 
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Table 7.2: Summary of the effects of antibiotics as a cocktail or individually on 
mortality and moult inhibition due to Vip3A, Cry1Ab and Dipel on 1st instar larvae of 
Heliothis virescens. 
 
 
Mortality1 
(7 days) 
Moult inhibition1 
(7 days) 
Antibiotic Vip3A Cry1Ab Dipel Vip3A Cry1Ab Dipel 
cocktail ne +ve +ve ne +ve +ve 
gentamicin -ve ne ne -ve +ve +ve 
penicillin -ve ne ne -ve ne ne 
rifampicin ne ne ne ne ne ne 
streptomycin ne ne -ve ne +ve +ve 
ampicillin ne -ve NT ne ne NT 
 
1
 Significantly increased toxicity with antibiotic treatment (+ve) compared with toxins alone; 
significantly decreased toxicity with antibiotic treatment (-ve); no significant effect of 
antibiotic treatment (ne); not tested (NT). 
 
The complexities of the relationship between antibiotic effects, larval susceptibility 
and Bt toxin used are apparent from the findings of the present study and other 
research.  Broderick et al. (2006, 2009) proposed that the effect of reduced Bt 
pathogenicity observed in lepidopteran larvae when reared on antibiotics was due to 
the elimination of important culturable gut microbiota.  Re-establishment of a gut 
bacterium, Enterobacter sp. NAB3, restored the pathogenicity of Bt in four of the five 
species examined (Broderick et al., 2006; Broderick et al., 2009). They suggested 
therefore that gut microbiota contribute to the mortality associated with Bt, probably 
through initiation of septicemia after permeabilisation of the gut epithelium by Bt 
toxins, allowing access of the gut microbiota to the hemocoel. Pathogenicity was not 
restored in H. virescens which had been noted to not contain detectable gut microbiota 
before antibiotic administration (Broderick et al., 2009).  This different response with 
H. virescens suggests that the gut microbiota may have been undetectable (Broderick 
et al., 2009) or that reduced pathogenicity of Bt is due to the direct effects of 
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antibiotic treatment (Raymond et al., 2009).  Raymond et al. (2009) demonstrated 
with 2nd and 3rd instar larvae of P. xylostella, that rifampicin reduced the 
pathogenicity of Btk in aseptic larvae. This suggested that antibiotics can persist in the 
tissues and haemolymph of lepidopteran larvae.  
 
With P. gossypiella antibiotics increased susceptibility to Cry1Ac, which suggested a 
protective role of gut microbiota with their suppression resulting in the increased 
pathogenicity of Cry1Ac (Broderick et al., 2009).  This role was also suggested by the 
observed significant reduction in larval mortality with Btk HD-1 on P. xylostella 
larvae with culturable gut microbiota (Raymond et al., 2009).  Another study has 
demonstrated synergism of zwittermicin A with Btk in L. dispar and it was 
hypothesized that the antimicrobial properties of this antibiotic altered the gut 
microbiota (Broderick et al., 2000).  The ingestion of a high-antibiotic secreting B. 
cereus strain has been observed to synergise Bt mortality in P. xylostella larvae, with 
confirmed reduction in the gut microbiota (Raymond et al., 2008). 
 
The applicability of these hypotheses to results in the present study is not clear, as 
information on the gut microbiota for H. virescens was not investigated.  However, 
the effects of the antibiotic cocktail on Dipel pathogenicity differed between 1st and 
3rd instar larvae and antibiotic effects on other Bt toxins showed varied trends.   
These results support the idea that a single hypothesis is unlikely to explain all the 
interactions between Bt toxins and lepidopteran larvae in the presence of antibiotics.  
The antibiotic cocktail had no effect on Vip3A pathogenicity, and this may be linked 
to differences in the mode of action of Vip3A compared with Cry toxins (section 
2.1.3.2).  
 
As discussed above, the present study shows that antibiotics, including ampicillin in 
artificial diet bioassays can have variable effects on mortality and moult inhibition in 
1st and 3rd instar larval stages of H. virescens.  The continued exclusion of antibiotics 
in artificial diet bioassays appears, therefore, to be appropriate to avoid potential 
effects on insect susceptibility.  
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Chapter 8 
 
Summary and General Discussion 
 
 
8.1 Summary of experimental findings 
 
Chapter 4: Susceptibility of H. virescens to Vip3A, Cry1Ab and Cry1Ac. 
 
- There was little variability in the natural susceptibility to Vip3A, Cry1Ab and 
Cry1Ac in all tested populations of H. virescens based on LC50 and MIC50 
data. 
- The toxicity of Vip3A was much lower compared with Cry1Ab and Cry1Ac. 
- Larval instars responded differently to Vip3A and Cry1Ab, with 1st to 4th 
instars all equally susceptible to Cry1Ab, whereas 4th instar larvae were much 
more tolerant to Vip3A compared with earlier instars. 
 
Chapter 5:  Vip3A selection, cross-resistance and genetics of resistance. 
  
- Successful selection of a Vip3A resistant population (WF06-Vip3ASEL) 
within 13 selected generations. 
- Vip3A resistance appeared to be relatively stable under laboratory conditions. 
- Little or no cross-resistance in Vip3A resistant population to Cry1Ab or 
Cry1Ac. 
- F1 reciprocal crosses between WF06-Vip3ASEL and WF06-UNSEL indicated 
a possible paternal influence on inheritance of resistance, which ranged from 
almost completely recessive to incompletely dominant. 
- Bioassays on F2 from a backcross of F1 progeny with WF06-Vip3ASEL using 
two discriminating concentrations of Vip3A indicated that resistance was 
polygenic. 
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Chapter 6: Fitness studies on Vip3A resistance. 
 
- Vip3A resistant populations showed both a fitness benefit (reduced larval 
development time) and fitness costs (reduced pupal weight, survival to adult 
eclosion, reduced egg viability, and reduced male mating success). 
- There were no apparent fitness costs or benefits in relation to fecundity, pupal 
development time and no change in adult sex ratio. 
 
Chapter 7: Antibiotic effects on larval susceptibility to Bt toxins. 
 
- The effect of antibiotics on H. virescens larval susceptibility to Bt toxins 
varied depending on antibiotic treatment, the Bt toxin used and the larval 
instar tested. 
- An antibiotic cocktail (gentamicin, penicillin, rifampicin and streptomycin) 
had an antagonistic trend on Dipel toxicity with 3rd instar larvae and a 
synergistic trend on Dipel toxicity with 1st instar larvae. 
- The antibiotic cocktail had a synergistic effect on Cry1Ab toxicity with 1st 
instar larvae and showed a similar trend with 3rd instar larvae. 
- The antibiotic cocktail had no effect on Vip3A toxicity with 1st instar larvae, 
with antagonistic effects of individual treatments of gentamicin and penicillin 
apparently masked by the cocktail mixture. 
- Individual antibiotic treatments (streptomycin and gentamicin) had synergistic 
effects with Dipel and Cry1Ab on moult inhibition, but no effects on mortality 
were apparent with the exception of antagonistic effects of ampicillin on 
Cry1Ab and of streptomycin on Dipel. 
 
 
8.2 General Discussion 
 
In the present study, susceptibility to Vip3A in field-derived populations of H. 
virescens demonstrated little variability between populations ranging from different 
geographical locations, for example, North Carolina, Mississippi and Arkansas, all of 
which are Bt cotton growing states, and a standard laboratory population.  This 
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suggested that the frequency of resistant alleles to Vip3A in the field populations was 
below a level that would cause an immediate problem for control.  This observation is 
supported by field studies on H. virescens with Bt cotton expressing Vip3A and a 
pyramided variety expressing both Vip3A and Cry1Ab (Mascarenhas et al., 2005; 
Adamczyk and Mahaffey, 2008; Bommireddy and Leonard, 2008).  
 
Control of H. virescens has been successful in Bt cotton varieties expressing Vip3A, 
with very few larvae surviving 14 days after infestation (Mascarenhas et al., 2005). 
Survival up to 7 days was found to be greater (Adamczyk and Mahaffey, 2008; 
Bommireddy and Leonard, 2008).  In all field trials, development of surviving larvae 
was severely inhibited, suggesting that it was unlikely that any larvae would have 
survived to pupation.   
 
The variation in expression of Cry1Ac and Vip3A in plant structures and the trend of 
reduced efficacy of toxins towards the end of the season (Greenplate, 1999; 
Adamczyk et al., 2001b; Llewellyn et al., 2007; Bommireddy and Leonard, 2008), 
could present a window of opportunity for later instar larvae to survive and hence 
undergo selection for resistance.  The potential for this to occur was demonstrated in 
the present study by the increased tolerance of 4th instar larvae of H. virescens to 
Vip3A compared with earlier instars.  However, in the planned commercialisation of 
Bt cotton expressing Vip3A, this toxin  will be pyramided with Cry1Ab (McCaffery et 
al., 2006; Kurtz et al., 2007) and field trials with such double constructs of Bt cotton 
have given very good control of H. virescens, with few survivors and little variation 
between plant structures.  Successful control with Vip3A-Cry1Ab cotton has also 
been demonstrated against H. zea, S. frugiperda and S. exigua (Adamczyk and 
Mahaffey, 2008; Bommireddy and Leonard, 2008).   
 
The use of pyramided Bt crops gives better control of insect pest complexes, taking 
advantage of the potential for one species that may be less susceptible to one of the 
toxins, to be susceptible to the other toxin and be controlled.  This combination in a 
high dose plus refuge strategy (Gould, 1998; Roush, 1998; Zhao et al., 2003; Bates et 
al., 2005; Bravo et al., 2008) should also lead to greater durability of the pyramided 
variety as compared to a single expression variety.  However, for this to occur it is 
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critical that there is no cross-resistance between the two expressed toxins in the 
pyramided variety. 
 
The selection of a Vip3A resistant H. virescens population in the present study 
enabled an assessment of cross-resistance and showed little or no evidence of cross-
resistance to either Cry1Ab or Cry1Ac.  These findings reinforce previous, reciprocal 
studies where a Cry1Ac resistant H. virescens and Cry1Ac H. zea population showed 
no cross-resistance to Vip3A (section 5.4).  The novel properties of Vip3A, with 
structural differences and no sequence homology with known Bt Cry toxins, and 
distinct binding sites and pore formation (Estruch et al., 1996; Yu et al., 1997; Lee et 
al., 2006) also suggests that cross-resistance mechanisms between Vip and Cry toxins 
are less likely to occur than between different Cry toxins.   
 
The observed lack of cross-resistance demonstrates the potential value of using 
Vip3A for insect control alongside other Bt crops that currently express Cry toxins, 
varieties available include Bt cotton expressing Cry1Ac alone, pyramided Cry1Ac and 
Cry2Ab, and pyramided Cry1Ac and Cry1F, and Bt corn expressing Cry1Ab 
(McCaffery et al., 2006).  Helicoverpa zea is less susceptible to Cry1Ac compared 
with H. virescens and there is some evidence, albeit disputed, for field-evolved 
resistance to Cry1Ac (Moar et al., 2008; Tabashnik et al., 2008a; Tabashnik et al., 
2008b).  The introduction of Vip3A could thus help to prevent Bt cotton field failures.  
Spodoptera frugiperda and S. exigua are also relatively tolerant to Cry1Ab but are 
highly susceptible to Vip3A (Adamczyk and Mahaffey, 2008).  Field resistance to Bt 
crops has been reported in S. frugiperda against Bt corn expressing Cry1F in Puerto 
Rico, resulting in field failure and the immediate discontinuation of commercial 
cultivation (Moar et al., 2008).  There is also evidence of resistance in B. fusca 
populations to Bt corn expressing Cry1Ab in South Africa, although field failure has 
not been reported (van Rensburg, 2007).   
 
The current IRM strategy in use with Bt crops combines high doses (expression) of 
toxin with the provision of refugia (non-Bt crop areas) (Gould, 1998; Roush, 1998; 
Zhao et al., 2003; Bates et al., 2005; Bravo et al., 2008).  There are several 
assumptions that this strategy follows regarding the development of resistance: that 
inheritance of resistance is recessive; that random mating occurs between resistant 
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and susceptible insects; and that high dose will kill all resistant heterozygotes and 
susceptible insects (taken as 25 times the concentration needed to kill all susceptible 
insects) (Bates et al., 2005).   
 
In order to develop and maintain IRM strategies it is essential to gain an 
understanding of the genetics of resistance to Bt toxins.  In the present study, the 
inheritance of resistance to Vip3A suggested a paternal influence, with resistant males 
of H. virescens showing an incompletely dominant to incompletely recessive mode of 
inheritance but resistant females showing an almost completely recessive mode of 
inheritance.  If this pattern of resistance occurred in the field, random mating between 
susceptible and resistant insects could lead to the survival of heterozygote resistant 
insects on Bt crops and thus increase the rate of development of resistance.   
 
However, the present study also found moult inhibition of larvae associated with 
resistance to Vip3A.  When moult inhibition data is taken into account, resistance to 
Vip3A is incompletely recessive, meeting the assumption of recessive resistance 
required for an effective high dose plus refuge strategy.  Resistance risk assessment 
modelling has indicated that if resistance to Vip3A is recessive, the frequency of 
resistance alleles should not increase more than 10-fold within 15 years, suggesting 
the risk of resistance is low (McCaffery et al., 2006).  The fitness costs linked with 
Vip3A resistance in the present work would also have the potential to maintain the 
effectiveness of an IRM strategy 
 
The apparent fitness benefit of faster development time for Vip3A resistant larvae of 
H. virescens is unlikely to be a significant fitness benefit in the field, due to the 
likelihood of overlapping generations and the observation that resistant males did not 
develop to adult eclosion faster than susceptible males and females.  Diet incorporated 
Vip3A bioassays also demonstrated moult/development inhibition in some surviving 
insects.   
 
Other laboratory Cry resistant insect populations vary in their ability to survive on Bt 
crops.  For example, resistant populations of P. xylostella, P. gossypiella and H. 
armigera completed development on Bt crops, whereas O. nubilalis and L. 
decemlineata did not survive on Bt crops and a H. virescens population did not 
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survive on Bt cotton or non-Bt cotton (Tabashnik et al., 2003).  The reasons for poor 
survival on Bt crops may include the prolonged exposure to the toxin and higher toxin 
concentrations with Bt crops, the expression of the toxin, whether in active or 
protoxin form, and the change in diet.  Plant chemistry may also affect survival, for 
example, the allelochemical gossypol, which accumulates in glands present 
throughout most of the vegetative and reproductive tissues of cotton, has been shown 
to impart plant resistance to H. virescens, H. zea and P. gossypiella (Gannaway, 1994; 
Romano and Scheffler, 2008; Tabashnik et al., 2003). 
 
 
8.3 Future Work 
 
The present work has provided information on the development of resistance, cross-
resistance, and fitness effects of resistance, and the effect of antibiotics on Bt toxicity. 
Further work should be conducted to build upon the knowledge and understanding 
gained thus far, including:  
 
- studies on baseline susceptibility to Vip3A in field derived H. virescens 
populations and other target insects through annual monitoring programmes; 
- investigation of the mechanism of resistance to Vip3A; for example using 
BBMV binding assays to determine whether loss of binding is involved; 
- utilization of genetics and fitness information in IRM computer models to look 
at potential resistance scenarios and the effectiveness of the current IRM 
strategy; 
- determination of cross-resistance to Cry1F and Cry2A, two other Bt toxins 
currently expressed in commercial Bt cotton; 
- studies on the fitness cost of resistant male mating success; determination of 
the presence or absence of spermatophores in mated adult females when 
paired with resistant males; investigate the randomness of mating between 
resistant and susceptible individuals (Zhao et al., 2008); 
- investigate the ability of the Vip3A resistant population to survive on non-Bt 
and Bt cotton (Tabashnik et al., 2003); 
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- determination of the presence of gut microbiota in H. virescens larvae to 
further understand the effects of antibiotics on Bt toxicity. 
  145
References 
 
Abbott, W. (1925) A method of computing the effectiveness of insecticide. Journal of 
Economic Entomology, 18, 265-267. 
Abney, M. R., Sorenson, C. E. & Bradley, J. R., Jr. (2007) Alternate crop hosts as 
resistance management refuges for tobacco budworm, Heliothis virescens, 
(Lepidoptera: Noctuidae) in North Carolina. Journal of Cotton Science, 11, 
35-39. 
Adamczyk, J. J., Adams, L. C. & Hardee, D. D. (2001a) Field efficacy and seasonal 
expression profiles for terminal leaves of single and double Bacillus 
thuringiensis toxin cotton genotypes. Journal of Economic Entomology, 94, 
1589-1593. 
Adamczyk, J. J., Hardee, D. D., Adams, L. C. & Sumerford, D. V. (2001b) 
Correlating differences in larval survival and development of bollworm 
(Lepidoptera: Noctuidae) and fall armyworm (Lepidoptera: Noctuidae) to 
differential expression of Cry1A (c) δ-endotoxin in various plant parts among 
commercial cultivars of transgenic Bacillus thuringiensis cotton. Journal of 
Economic Entomology, 94, 284-290. 
Adamczyk, J. J. & Gore, J. (2004) Laboratory and field performance of cotton 
containing Cry1Ac, Cry1F, and both Cry1Ac and Cry1F (Widestrike®) 
against beet armyworm and fall armyworm larvae (Lepidoptera: Noctuidae). 
Florida Entomologist, 87, 427-432. 
Adamczyk, J. J. & Mahaffey, J. S. (2008) Efficacy of Vip3A and Cry1Ab transgenic 
traits in cotton against various lepidopteran pests. Florida Entomologist, 91, 
570-575. 
Aimanova, K. G., Zhuang, M. B. & Gill, S. S. (2006) Expression of Cry1Ac cadherin 
receptors in insect midgut and cell lines. Journal of Invertebrate Pathology, 
92, 178-187. 
Akhurst, R. J., James, W., Bird, L. J. & Beard, C. (2003) Resistance to the Cry1Ac δ-
endotoxin of Bacillus thuringiensis in the cotton bollworm, Helicoverpa 
armigera (Lepidoptera: Noctuidae). Journal of Economic Entomology, 96, 
1290-1299. 
Ali, M. I., Luttrell, R. G. & Young, S. Y. (2006) Susceptibilities of Helicoverpa zea 
and Heliothis virescens (Lepidoptera: Noctuidae) populations to Cry1Ac 
insecticidal protein. Journal of Economic Entomology, 99, 164-175. 
Ali, M. I. & Luttrell, R. G. (2007) Susceptibility of bollworm and tobacco budworm 
(Lepidoptera: Noctuidae) to Cry2Ab2 insecticidal protein. Journal of 
Economic Entomology, 100, 921-931. 
  146
Alves, A. P., Spencer, T. A., Tabashnik, B. E. & Siegfried, B. D. (2006) Inheritance 
of resistance to the Cry1Ab Bacillus thuringiensis toxin in Ostrinia nubilalis 
(Lepidoptera: Crambidae). Journal of Economic Entomology, 99, 494-501. 
Andow, D. A. & Alstad, D. N. (1998) F2 screen for rare resistance alleles. Journal of 
Economic Entomology, 91, 572-578. 
Andow, D. A., Alstad, D. N., Pang, Y. H., Bolin, P. C. & Hutchison, W. D. (1998) 
Using an F2 screen to search for resistance alleles to Bacillus thuringiensis 
toxin in European corn borer (Lepidoptera: Crambidae). Journal of Economic 
Entomology, 91, 579-584. 
Andow, D. A., Olson, D. M., Hellmich, R. L., Alstad, D. N. & Hutchison, W. D. 
(2000) Frequency of resistance to Bacillus thuringiensis toxin Cry1Ab in an 
Iowa population of European corn borer (Lepidoptera: Crambidae). Journal of 
Economic Entomology, 93, 26-30. 
Andow, D. A. & Hilbeck, A. (2004) Science-based risk assessment for nontarget 
effects of transgenic crops. Bioscience, 54, 637-649. 
Anilkumar, K. J., Rodrigo-Simón, A., Ferré, J., Pusztai-Carey, M., Sivasupramaniam, 
S. & Moar, W. J. (2008) Production and characterization of Bacillus 
thuringiensis Cry1Ac-resistant cotton bollworm Helicoverpa zea (Boddie). 
Applied and Environmental Microbiology, 74, 462-469. 
Bacheler, J. S. & Van Duyn, J. W. (2009) Insect control: insect control on cotton. 
2009 North Carolina Agricultural Chemicals Manual. pp. 84-86. College of 
Agriculture and Life Sciences, North Carolina State University. 
http://ipm.ncsu.edu/agchem/agchem.html [Accessed 01 June 2009]. 
Bates, S. L., Zhao, J. Z., Roush, R. T. & Shelton, A. M. (2005) Insect resistance 
management in GM crops: past, present and future. Nature Biotechnology, 23, 
57-62. 
Baxter, S. W., Zhao, J. Z., Gahan, L. J., Shelton, A. M., Tabashnik, B. E. & Heckel, 
D. G. (2005) Novel genetic basis of field-evolved resistance to Bt toxins in 
Plutella xylostella. Insect Molecular Biology, 14, 327-334. 
Beard, C. E., Court, L., Boets, A., Mourant, R., Van Rie, J. & Akhurst, R. J. (2008) 
Unusually high frequency of genes encoding vegetative insecticidal proteins in 
an Australian Bacillus thuringiensis collection. Current Microbiology, 57, 
195-199. 
Beegle, C. C., Lewis, L. C., Lynch, R. E. & Martinez, A. J. (1981) Interaction of 
larval age and antibiotic on the susceptibility of 3 insect species to Bacillus 
thuringiensis. Journal of Invertebrate Pathology, 37, 143-153. 
 
  147
Beegle, C. C. (1990) Bioassay methods for quantification of Bacillus thuringiensis δ-
endotoxin. In: Hickle, L. A. & Fitch, W. L. (eds.) Analytical Chemistry of 
Bacillus thuringiensis. American Chemical Society, Washington DC, USA. 
pp. 14-21. 
Beegle, C. C. & Yamamoto, T. (1992) Invitation paper (C.P. Alexander Fund): 
history of Bacillus thuringiensis Berliner research and development. Canadian 
Entomologist, 124, 587-616. 
Bell, M. R. & Romine, C. L. (1980) Tobacco budworm (Lepidoptera: Noctuidae) 
field-evaluation of microbial control in cotton using Bacillus thuringiensis and 
a nuclear polyhedrosis-virus with a feeding adjuvant. Journal of Economic 
Entomology, 73, 427-430. 
Bell, M. R. & Hayes, J. L. (1994) Area-wide management of cotton bollworm and 
tobacco budworm (Lepidoptera: Noctuidae) through application of a nuclear 
polyhedrosis-virus on early-season alternate hosts. Journal of Economic 
Entomology, 87, 53-57. 
Berliner, E. (1911) Über die schlaffsucht der mehlmottenraupe. Z. Gesamte 
Getreidewe. (Berlin), 3, 63-70. 
Bernhard, K., Jarrett, P., Meadows, M., Butt, J., Ellis, D. J., Roberts, G. M., Pauli, S., 
Rodgers, P. & Burges, H. D. (1997) Natural isolates of Bacillus thuringiensis: 
worldwide distribution, characterization, and activity against insect pests. 
Journal of Invertebrate Pathology, 70, 59-68. 
Bird, L. J. & Akhurst, R. J. (2004) Relative fitness of CrylA-resistant and -susceptible 
Helicoverpa armigera (Lepidoptera: Noctuidae) on conventional and 
transgenic cotton. Journal of Economic Entomology, 97, 1699-1709. 
Bird, L. J. & Akhurst, R. J. (2005) Fitness of Cry1A-resistant and -susceptible 
Helicoverpa armigera (Lepidoptera: Noctuidae) on transgenic cotton with 
reduced levels of Cry1Ac. Journal of Economic Entomology, 98, 1311-1319. 
Bird, L. J. & Akhurst, R. J. (2007) Effects of host plant species on fitness costs of Bt 
resistance in Helicoverpa armigera (Lepidoptera: Noctuidae). Biological 
Control, 40, 196-203. 
Bizzarri, M. F. & Bishop, A. H. (2007) Recovery of Bacillus thuringiensis in 
vegetative form from the phylloplane of clover (Trifolium hybridum) during a 
growing season. Journal Of Invertebrate Pathology, 94, 38-47. 
 
  148
Blanco, C. A., Ali, M. I., Luttrell, R. G., Sivasupramaniam, S. & Martinez-Carrillo, J. 
L. (2005) Susceptibility of four Heliothis virescens and Helicoverpa zea 
reference colonies to homogenous Cry1Ac-incorporated insect diet: 
implications for an area-wide monitoring program, Proceedings of Beltwide 
Cotton Conference 2005. National Cotton Council of America, Memphis, TN. 
pp.1226-1233. 
Blanco, C. A., Teran-Vargas, A. P., Lopez, J. D., Kauffman, J. V. & Wei, X. K. 
(2007) Densities of Heliothis virescens and Helicoverpa zea (Lepidoptera: 
Noctuidae) in three plant hosts. Florida Entomologist, 90, 742-750. 
Blanco, C. A., Storer, N. P., Abel, C. A., Jackson, R., Leonard, R., Lopez, J. D., 
Payne, G., Siegfried, B. D., Spencer, T. & Teran-Vargas, A. P. (2008) 
Baseline susceptibility of tobacco budworm (Lepidoptera: Noctuidae) to 
Cry1F toxin from Bacillus thuringiensis. Journal of Economic Entomology, 
101, 168-173. 
Blanco, C. A., Andow, D. A., Abel, C. A., Sumerford, D. V., Hernandez, G., Lopez, J. 
D., Adams, L., Groot, A., Leonard, R., Parker, R., Payne, G., Perera, O. P., 
Teran-Vargas, A. P. & Azuara-Dominguez, A. (2009) Bacillus thuringiensis 
CrylAc resistance frequency in tobacco budworm (Lepidoptera: Noctuidae). 
Journal of Economic Entomology, 102, 381-387. 
Bommireddy, P. L. & Leonard, B. R. (2008) Survivorship of Helicoverpa zea and 
Heliothis virescens on cotton plant structures expressing a Bacillus 
thuringiensis vegetative insecticidal protein. Journal of Economic 
Entomology, 101, 1244-1252. 
Bonnefoi, A. & de Barjac, H. (1963) Classification des souches du groupe Bacillus 
thuringiensis par la determination de l'antigene flagellaire. Entomophaga, 8, 
223-229. 
Bourguet, D., Genissel, A. & Raymond, M. (2000) Insecticide resistance and 
dominance levels. Journal of Economic Entomology, 93, 1588-1595. 
Bourguet, D., Desquilbet, M. & Lemarié, S. (2005) Regulating insect resistance 
management: the case of non-Bt corn refuges in the US. Journal of 
Environmental Management, 76, 210-220. 
Bravo, A., Gómez, I., Conde, J., Muñoz-Garay, C., Sánchez, J., Miranda, R., Zhuang, 
M., Gill, S. S. & Soberón, M. (2004) Oligomerization triggers binding of a 
Bacillus thuringiensis Cry1Ab pore-forming toxin to aminopeptidase N 
receptor leading to insertion into membrane microdomains. Biochimica Et 
Biophysica Acta-Biomembranes, 1667, 38-46. 
Bravo, A., Gill, S. S. & Soberón, M. (2007) Mode of action of Bacillus thuringiensis 
Cry and Cyt toxins and their potential for insect control. Toxicon, 49, 423-435. 
  149
Bravo, A. & Soberón, M. (2008) How to cope with insect resistance to Bt toxins? 
Trends in Biotechnology, 26, 573-579. 
Broderick, N. A., Goodman, R. M., Raffa, K. F. & Handelsman, J. (2000) Synergy 
between zwittermicin A and Bacillus thuringiensis subsp. kurstaki against 
gypsy moth (Lepidoptera: Lymantriidae). Environmental Entomology, 29, 
101-107. 
Broderick, N. A., Raffa, K. F. & Handelsman, J. (2006) Midgut bacteria required for 
Bacillus thuringiensis insecticidal activity. Proceedings of the National 
Academy of Sciences of the United States of America, 103, 15196-15199. 
Broderick, N. A., Robinson, C. J., McMahon, M. D., Holt, J., Handelsman, J. & 
Raffa, K. F. (2009) Contributions of gut bacteria to Bacillus thuringiensis-
induced mortality vary across a range of Lepidoptera. BMC Biology, 7:11. 
Burrack, H. J. (2009) Insect control: insect control on flue-cured and burley tobacco. 
2009 North Carolina Agricultural Chemicals Manual. pp. 95-99 College of 
Agriculture and Life Sciences, North Carolina State University. 
http://ipm.ncsu.edu/agchem/agchem.html [Accessed 01 June 2009]. 
Capinera, J. L. (2001) Tobacco Budworm, Heliothis virescens (Fabricius) (Insecta: 
Lepidoptera: Noctuidae). University of Florida.  
http://edis.ifas.ufl.edu/IN376#FOOTNOTE_1. [Accessed 01 June 2009]. 
Carrière, Y., Ellers-Kirk, C., Liu, Y. B., Sims, M. A., Patin, A. L., Dennehy, T. J. & 
Tabashnik, B. E. (2001a) Fitness costs and maternal effects associated with 
resistance to transgenic cotton in the pink bollworm (Lepidoptera: 
Gelechiidae). Journal of Economic Entomology, 94, 1571-1576. 
Carrière, Y., Ellers-Kirk, C., Patin, A. L., Sims, M. A., Meyer, S., Liu, Y. B., 
Dennehy, T. J. & Tabashnik, B. E. (2001b) Overwintering cost associated with 
resistance to transgenic cotton in the pink bollworm (Lepidoptera: 
Gelechiidae). Journal of Economic Entomology, 94, 935-941. 
Carrière, Y. & Tabashnik, B. E. (2001) Reversing insect adaptation to transgenic 
insecticidal plants. Proceedings of the Royal Society of London Series B-
Biological Sciences, 268, 1475-1480. 
Carrière, Y., Ellers-Kirk, C., Biggs, R., Degain, B., Holley, D., Yafuso, C., Evans, P., 
Dennehy, T. J. & Tabashnik, B. E. (2005) Effects of cotton cultivar on fitness 
costs associated with resistance of pink bollworm (Lepidoptera: Gelechiidae) 
to Bt cotton. Journal of Economic Entomology, 98, 947-954. 
  150
Carrière, Y., Ellers-Kirk, C., Biggs, R. W., Nyboer, M. E., Unnithan, G. C., Dennehy, 
T. J. & Tabashnik, B. E. (2006) Cadherin-based resistance to Bacillus 
thuringiensis cotton in hybrid strains of pink bollworm: fitness costs and 
incomplete resistance. Journal of Economic Entomology, 99, 1925-1935. 
Carrière, Y., Ellers-Kirk, C., Biggs, R. W., Sims, M. A., Dennehy, T. J. & Tabashnik, 
B. E. (2007) Effects of resistance to Bt cotton on diapause in the pink 
bollworm, Pectinophora gossypiella. Journal of Insect Science, 7:49, 12 pp. 
Catchot, A., Andrews, G., Burdine, B., Cook, D., Daves, C., Dodds, D., Gore, J., 
Jackson, R., Koger, T., Larson, E., Musser, F., McKibben, P., Reed, J., 
Robbins, J., Smith, J. & Winters, S. (2008) Insect control guide for cotton, 
soybeans, corn, grain sorghum, wheat, sweetpotatoes, and pasture. 
Mississippi State University Extension Service.  
http://msucares.com/pubs/publications/p2471.pdf [Accessed 09 June 2009]. 
Cattaneo, M. G., Yafuso, C., Schmidt, C., Huang, C. Y., Rahman, M., Olson, C., 
Ellers-Kirk, C., Orr, B. J., Marsh, S. E., Antilla, L., Dutilleu, P. & Carrière, Y. 
(2006) Farm-scale evaluation of the impacts of transgenic cotton on 
biodiversity, pesticide use, and yield. Proceedings of the National Academy of 
Sciences of the United States of America, 103, 7571-7576. 
Chankhamhaengdecha, S. T., Tantichodok, A. & Panbangred, W. (2008) Spore stage 
expression of a vegetative insecticidal gene increase toxicity of Bacillus 
thuringiensis subsp aizawai SP41 against Spodoptera exigua. Journal Of 
Biotechnology, 136,  122-128. 
 
Chitkowski, R. L., Turnipseed, S. G., Sullivan, M. J. & Bridges, W. C. (2003) Field 
and laboratory evaluations of transgenic cottons expressing one or two 
Bacillus thuringiensis var. kurstaki Berliner proteins for management of 
noctuid (Lepidoptera) pests. Journal of Economic Entomology, 96, 755-762. 
Cohen, M. B., Chen, M., Bentur, J. S. & Heong, K. L. (2008) Bt rice in Asia: Potential 
benefits, impact, and sustainability. In: Romeis, J., Shelton, A. M. & Kennedy, 
G. G. (eds.) Integration of Insect-Resistant Genetically Modified Crops within 
IPM Programs. Springer Science + Business Media B.V. pp. 223-248. 
Cook, D. R., Leonard, B. R., Gore, J. & Temple, J. H. (2005) Baseline responses of 
bollworm, Helicoverpa zea (Boddie), and tobacco budworm, Heliothis 
virescens (F.), to indoxacarb and pyridalyl. Journal of Agricultural and Urban 
Entomology, 22, 99-109. 
Crawley, M. J. (2007) The R Book. Chichester, West Sussex, UK, John Wiley & Sons 
Ltd.  
  151
Crickmore, N., Zeigler, D. R., Feitelson, J., Schnepf, E., Van Rie, J., Lereclus, D., 
Baum, J. & Dean, D. H. (1998) Revision of the nomenclature for the Bacillus 
thuringiensis pesticidal crystal proteins. Microbiology and Molecular Biology 
Reviews, 62, 807-813. 
Crickmore, N., Zeigler, D. R., Schnepf, E., Van Rie, J., Lereclus, D., Baum, J., Bravo, 
A. & Dean, D. H. (2009) Bacillus thuringiensis toxin nomenclature, 
http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/ [Accessed 20 June 
2009]. 
de Maagd, R. A., Bravo, A. & Crickmore, N. (2001) How Bacillus thuringiensis has 
evolved specific toxins to colonize the insect world. Trends in Genetics, 17, 
193-199. 
de Maagd, R. A., Bravo, A., Berry, C., Crickmore, N. & Schnepf, H. E. (2003) 
Structure, diversity, and evolution of protein toxins from spore-forming 
entomopathogenic bacteria. Annual Review of Genetics, 37, 409-433. 
Dively, G. P. (2005) Impact of transgenic VIP3A x Cry1Ab lepidopteran-resistant 
field corn on the nontarget arthropod community. Environmental Entomology, 
34, 1267-1291. 
Donovan, W. P., Donovan, J. C. & Engleman, J. T. (2001) Gene knockout 
demonstrates that Vip3A contributes to the pathogenesis of Bacillus 
thuringiensis toward Agrotis ipsilon and Spodoptera exigua. Journal of 
Invertebrate Pathology, 78, 45-51. 
Downes, S., Parker, T. L. & Mahon, R. J. (2009) Frequency of alleles conferring 
resistance to the Bacillus thuringiensis toxins Cry1Ac and Cry2Ab in 
Australian populations of Helicoverpa punctigera (Lepidoptera: Noctuidae) 
from 2002 to 2006. Journal of Economic Entomology, 102, 733-742. 
Dulmage, H. T. (1970) Insecticidal activity of HD-1, a new isolate of Bacillus 
thuringiensis var. alesti. Journal of Invertebrate Pathology, 15, 232-239. 
Dulmage, H. T., Boening, O. P., Rehnborg, C. S. & Hansen, G. D. (1971) Proposed 
standardized bioassay for formulations of Bacillus thuringiensis based on the 
International Unit. Journal of Invertebrate Pathology, 18, 240-245. 
Estruch, J. J., Warren, G. W., Mullins, M. A., Nye, G. J., Craig, J. A. & Koziel, M. G. 
(1996) Vip3A, a novel Bacillus thuringiensis vegetative insecticidal protein 
with a wide spectrum of activities against lepidopteran insects. Proceedings of 
the National Academy of Sciences of the United States of America, 93, 5389-
5394. 
  152
Fabrick, J. A. & Tabashnik, B. E. (2007) Binding of Bacillus thuringiensis toxin 
Cry1Ac to multiple sites of cadherin in pink bollworm. Insect Biochemistry 
and Molecular Biology, 37, 97-106. 
Fang, J., Xu, X. L., Wang, P., Zhao, J. Z., Shelton, A. M., Cheng, J., Feng, M. G. & 
Shen, Z. C. (2007) Characterization of chimeric Bacillus thuringiensis Vip3 
toxins. Applied and Environmental Microbiology, 73, 956-961. 
Feitelson, J. S., Payne, J. & Kim, L. (1992) Bacillus thuringiensis: Insects and 
beyond. Bio-Technology, 10, 271-275. 
Ferré, J., Real, M. D., Vanrie, J., Jansens, S. & Peferoen, M. (1991) Resistance to the 
Bacillus thuringiensis bioinsecticide in a field population of Plutella xylostella 
is due to a change in a midgut membrane receptor. Proceedings of the 
National Academy of Sciences of the United States of America, 88, 5119-5123. 
Ferré, J. & Van Rie, J. (2002) Biochemistry and genetics of insect resistance to 
Bacillus thuringiensis. Annual Review of Entomology, 47, 501-533. 
Ferré, J., Van Rie, J. & MacIntosh, S. C. (2008) Insecticidal Genetically Modified 
Crops and Insect Resistance Management (IRM). In: Romeis, J., Shelton, A. 
M. & Kennedy, G. G. (eds.) Integration of Insect-Resistant Genetically 
Modified Crops within IPM Programs. Springer Science + Business Media 
B.V. pp. 41-86. 
Fitt, G. P. (1989) The ecology of Heliothis species in relation to agroecosystems 
Annual Review of Entomology, 34, 17-52. 
Fitt, G. P. (1990) Host selection in the Heliothinae. In: Bailey, W. J. & Ridsdill-
Smith, T. J. (eds.) Reproductive Behaviour in Insects - Individuals and 
Populations. London, Chapman & Hall. pp.172-201. 
Fitt, G. P. (2000) An Australian approach to IPM in cotton: integrating new 
technologies to minimise insecticide dependence. Crop Protection, 19, 793-
800. 
Fitt, G. P. (2008) Have Bt crops led to changes in insecticide use patterns and 
impacted IPM? In: Romeis, J., Shelton, A. M. & Kennedy, G. G. (eds.) 
Integration of Insect-Resistant Genetically Modified Crops within IPM 
Programs. Springer Science + Business Media B.V. pp. 303-328. 
Forcada, C., Alcacer, E., Garcera, M. D. & Martinez, R. (1996) Differences in the 
midgut proteolytic activity of two Heliothis virescens strains, one susceptible 
and one resistant to Bacillus thuringiensis toxins. Archives of Insect 
Biochemistry and Physiology, 31, 257-272. 
  153
Forcada, C., Alcacer, E., Garcera, M. D., Tato, A. & Martinez, R. (1999) Resistance 
to Bacillus thuringiensis Cry1Ac toxin in three strains of Heliothis virescens: 
proteolytic and SEM study of the larval midgut. Archives of Insect 
Biochemistry and Physiology, 42, 51-63. 
Fye, R. E. & McAda, W. C. (1972) Laboratory studies on the development, longevity 
and fecundity of six lepidopterous pests of cotton in Arizona. USDA Technical 
Bullettin, 1454, pp. 73. 
Gahan, L. J., Ma, Y. T., Coble, M. L. M., Gould, F., Moar, W. J. & Heckel, D. G. 
(2005) Genetic basis of resistance to Cry1Ac and Cry2Aa in Heliothis 
virescens (Lepidoptera: Noctuidae). Journal of Economic Entomology, 98, 
1357-1368. 
Gannaway, J. R. (1994) Breeding for Insect Resistance. In: Matthews, G. A. & 
Tunstall, J. P. (eds.) Insect Pests of Cotton. Wallingford, Oxon, UK, CAB 
INTERNATIONAL. pp. 431-453. 
Gao, Y., Fencil, K. J., Xu, X. P., Schwedler, D. A., Gilbert, J. R. & Herman, R. A. 
(2006) Purification and characterization of a chimeric Cry1F δ-endotoxin 
expressed in transgenic cotton plants. Journal of Agricultural and Food 
Chemistry, 54, 829-835. 
Gassmann, A. J., Carrière, Y. & Tabashnik, B. E. (2009) Fitness Costs of Insect 
Resistance to Bacillus thuringiensis. Annual Review of Entomology, 54, 147-
163. 
Gatehouse, J. A. (2008) Biotechnological prospects for engineering insect-resistant 
plants. Plant Physiology, 146, 881-887. 
Gill, S. S., Cowles, E. A. & Pietrantonio, P. V. (1992) The mode of action of Bacillus 
thuringiensis endotoxins. Annual Review of Entomology, 37, 615-636. 
Glare, T. R. & O'Callaghan, M. (2000) Bacillus thuringiensis: Biology, Ecology and 
Safety. Chichester, West Sussex, UK, John Wiley & Sons Ltd. 
Goldberg, L. J. & Margalit, J. (1977) Bacterial spore demonstrating rapid larvicidal 
activity against Anopheles sergentii, Uranotaenia unguiculata, Culex 
univattus, Aedes aegypri and Culex pipiens. Mosquito News, 37, 355-361. 
González-Cabrera, J., Herrero, S., Sayyed, A. H., Escriche, B., Liu, Y. B., Meyer, S. 
K., Wright, D. J., Tabashnik, B. E. & Ferré, J. (2001) Variation in 
susceptibility to Bacillus thuringiensis toxins among unselected strains of 
Plutella xylostella. Applied and Environmental Microbiology, 67, 4610-4613. 
  154
Gore, J., Adamczyk, J. J. & Blanco, C. A. (2005) Selective feeding of tobacco 
budworm and bollworm (Lepidoptera: Noctuidae) on meridic diet with 
different concentrations of Bacillus thuringiensis proteins. Journal of 
Economic Entomology, 98, 88-94. 
Gould, F. & Anderson, A. (1991) Effects of Bacillus thuringiensis and HD-73 δ-
endotoxin on growth, behaviour, and fitness of susceptible and toxin-adapted 
strains of Heliothis virescens (Lepidoptera: Noctuidae). Environmental 
Entomology, 20, 30-38. 
Gould, F., Martinez-Ramirez, A., Anderson, A., Ferré, J., Silva, F. J. & Moar, W. J. 
(1992) Broad-spectrum resistance to Bacillus thuringiensis toxins in Heliothis 
virescens. Proceedings of the National Academy of Sciences of the United 
States of America, 89, 7986-7990. 
Gould, F., Anderson, A., Reynolds, A., Bumgarner, L. & Moar, W. (1995) Selection 
and genetic analysis of a Heliothis virescens (Lepidoptera: Noctuidae) strain 
with high levels of resistance to Bacillus thuringiensis toxins. Journal of 
Economic Entomology, 88, 1545-1559. 
Gould, F., Anderson, A., Jones, A., Sumerford, D., Heckel, D. G., Lopez, J., Micinski, 
S., Leonard, R. & Laster, M. (1997) Initial frequency of alleles for resistance 
to Bacillus thuringiensis toxins in field populations of Heliothis virescens. 
Proceedings of the National Academy of Sciences of the United States of 
America, 94, 3519-3523. 
Gould, F. (1998) Sustainability of transgenic insecticidal cultivars: integrating pest 
genetics and ecology. Annual Review of Entomology, 43, 701-726. 
Gould, F., Cohen, M. B., Bentur, J. S., Kennedy, G. G. & Van Duyn, J. (2006) Impact 
of small fitness costs on pest adaptation to crop varieties with multiple toxins: 
a heuristic model. Journal of Economic Entomology, 99, 2091-2099. 
Grafius, E. J. & Douches, D. S. (2008) The present role and future role of insect-
resistant genetically modified potato cultivars in IPM. In: Romeis, J., Shelton, 
A. M. & Kennedy, G. G. (eds.) Integration of Insect-Resistant Genetically 
Modified Crops within IPM Programs. Springer Science + Business Media 
B.V. pp. 195-222. 
Greenplate, J. T. (1999) Quantification of Bacillus thuringiensis insect control protein 
Cry1Ac over time in Bollgard cotton fruit and terminals. Journal of Economic 
Entomology, 92, 1377-1383. 
Griffitts, J. S. & Aroian, R. V. (2005) Many roads to resistance: how invertebrates 
adapt to Bt toxins. Bioessays, 27, 614-624. 
  155
Groeters, F. R., Tabashnik, B. E., Finson, N. & Johnson, M. W. (1993) Resistance to 
Bacillus thuringiensis affects mating success of the diamondback moth 
(Lepidoptera: Plutellidae). Journal of Economic Entomology, 86, 1035-1039. 
Groeters, F. R., Tabashnik, B. E., Finson, N. & Johnson, M. W. (1994) Fitness costs 
of resistance to Bacillus thuringiensis in the diamondback moth (Plutella 
xylostella). Evolution, 48, 197-201. 
Gunning, R. V., Dang, H. T., Kemp, F. C., Nicholson, I. C. & Moores, G. D. (2005) 
New resistance mechanism in Helicoverpa armigera threatens transgenic 
crops expressing Bacillus thuringiensis Cry1Ac toxin. Applied and 
Environmental Microbiology, 71, 2558-2563. 
Guo, X., Huang, C., Jin, S., Liang, S., Nie, Y. & Zhang, X. (2007) Agrobacterium-
mediated transformation of Cry1C, Cry2A and Cry9C genes into Gossypium 
hirsutum and plant regeneration. Biologia Plantarum, 51, 242-248. 
Han, L. Z., Liu, P. L., Hou, M. L. & Peng, Y. F. (2008) Baseline susceptibility of 
Cnaphalocrocis medinalis (Lepidoptera: Pyralidae) to Bacillus thuringiensis 
toxins in China. Journal of Economic Entomology, 101, 1691-1696. 
Han, S., Craig, J. A., Putnam, C. D., Carozzi, N. B. & Tainer, J. A. (1999) Evolution 
and mechanism from structures of an ADP-ribosylating toxin and NAD 
complex. Nature Structural Biology, 6, 932-936. 
Hansen, B. M. & Salamitou, S. (2000) Virulence of Bacillus thuringiensis. In: 
Charles, J., Delécluse, A. & Nielson-Leroux, C. (eds.) Entomopathogenic 
bacteria: from laboratory to field apllication. Kluwer Academic Publishers. 
Hartl, D. L. (1992) A primer of population genetics. 2nd edition. Sunderland, 
Massachusetts, Sinauer Associates. 
Hartl, D. L. & Jones, E. W. (1999) Essential Genetics. 2nd edition. Sudbury, 
Massachusetts, Jones and Bartlett Publishers. 
Heckel, D. G., Gahan, L. J., Baxter, S. W., Zhao, J. Z., Shelton, A. M., Gould, F. & 
Tabashnik, B. E. (2007) The diversity of Bt resistance genes in species of 
Lepidoptera. Journal of Invertebrate Pathology, 95, 192-197. 
Hellmich, R. L., Albajes, R., Bergvinson, D., Prasifka, J. R., Wang, Z. W. & Weiss, 
M. J. (2008) The present and future role of insect-resistant genetically 
modified maize in IPM. In: Romeis, J., Shelton, A. M. & Kennedy, G. G. 
(eds.) Integration of Insect-Resistant Genetically Modified Crops within IPM 
Programs. Springer Science + Business Media B.V. pp. 119-158. 
  156
Henneberry, T. J. (1994) Effects of temperature on tobacco budworm (Lepidoptera: 
Noctuidae) pupal diapause, initiation and final stage of movement of 
stemmatal eyespots and adult emergence. Southwestern Entomologist, 19, 
329-333. 
Hernández-Rodríguez, C. S., Van Vliet, A., Bautsoens, N., Van Rie, J. & Ferré, J. 
(2008) Specific binding of Bacillus thuringiensis Cry2A insecticidal proteins 
to a common site in the midgut of Helicoverpa species. Applied and 
Environmental Microbiology, 74, 7654-7659. 
Herrero, S., Gechev, T., Bakker, P. L., Moar, W. J. & de Maagd, R. A. (2005) 
Bacillus thuringiensis Cry1Ca-resistant Spodoptera exigua lacks expression of 
one of four aminopeptidase N genes. BMC Genomics, 6:96. 
Higginson, D. M., Morin, S., Nyboer, M. E., Biggs, R. W., Tabashnik, B. E. & 
Carrière, Y. (2005) Evolutionary trade-offs of insect resistance to Bacillus 
thuringiensis crops: fitness cost affecting paternity. Evolution, 59, 915-920. 
Hofmann, C. & Luthy, P. (1986) Binding and activity of Bacillus thuringiensis δ-
endotoxin to invertebrate cells. Archives of Microbiology, 146, 7-11. 
Hofmann, C., Luthy, P., Hutter, R. & Pliska, V. (1988) Binding of the δ-endotoxin 
from Bacillus thuringiensis to brush-border membrane vesicles of the cabbage 
butterfly (Pieris brassicae). European Journal of Biochemistry, 173, 85-91. 
Hofte, H. & Whiteley, H. R. (1989) Insecticidal crystal proteins of Bacillus 
thuringiensis. Microbiological Reviews, 53, 242-255. 
Huang, F., Leonard, R., Moore, S., Yue, B., Parker, R., Reagan, T., Stout, M., Cook, 
D., Akbar, W., Chilcutt, C., White, W., Lee, D. & Biles, S. (2008) 
Geographical susceptibility of Louisiana and Texas populations of the 
sugarcane borer, Diatraea saccharalis (F.) (Lepidoptera: Crambidae) to 
Bacillus thuringiensis Cry1Ab protein. Crop Protection, 27, 799-806. 
Huang, F. N. (2006) Detection and monitoring of insect reistance to transgenic Bt 
crops. Insect Science, 13, 73-84. 
Huang, H. Z. & Ottea, J. A. (2004) Development of pyrethroid substrates for esterases 
associated with pyrethroid resistance in the tobacco budworm, Heliothis 
virescens (F.). Journal of Agricultural and Food Chemistry, 52, 6539-6545. 
Ibargutxi, M. A., Estela, A., Ferré, J. & Caballero, P. (2006) Use of Bacillus 
thuringiensis toxins for control of the cotton pest Earias insulana (Boisd.) 
(Lepidoptera: Noctuidae). Applied and Environmental Microbiology, 72, 437-
442. 
  157
Imai, K. & Mori, Y. (1999) Levels, inheritance and stability of resistance to Bacillus 
thuringiensis formulation in a field population of the diamondback moth, 
Plutella xylostella (Lepidoptera: Plutellidae) from Thailand. Applied 
Entomology and Zoology, 34, 23-29. 
Ishiwata, S. (1901) On a kind of severe flacherie (sotto disease). Dainihon Sanshi 
Kaiho, 114, 1-5. 
Jackson, R. E., Marcus, M. A., Gould, F., Bradley, Jr. & Van Duyn, J. W. (2007) 
Cross-resistance responses of Cry1Ac-selected Heliothis virescens 
(Lepidoptera: Noctuidae) to the Bacillus thuringiensis protein Vip3A. Journal 
of Economic Entomology, 100, 180-186. 
James, C. (1997) Global Status of Transgenic Crops in 1997. ISAAA Briefs No. 5. 
ISAAA: Ithaca, NY. 
James, C. (2005) Global Status of Commercialized Biotech/GM Crops: 2005. ISAAA 
Brief No. 34. ISAAA: Ithaca, NY. 
James, C. (2008) Global Status of Commercialized Biotech/GM Crops: 2008. ISAAA 
Brief No. 39. ISAAA: Ithaca, NY. 
Janmaat, A. F. & Myers, J. (2003) Rapid evolution and the cost of resistance to 
Bacillus thuringiensis in greenhouse populations of cabbage loopers, 
Trichoplusia ni. Proceedings of the Royal Society of London Series B-
Biological Sciences, 270, 2263-2270. 
Jensen, G. B., Hansen, B. M., Eilenberg, J. & Mahillon, J. (2003) The hidden 
lifestyles of Bacillus cereus and relatives. Environmental Microbiology, 5, 
631-640. 
 
Johnston, K. A., Lee, M. J., Brough, G., Hilder, V. A., Gatehouse, A. M. R. & 
Gatehouse, J. A. (1995) Protease activites in the larval midgut of Heliothis 
virescens: Evidence for trypsin and chymotrypsin-like enzymes. Insect 
Biochemistry and Molecular Biology, 25, 375-383. 
Jucovic, M., Walters, F. S., Warren, G. W., Palekar, N. V. & Chen, J. S. (2008) From 
enzyme to zymogen: engineering Vip2, an ADP-ribosyltransferase from 
Bacillus cereus, for conditional toxicity. Protein Engineering Design & 
Selection, 21, 631-638. 
Jurat-Fuentes, J. L. & Adang, M. J. (2001) Importance of Cry1 δ-endotoxin domain II 
loops for binding specificity in Heliothis virescens (L.). Applied and 
Environmental Microbiology, 67, 323-329. 
  158
Jurat-Fuentes, J. L., Gould, F. L. & Adang, M. J. (2002) Altered glycosylation of 63- 
and 68-kilodalton microvillar proteins in Heliothis virescens correlates with 
reduced Cry1 toxin binding, decreased pore formation, and increased 
resistance to Bacillus thuringiensis Cry1 toxins. Applied and Environmental 
Microbiology, 68, 5711-5717. 
Jurat-Fuentes, J. L., Gould, F. L. & Adang, M. J. (2003) Dual resistance to Bacillus 
thuringiensis Cry1Ac and Cry2Aa toxins in Heliothis virescens suggests 
multiple mechanisms of resistance. Applied and Environmental Microbiology, 
69, 5898-5906. 
Jurat-Fuentes, J. L., Gahan, L. J., Gould, F. L., Heckel, D. G. & Adang, M. J. (2004) 
The HevCaLP protein mediates binding specificity of the Cry1A class of 
Bacillus thuringiensis toxins in Heliothis virescens. Biochemistry, 43, 14299-
14305. 
Jurat-Fuentes, J. L. & Adang, M. J. (2006) Cry toxin mode of action in susceptible 
and resistant Heliothis virescens larvae. Journal of Invertebrate Pathology, 92, 
166-171. 
Kain, W. C., Zhao, J. Z., Janmaat, A. F., Myers, J., Shelton, A. M. & Wang, P. (2004) 
Inheritance of resistance to Bacillus thuringiensis Cry1Ac toxin in a 
greenhouse-derived strain of cabbage looper (Lepidoptera: Noctuidae). 
Journal of Economic Entomology, 97, 2073-2078. 
Kanga, L. H. B., Plapp, F. W., Elzen, G. W., Wall, M. L. & Lopez, J. D. (1995) 
Monitoring for resistance to organophosphorus, carbamate, and cyclodiene 
insecticides in tobacco budworm adults (Lepidoptera: Noctuidae) Journal of 
Economic Entomology, 88, 1144-1149. 
Karumbaiah, L., Oppert, B., Jurat-Fuentes, J. L. & Adang, M. J. (2007) Analysis of 
midgut proteinases from Bacillus thuringiensis-susceptible and -resistant 
Heliothis virescens (Lepidoptera: Noctuidae). Comparative Biochemistry and 
Physiology B-Biochemistry & Molecular Biology, 146, 139-146. 
King, A. B. S. (1994) Heliothis/Helicoverpa (Lepidoptera: Noctuidae). In: Matthews, 
G. A. & Tunstall, J. P. (eds.) Insect Pests of Cotton. Wallingford, Oxon, UK, 
CAB INTERNATIONAL. pp. 39-106. 
King, E. G. & Coleman, R. J. (1989) Potential for biological control of Heliothis 
species. Annual Review of Entomology, 34, 53-75. 
Krieg, A., Huger, A. M., Langenbruch, G. A. & Schnetter, W. (1983) Bacillus 
thuringiensis var. tenebrionis, a new pathotype effective against larvae of 
Coleoptera. Zeitschrift Fur Angewandte Entomologie,  96, 500-508. 
  159
Kurtz, R. W., McCaffery, A. & O'Reilly, D. (2007) Insect resistance management for 
Syngenta's VipCot™ transgenic cotton. Journal of Invertebrate Pathology, 95, 
227-230. 
Lee, M. K., Rajamohan, F., Gould, F. & Dean, D. H. (1995) Resistance to Bacillus 
thuringiensis Cry1A δ-endotoxins in a laboratory selected Heliothis virescens 
strain is related to receptor alteration. Applied and Environmental 
Microbiology,  61, 3836-3842. 
Lee, M. K., Walters, F. S., Hart, H., Palekar, N. & Chen, J. S. (2003) Mode of action 
of the Bacillus thuringiensis vegetative insecticidal protein Vip3A differs from 
that of Cry1Ab δ-endotoxin. Applied and Environmental Microbiology, 69, 
4648-4657. 
Lee, M. K., Miles, P. & Chen, J. S. (2006) Brush border membrane binding properties 
of Bacillus thuringiensis Vip3A toxin to Heliothis virescens and Helicoverpa 
zea midguts. Biochemical and Biophysical Research Communications, 339, 
1043-1047. 
Li, C., Xu, N., Huang, X., Wang, W., Cheng, J., Wu, K. & Shen, Z. (2007) Bacillus 
thuringiensis Vip3 mutant proteins: Insecticidal activity and trypsin 
sensitivity. Biocontrol Science And Technology, 17, 699-708. 
Li, H. R., Buschman, L. L., Huang, F. N., Zhu, K. Y., Bonning, B. & Oppert, B. 
(2007) DiPel-Selected Ostrinia nubilalis larvae are not resistant to transgenic 
corn expressing Bacillus thuringiensis Cry1Ab. Journal of Economic 
Entomology, 100, 1862-1870. 
Liang, G. M., Wu, K. M., Yu, H. K., Li, K. K., Feng, X. & Guo, Y. Y. (2008) 
Changes of inheritance mode and fitness in Helicoverpa armigera (Hubner) 
(Lepidoptera: Noctuidae) along with its resistance evolution to Cry1Ac toxin. 
Journal of Invertebrate Pathology, 97, 142-149.Liao, C. Y., Heckel, D. G. & 
Akhurst, R. (2002) Toxicity of Bacillus thuringiensis insecticidal proteins for 
Helicoverpa armigera and Helicoverpa punctigera (Lepidoptera: Noctuidae), 
major pests of cotton. Journal of Invertebrate Pathology, 80, 55-63. 
Liu, J., Song, F., Zhang, J., Liu, R., He, K., Tan, J., & Huang, D. (2007) Identification 
of vip3A-type genes from Bacillus thuringiensis strains and characterization of 
a novel vip3A-type gene. Letters In Applied Microbiology, 45, 432-438. 
 
Liu, Y. B., Tabashnik, B. E. & PusztaiCarey, M. (1996) Field-evolved resistance to 
Bacillus thuringiensis toxin CryIC in diamondback moth (Lepidoptera: 
Plutellidae). Journal of Economic Entomology, 89, 798-804. 
Liu, Y. B. & Tabashnik, B. E. (1997) Inheritance of resistance to the Bacillus 
thuringiensis toxin Cry1C in the diamondback moth. Applied and 
Environmental Microbiology, 63, 2218-2223. 
  160
Liu, Y. B., Tabashnik, B. E., Dennehy, T. J., Patin, A. L. & Bartlett, A. C. (1999) 
Development time and resistance to Bt crops. Nature, 400, 519-519. 
Llewellyn, D. J., Mares, C. L. & Fitt, G. P. (2007) Field performance and seasonal 
changes in the efficacy against Helicoverpa armigera (Hubner) of transgenic 
cotton expressing the insecticidal protein Vip3A. Agricultural and Forest 
Entomology, 9, 93-101. 
Loeb, M. J., Martin, P. A. W., Hakim, R. S., Goto, S. & Takeda, M. (2001) 
Regeneration of cultured midgut cells after exposure to sublethal doses of 
toxin from two strains of Bacillus thuringiensis. Journal of Insect Physiology, 
47, 599-606. 
Luo, K., Sangadala, S., Masson, L., Mazza, A., Brousseau, R. & Adang, M. J. (1997) 
The Heliothis virescens 170kDa aminopeptidase functions as "receptor A" by 
mediating specific Bacillus thuringiensis Cry1A δ-endotoxin binding and pore 
formation. Insect Biochemistry and Molecular Biology, 27, 735-743. 
Luttrell, R. G., Wan, L. & Knighten, K. (1999) Variation in susceptibility of noctuid 
(Lepidoptera) larvae attacking cotton and soybean to purified endotoxin 
proteins and commercial formulations of Bacillus thuringiensis. Journal of 
Economic Entomology, 92, 21-32. 
MacIntosh, S. C., Stone, T. B., Sims, S. R., Hunst, P. L., Greenplate, J. T., Marrone, 
P. G., Perlak, F. J., Fischhoff, D. A. & Fuchs, R. L. (1990) Specificity and 
efficacy of purified Bacillus thuringiensis proteins against agronomically 
important insects. Journal of Invertebrate Pathology, 56, 258-266. 
Mahon, R. J., Olsen, K. M., Garsia, K. A. & Young, S. R. (2007) Resistance to 
Bacillus thuringiensis toxin Cry2Ab in a strain of Helicoverpa armigera 
(Lepidoptera: Noctuidae) in Australia. Journal of Economic Entomology, 100, 
894-902. 
Malone, L. A., Gatehouse, A. M. R. & Barratt, B. I. P. (2008) Beyond Bt: Alternative 
strategies for insect-resistant genetically modified crops. In: Romeis, J., 
Shelton, A. M. & Kennedy, G. G. (eds.) Integration of Insect-Resistant 
Genetically Modified Crops within IPM Programs. Springer Science + 
Business Media B.V. pp. 357-418. 
Marroquin, L. D., Elyassnia, D., Griffitts, J. S., Feitelson, J. S. & Aroian, R. V. (2000) 
Bacillus thuringiensis (Bt) toxin susceptibility and isolation of resistance 
mutants in the nematode Caenorhabditis elegans. Genetics, 155, 1693-1699. 
Martinez-Ramirez, A. C., Escriche, B., Real, M. D., Silva, F. J. & Ferré, J. (1995) 
Inheritance of resistance to a Bacillus thuringiensis toxin in a field population 
of diamondback moth (Plutella xylostella). Pesticide Science, 43, 115-120. 
  161
Mascarenhas, V. J., Shotkoski, F. & Boykin, R. (2003) Field performance of Vip 
cotton against various lepidopteran cotton pests in the U.S. Proceedings of the 
Beltwide Cotton Conference 2003. National Cotton Council of America, 
Memphis, TN. pp. 1316-1322. 
Mascarenhas, V., Burd, T., Green, M., Martin, S. & Minton, B. (2005) Field studies 
of VipCot™ support high dose efficacy towards TBW, Heliothis virescens. 
Proceedings of the Beltwide Cotton Conference 2005. National Cotton 
Council of America, Memphis, TN. pp. 1421-1425. 
Matten, S. R., Head, G. P. & Quemada, H. D. (2008) How Governmental Regulation 
Can Help or Hinder the Integration of Bt Crops within IPM Programs. In: 
Romeis, J., Shelton, A. M. & Kennedy, G. G. (eds.) Integration of Insect-
Resistant Genetically Modified Crops within IPM Programs. Springer Science 
+ Business Media B.V. pp. 41-86. 
McCaffery, A. R. (1998) Resistance to insecticides in heliothine Lepidoptera: a global 
view. Philosophical Transactions of the Royal Society of London Series B-
Biological Sciences, 353, 1735-1750. 
McCaffery, A., Caprio, M., Jackson, R., Marcus, M., Martin, T., Dickerson, D., 
Negrotto, D., O'Reilly, D., Chen, E. & Lee, M. (2006) Effective IRM with the 
novel insecticidal protein Vip3A. Proceedings of the Beltwide Cotton 
Conference 2006. National Cotton Council of America, Memphis, TN. pp. 
1229-1235. 
McGaughey, W. H. (1985) Insect resistance to the biological insecticide Bacillus 
thuringiensis. Science, 229, 193-194. 
Meihls, L. N., Higdon, M. L., Siegfried, B. D., Miller, N. J., Sappington, T. W., 
Ellersieck, M. R., Spencer, T. A. & Hibbard, B. E. (2008) Increased survival 
of western corn rootworm on transgenic corn within three generations of on-
plant greenhouse selection. Proceedings of the National Academy of Sciences 
of the United States of America, 105, 19177-19182. 
Milne, R., Liu, Y. H., Gauthier, D. & van Frankenhuyzen, K. (2008) Purification of 
Vip3Aa from Bacillus thuringiensis HD-1 and its contribution to toxicity of 
HD-1 to spruce budworm (Choristoneura fumiferana) and gypsy moth 
(Lymantria dispar) (Lepidoptera). Journal Of Invertebrate Pathology, 99, 
166-172. 
Moar, W., Roush, R., Shelton, A., Ferré, J., MacIntosh, S., Leonard, B. R. & Abel, C. 
(2008) Field-evolved resistance to Bt toxins. Nature Biotechnology, 26, 1072-
1074. 
  162
Morin, S., Biggs, R. W., Sisterson, M. S., Shriver, L., Ellers-Kirk, C., Higginson, D., 
Holley, D., Gahan, L. J., Heckel, D. G., Carrière, Y., Dennehy, T. J., Brown, J. 
K. & Tabashnik, B. E. (2003) Three cadherin alleles associated with resistance 
to Bacillus thuringiensis in pink bollworm. Proceedings of the National 
Academy of Sciences of the United States of America, 100, 5004-5009. 
Naranjo, S. E., Head, G. & Dively, G. P. (2005) Field studies assessing arthropod 
non-target effects in Bt transgenic crops: introduction. Environmental 
Entomology, 34, 1178-1180. 
Naranjo, S. E., Ruberson, J. R., Sharma, H. C., Wilson, L. & Wu, K. (2008) The 
Present and Future Role of Insect-Resistant Genetically Modified Cotton in 
IPM. In: Romeis, J., Shelton, A. M. & Kennedy, G. G. (eds.) Integration of 
Insect-Resistant Genetically Modified Crops within IPM Programs. Springer 
Science + Business Media B.V. pp. 159-194. 
Neunzig, H. (1969) The biology of the tobacco budworm and the corn earworm in 
North Carolina. North Carloina Agricultural Experimental Station Technical 
Bulletin, 196, pp.76. 
Olsen, K. M., Daly, J. C., Holt, H. E. & Finnegan, E. J. (2005) Season-long variation 
in expression of Cry1Ac gene and efficacy of Bacillus thuringiensis toxin in 
transgenic cotton against Helicoverpa armigera (Lepidoptera: Noctuidae). 
Journal of Economic Entomology, 98, 1007-1017. 
Oltean, D. I., Pullikuth, A. K., Lee, H. K. & Gill, S. S. (1999) Partial purification and 
characterization of Bacillus thuringiensis Cry1A toxin receptor A from 
Heliothis virescens and cloning of the corresponding cDNA. Applied and 
Environmental Microbiology, 65, 4760-4766. 
Oppert, B., Kramer, K. J., Johnson, D., Upton, S. J. & McGaughey, W. H. (1996) 
Luminal proteinases from Plodia interpunctella and the hydrolysis of Bacillus 
thuringiensis CryIA(c) protoxin. Insect Biochemistry and Molecular Biology, 
26, 571-583. 
Oppert, B., Kramer, K. J., Beeman, R. W., Johnson, D. & McGaughey, W. H. (1997) 
Proteinase-mediated insect resistance to Bacillus thuringiensis toxins. Journal 
of Biological Chemistry, 272, 23473-23476. 
Oppert, B. (1999) Protease interactions with Bacillus thuringiensis insecticidal toxins. 
Archives of Insect Biochemistry and Physiology, 42, 1-12. 
Oppert, B., Hammel, R., Throne, J. E. & Kramer, K. J. (2000) Fitness costs of 
resistance to Bacillus thuringiensis in the Indianmeal moth, Plodia 
interpunctella. Entomologia Experimentalis Et Applicata, 96, 281-287. 
  163
Ottea, J. A., Ibrahim, S. A., Younis, A. M. & Young, R. J. (2000) Mechanisms of 
pyrethroid resistance in larvae and adults from a cypermethrin-selected strain 
of Heliothis virescens (F.). Pesticide Biochemistry and Physiology, 66, 20-32. 
Peferoen, M. (1997) Insect control with transgenic plants expressing Bacillus 
thuringiensis crystal proteins. In: Carozzi, N. & Koziel, M. (eds.) Advances in 
Insect Control. Taylor & Francis Ltd. 
R Development Core Team (2009). R: A language and environment for statistical 
computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-
900051-07-0, URL http://www.R-project.org. [Accessed 01 June 2009] 
Rajamohan, F., Alcantara, E., Lee, M. K., Chen, X. J., Curtiss, A. & Dean, D. H. 
(1995) Single amino acid changes in domain II of Bacillus thuringiensis 
Cry1Ab β-endotoxin affect irreversible binding to Maduca sexta midgut 
membrane-vesicles. Journal of Bacteriology, 177, 2276-2282. 
Rang, C., Gil, P., Neisner, N., Van Rie, J. & Frutos, R. (2005) Novel Vip3-related 
protein from Bacillus thuringiensis. Applied and Environmental Microbiology, 
71, 6276-6281. 
Raymond, B., Sayyed, A. H. & Wright, D. J. (2005) Genes and environment interact 
to determine the fitness costs of resistance to Bacillus thuringiensis. 
Proceedings of the Royal Society B-Biological Sciences, 272, 1519-1524. 
Raymond, B., Sayyed, A. H., Hails, R. S. & Wright, D. J. (2007a) Exploiting 
pathogens and their impact on fitness costs to manage the evolution of 
resistance to Bacillus thuringiensis. Journal of Applied Ecology, 44, 768-780. 
Raymond, B., Sayyed, A. H. & Wright, D. J. (2007b) Host plant and population 
determine the fitness costs of resistance to Bacillus thuringiensis. Biology 
Letters, 3, 82-85. 
Raymond, B., Lijek, R. S., Griffiths, R. I. & Bonsall, M. B. (2008) Ecological 
consequences of ingestion of Bacillus cereus on Bacillus thuringiensis 
infections and on the gut flora of a lepidopteran host. Journal of Invertebrate 
Pathology, 99, 103-111. 
Raymond, B., Johnston, P. R., Wright, D. J., Ellis, R. J., Crickmore, N. & Bonsall, M. 
B. (2009) A mid-gut microbiota is not required for the pathogenicity of 
Bacillus thuringiensis to diamondback moth larvae. Environmental 
Microbiology, 11, 2556-2563. 
Reed, D. H. & Bryant, E. H. (2004) Phenotypic correlations among fitness and its 
components in a population of the housefly. Journal Of Evolutionary Biology, 
17, 919-923. 
 
  164
Reik, W. & Walter, J. (2001) Genomic imprinting: parental influence on the genome. 
Nature Reviews Genetics, 2, 21–32. 
 
Rodrigo-Simón, A., Caccia, S. & Ferré, J. (2008) Bacillus thuringiensis Cry1Ac 
toxin-binding and pore-forming activity in brush border membrane vesicles 
prepared from anterior and posterior midgut regions of lepidopteran larvae. 
Applied and Environmental Microbiology, 74, 1710-1716. 
Romano, G. B. & Scheffler, J. A. (2008) Lowering seed gossypol content in glanded 
cotton (Gossypium hirsutum L.) lines. Plant Breeding, 127, 619-624. 
Romeis, J., Meissle, M. & Bigler, F. (2006) Transgenic crops expressing Bacillus 
thuringiensis toxins and biological control. Nature Biotechnology, 24, 63-71. 
Roush, R. T. & McKenzie, J. A. (1987) Ecological genetics of insecticide and 
acaricide resistance. Annual Review of Entomology, 32, 361-380. 
Roush, R. T. (1997) Bt-transgenic crops: just another pretty insecticide or a chance for 
a new start in resistance management? Pesticide Science, 51, 328-334. 
Roush, R. T. (1998) Two-toxin strategies for management of insecticidal transgenic 
crops: can pyramiding succeed where pesticide mixtures have not? 
Philosophical Transactions of the Royal Society of London Series B-
Biological Sciences, 353, 1777-1786. 
Saeglitz, C., Bartsch, D., Eber, S., Gathmann, A., Priesnitz, K. U. & Schuphan, I. 
(2006) Monitoring the Cry1Ab susceptibility of European corn borer in 
Germany. Journal of Economic Entomology, 99, 1768-1773. 
Sakamoto, N., Saito, S., Hirose, T., Suzuki, M., Matsuo, S., Izumi, K., Nagatomi, T., 
Ikegami, H., Umeda, K., Tsushima, K. & Matsuo, N. (2002) The discovery of 
pyridalyl: a novel insecticidal agent for controlling lepidopterous pests. 10th 
IUPAC International Congress on the Chemistry of Crop Protection. Basel, 
Switzerland. 
Salgado, V. L. (1998) Studies on the mode of action of spinosad: insect symptoms 
and physiological correlates. Pesticide Biochemistry and Physiology, 60, 91-
102. 
Sanvido, O., Romeis, J. & Bigler, F. (2007) Ecological impacts of genetically 
modified crops: ten years of field research and commercial cultivation. Green 
Gene Technology: Research in an Area of Social Conflict, 107, 235-278. 
Sayyed, A. H., Ferré, J. & Wright, D. J. (2000a) Mode of inheritance and stability of 
resistance to Bacillus thuringiensis var. kurstaki in a diamondback moth 
(Plutella xylostella) population from Malaysia. Pest Management Science, 56, 
743-748. 
  165
Sayyed, A. H., Haward, R., Herrero, S., Ferré, J. & Wright, D. J. (2000b) Genetic and 
biochemical approach for characterization of resistance to Bacillus 
thuringiensis toxin Cry1Ac in a field population of the diamondback moth, 
Plutella xylostella. Applied and Environmental Microbiology, 66, 1509-1516. 
Sayyed, A. H. & Wright, D. J. (2001a) Cross-resistance and inheritance of resistance 
to Bacillus thuringiensis toxin Cry1Ac in diamondback moth (Plutella 
xylostella L.) from lowland Malaysia. Pest Management Science, 57, 413-421. 
Sayyed, A. H. & Wright, D. J. (2001b) Fitness costs and stability of resistance to 
Bacillus thuringiensis in a field population of the diamondback moth Plutella 
xylostella L. Ecological Entomology, 26, 502-508. 
Sayyed, A. H., Cerda, H. & Wright, D. J. (2003) Could Bt transgenic crops have 
nutritionally favourable effects on resistant insects? Ecology Letters, 6, 167-
169. 
Sayyed, A. H., Raymond, B., Ibiza-Palacios, M. S., Escriche, B. & Wright, D. J. 
(2004) Genetic and biochemical characterization of field-evolved resistance to 
Bacillus thuringiensis toxin Cry1Ac in the diamondback moth, Plutella 
xylostella. Applied and Environmental Microbiology, 70, 7010-7017. 
Sayyed, A. H., Gatsi, R., Ibiza-Palaeios, M. S., Escriche, B., Wright, D. J. & 
Crickmore, N. (2005) Common, but complex, mode of resistance of Plutella 
xylostella to Bacillus thuringiensis toxins Cry1Ab and Cry1Ac. Applied and 
Environmental Microbiology, 71, 6863-6869. 
Schnepf, E., Crickmore, N., Van Rie, J., Lereclus, D., Baum, J., Feitelson, J., Zeigler, 
D. R. & Dean, D. H. (1998) Bacillus thuringiensis and its pesticidal crystal 
proteins. Microbiology and Molecular Biology Reviews, 62, 775-806. 
Scott, J. G. (2008) Unraveling the mystery of spinosad resistance in insects. Journal 
of Pesticide Science, 33, 221-227. 
Selvapandiyan, A., Arora, N., Rajagopal, R., Jalali, S. K., Venkatesan, T., Singh, S. P. 
& Bhatnagar, R. K. (2001) Toxicity analysis of N- and C-terminus-deleted 
vegetative insecticidal protein from Bacillus thuringiensis. Applied and 
Environmental Microbiology, 67, 5855-5858. 
Shelton, A. M., Robertson, J. L., Tang, J. D., Perez, C., Eigenbrode, S. D., Preisler, H. 
K., Wilsey, W. T. & Cooley, R. J. (1993) Resistance of diamondback moth 
(Lepidoptera: Plutellidae) to Bacillus thuringiensis subspecies in the field. 
Journal of Economic Entomology, 86, 697-705. 
Shelton, A. M. (2007) Considerations on the use of transgenic crops for insect control. 
Journal of Development Studies, 43, 890-900. 
  166
Shelton, A. M., Fuchs, M. & Shotkoski, F. A. (2008) Transgenic vegetables and fruits 
for control of insects and insect-vectored pathogens. In: Romeis, J., Shelton, 
A. M. & Kennedy, G. G. (eds.) Integration of Insect-Resistant Genetically 
Modified Crops within IPM Programs. Springer Science + Business Media 
B.V. pp. 249-272. 
Shi, Y. X., Ma, W. L., Yuan, M. J., Sun, F. & Pang, Y. (2007) Cloning of vip1/vip2 
genes and expression of Vip1Ca/Vip2Ac proteins in Bacillus thuringiensis. 
World Journal of Microbiology & Biotechnology, 23, 501-507. 
Sims, S. R. & Stone, T. B. (1991) Genetic basis of tobacco budworm resistance to an 
engineered Pseudomonas fluorescens expressing the δ-endotoxin of Bacillus 
thuringiensis kurstaki. Journal of Invertebrate Pathology, 57, 206-210. 
Sjoblad, R. D., McClintock, J. T. & Engler, R. (1992) Toxicological consideration for 
protein components of biological pesticide products.  Regulatory Toxicology 
and Pharmacology, 15, 3-9. 
Sokal, R. R. & Rohlf, F. J. (1995) Biometry. 3rd edition. Freeman and Company, New 
York, N.Y. 
Sparks, T. C. (1981) Development of insecticide resistance in Heliothis zea and 
Heliothis virescens in North America. Bulletin of the Entomological Society of 
America, 27, 186-192. 
Sparks, T. C., Graves, J. B. & Leonard, B. R. (1993) Insecticide resistance and the 
tobacco budworm: past, present and future. Reviews in Pesticide Toxicology, 
2, 149-183. 
Stone, B. F. (1968) A formula for determining degree of dominance in cases of 
monofactorial inheritance of resistance to chemicals. Bulletin of the World 
Health Organisation, 38, 325-326. 
Stone, T. B., Sims, S. R. & Marrone, P. G. (1989) Selection of tobacco budworm for 
resistance to a genetically engineered Pseudomonas fluorescens containing the 
δ-endotoxin of Bacillus thuringiensis subsp. kurstaki. Journal of Invertebrate 
Pathology, 53, 228-234. 
Tabashnik, B. E., Cushing, N. L., Finson, N. & Johnson, M. W. (1990) Field 
development of resistance to Bacillus thuringiensis in diamondback moth 
(Lepidoptera: Plutellidae). Journal of Economic Entomology, 83, 1671-1676. 
Tabashnik, B. E. (1991) Determining the mode of inheritance of pesticide resistance 
with backcross experiments. Journal of Economic Entomology, 84, 703-712. 
  167
Tabashnik, B. E., Schwartz, J. M., Finson, N. & Johnson, M. W. (1992) Inheritance of 
resistance to Bacillus thuringiensis in diamondback moth (lepidoptera, 
plutellidae). Journal of Economic Entomology, 85, 1046-1055. 
Tabashnik, B. E. (1994) Evolution of resistance to Bacillus thuringiensis. Annual 
Review of Entomology, 39, 47-79. 
Tabashnik, B. E., Malvar, T., Liu, Y. B., Finson, N., Borthakur, D., Shin, B. S., Park, 
S. H., Masson, L., DeMaagd, R. A. & Bosch, D. (1996) Cross-resistance of the 
diamondback moth indicates altered interactions with domain II of Bacillus 
thuringiensis toxins. Applied and Environmental Microbiology, 62, 2839-
2844. 
Tabashnik, B. E., Liu, Y. B., Finson, N., Masson, L. & Heckel, D. G. (1997a) One 
gene in diamondback moth confers resistance to four Bacillus thuringiensis 
toxins. Proceedings of the National Academy of Sciences of the United States 
of America, 94, 1640-1644. 
Tabashnik, B. E., Liu, Y. B., Malvar, T., Heckel, D. G., Masson, L., Ballester, V., 
Granero, F., Mensua, J. L. & Ferré, J. (1997b) Global variation in the genetic 
and biochemical basis of diamondback moth resistance to Bacillus 
thuringiensis. Proceedings of the National Academy of Sciences of the United 
States of America, 94, 12780-12785. 
Tabashnik, B. E., Liu, Y. B., Malvar, T., Heckel, D. G., Masson, L. & Ferré, J. (1998) 
Insect resistance to Bacillus thuringiensis: uniform or diverse? Philosophical 
Transactions of the Royal Society B: Biological Sciences, 353, 1751-1756. 
Tabashnik, B. E., Liu, Y. B., de Maagd, R. A. & Dennehy, T. J. (2000) Cross-
resistance of pink bollworm (Pectinophora gossypiella) to Bacillus 
thuringiensis toxins. Applied and Environmental Microbiology, 66, 4582-
4584. 
Tabashnik, B. E., Liu, T. B., Dennehy, T. J., Sims, M. A., Sisterson, M. S., Biggs, R. 
W. & Carrière, Y. (2002) Inheritance of resistance to Bt toxin Cry1Ac in a 
field-derived strain of pink bollworm (Lepidoptera: Gelechiidae). Journal of 
Economic Entomology, 95, 1018-1026. 
Tabashnik, B. E., Carrière, Y., Dennehy, T. J., Morin, S., Sisterson, M. S., Roush, R. 
T., Shelton, A. M. & Zhao, J. Z. (2003) Insect resistance to transgenic Bt 
crops: lessons from the laboratory and field. Journal of Economic Entomology, 
96, 1031-1038. 
Tabashnik, B. E., Liu, Y. B., Unnithan, D. C., Carrière, W., Dennehy, T. J. & Morin, 
S. (2004) Shared genetic basis of resistance to Bt toxin Cry1Ac in independent 
strains of pink bollworm. Journal of Economic Entomology, 97, 721-726. 
  168
Tabashnik, B. E., Biggs, R. W., Fabrick, J. A., Gassmann, A. J., Dennehy, T. J., 
Carrière, Y. & Morin, S. (2006) High-level resistance to Bacillus thuringiensis 
toxin CrylAc and cadherin genotype in pink bollworm. Journal of Economic 
Entomology, 99, 2125-2131. 
Tabashnik, B. E. (2008) Delaying insect resistance to transgenic crops. Proceedings 
of the National Academy of Sciences of the United States of America, 105, 
19029-19030. 
Tabashnik, B. E., Gassmann, A. J., Crowder, D. W. & Carrière, Y. (2008a) Insect 
resistance to Bt crops: evidence versus theory. Nature Biotechnology, 26, 199-
202. 
Tabashnik, B. E., Gassmann, A. J., Crowder, D. W. & Carrière, Y. (2008b) Field-
evolved resistance to Bt toxins. Nature Biotechnology, 26, 1074-1076. 
Tabashnik, B. E. & Carrière, Y. (2009) Insect resistance to genetically modified 
crops. In: Ferry, N. & Gatehouse, A. M. R. (eds.) Environmental impact of 
genetically modified crops. Wallingford, Oxfordshire, CAB International, pp. 
74-100. 
Tang, J. D., Shelton, A. M., VanRie, J., DeRoeck, S., Moar, W. J., Roush, R. T. & 
Peferoen, M. (1996) Toxicity of Bacillus thuringiensis spore and crystal 
protein to resistant diamondback moth (Plutella xylostella). Applied and 
Environmental Microbiology, 62, 564-569. 
Temple, J. H., Pommireddy, P. L., Cook, D. R., Marcon, P. & Leonard, B. R. (2009) 
Susceptibility of selected lepidopteran pests to rynaxypyr, a novel insecticide. 
Journal of Cotton Science, 13, 23-31. 
Vaeck, M., Reynaerts, A., Hofte, H., Jansens, S., Debeuckeleer, M., Dean, C., 
Zabeau, M., Vanmontagu, M. & Leemans, J. (1987) Transgenic plants 
protected from insect attack. Nature, 328, 33-37. 
van Frankenhuyzen, K. (1993) The Challenge of Bacillus thuringiensis. In: Entwistle, 
P. F., Cory, J. S., Bailey, M. J. & Higgs, S. (eds.) Bacillus thuringiensis, An 
Environmental Biopesticide: Theory and Practice. John Wiley and Sons Ltd. 
van Frankenhuyzen, K. (2009) Insecticidal activity of Bacillus thuringiensis crystal 
proteins. Journal Of Invertebrate Pathology, 101, 1-16. 
 
van Rensburg, J. B. J. (2007) First report of field resistance by the stem borer, 
Busseola fusca (Fuller) to Bt-transgenic maize. South African Journal of Plant 
and Soil, 24, 147-151. 
  169
Van Rie, J., Jansens, S., Hofte, H., Degheele, D. & Vanmellaert, H. (1989) Specificity 
of Bacillus thuringiensis δ-endotoxins importance of specific receptors on the 
brush-border membrane of the mid-gut of target insects. European Journal of 
Biochemistry, 186, 239-247. 
Van Rie, J., McGaughey, W. H., Johnson, D. E., Barnett, B. D. & Vanmellaert, H. 
(1990) Mechanism of insect resistance to the microbial insecticide Bacillus 
thuringiensis. Science, 247, 72-74. 
Vilas-Bôas, G. T., Peruca, A. P. S. & Arantes, O. M. N. (2007) Biology and 
taxonomy of Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis. 
Canadian Journal Of Microbiology, 53, 673-687. 
Waldvogel, M. & Gould, F. (1990) Variation in oviposition preference of Heliothis 
virescens in relation to macroevolutionary patterns of Heliothine host range. 
Evolution, 44, 1326-1337. 
Warren, G. W. (1997) Vegetative Insecticidal Proteins: Novel Proteins for Control of 
Corn Pests. In: Carozzi, N. & Koziel, M. (eds.) Advances in Insect Control: 
The role of transgenic plants. Taylor and Francis Ltd. pp. 109-121. 
Whalon, M. E., Mota-Sanchez, D. & Hollingworth, R. M. (2008) Analysis of Global 
Pesticide Resistance in Arthropods. In: Whalon, M. E., Mota-Sanchez, D. & 
Hollingworth, R. M. (eds.) Global Pesticide Resistance in Arthropods. CABI. 
Whitehouse, M. E. A., Wilson, L. J. & Constable, G. A. (2007) Target and non-target 
effects on the invertebrate community of Vip cotton, a new insecticidal 
transgenic. Australian Journal of Agricultural Research, 58, 273-285. 
Willi, Y., Van Buskirk, J. & Hoffmann A. A. (2006) Limits to the adaptive potential 
of small populations. Annual Review of Ecology, Evolution and Systematics, 
37, 433–458. 
Wing, K. D., Sacher, M., Kagaya, Y., Tsurubuchi, Y., Mulderig, L., Connair, M. & 
Schnee, M. (2000) Bioactivation and mode of action of the oxadiazine 
indoxacarb in insects. Crop Protection, 19, 537-545. 
Wright, D. J., Iqbal, M., Granero, F. & Ferré, J. (1997) A change in a single midgut 
receptor in the diamondback moth (Plutella xylostella) is only in part 
responsible for field resistance to Bacillus thuringiensis subsp. kurstaki and B. 
thuringiensis subsp. aizawai. Applied and Environmental Microbiology, 63, 
1814-1819. 
Wu, K. M., Guo, Y. Y. & Gao, S. S. (2002) Evaluation of the natural refuge function 
for Helicoverpa armigera (Lepidoptera: Noctuidae) within Bacillus 
thuringiensis transgenic cotton growing areas in north China. Journal of 
Economic Entomology, 95, 832-837. 
  170
Wyss, C. F., Young, H. P., Shukla, J. & Roe, R. M. (2003) Biology and genetics of a 
laboratory strain of the tobacco budworm, Heliothis virescens (Lepidoptera: 
Noctuidae), highly resistant to spinosad. Crop Protection, 22, 307-314. 
Xie, R. Y., Zhuang, M. B., Ross, L. S., Gomez, I., Oltean, D. I., Bravo, A., Soberón, 
M. & Gill, S. S. (2005) Single amino acid mutations in the cadherin receptor 
from Heliothis virescens affect its toxin binding ability to Cry1A toxins. 
Journal of Biological Chemistry, 280, 8416-8425. 
Xu, X. J., Yu, L. Y. & Wu, Y. D. (2005) Disruption of a cadherin gene associated 
with resistance to Cry1Ac δ-endotoxin of Bacillus thuringiensis in 
Helicoverpa armigera. Applied and Environmental Microbiology, 71, 948-
954. 
Yu, C. G., Mullins, M. A., Warren, G. W., Koziel, M. G. & Estruch, J. J. (1997) The 
Bacillus thuringiensis vegetative insecticidal protein Vip3A lyses midgut 
epithelium cells of susceptible insects. Applied and Environmental 
Microbiology, 63, 532-536. 
Zhang, X. B., Candas, M., Griko, N. B., Taussig, R. & Bulla Jr., L. A. (2006) A 
mechanism of cell death involving an adenylyl cyclase/PKA signaling 
pathway is induced by the Cry1Ab toxin of Bacillus thuringiensis. 
Proceedings of the National Academy of Sciences of the United States of 
America, 103, 9897-9902. 
Zhao, J. Z., Li, Y. X., Collins, H. L., Cao, J., Earle, E. D. & Shelton, A. M. (2001) 
Different cross-resistance patterns in the diamondback moth (Lepidoptera: 
Plutellidae) resistant to Bacillus thuringiensis toxin CrylC. Journal of 
Economic Entomology, 94, 1547-1552. 
Zhao, J. Z., Cao, J., Li, Y. X., Collins, H. L., Roush, R. T., Earle, E. D. & Shelton, A. 
M. (2003) Transgenic plants expressing two Bacillus thuringiensis toxins 
delay insect resistance evolution. Nature Biotechnology, 21, 1493-1497. 
Zhao, J. Z., Cao, J., Collins, H. L., Bates, S. L., Roush, R. T., Earle, E. D. & Shelton, 
A. M. (2005) Concurrent use of transgenic plants expressing a single and two 
Bacillus thuringiensis genes speeds insect adaptation to pyramided plants. 
Proceedings of the National Academy of Sciences of the United States of 
America, 102, 8426-8430. 
Zhao, X. C., Wu, K. M., Liang, G. M. & Guo, Y. Y. (2008) Altered mating behaviour 
in a Cry1Ac-resistant strain of Helicoverpa armigera (Lepidoptera: 
Noctuidae). Journal of Applied Entomology, 132, 360-365. 
Zhu, C., Ruan, L., Peng, D., Yu, Z. & Sun, M. (2006) Vegetative insecticidal protein 
enhancing the toxicity of Bacillus thuringiensis subsp. kurstaki against 
Spodoptera exigua. Letters in Applied Microbiology, 42, 109-114. 
  171
Appendix 1 
 
Comparative toxicity of Bt toxins against different larval instars of the NCSU 
and WF06 populations 
 
 
Table A.1.1: LC50 values of the NCSU population for 1st, 2nd, 3rd and 4th instar 
Heliothis virescens larvae to Vip3A in a diet incorporation assay after 7 days (linked 
to Figure 4.1). 
Larval instar LC50 µg ml-1 95 % CI1 Slope (± se)  n2 
1 1.69 0.98 – 2.92  a 0.52 (± 0.10) 336 
2 1.77 1.40 – 2.23  a 1.47 (± 0.25) 240 
3 1.50 1.20 – 1.87  a 1.52 (± 0.21) 288 
4 5.11 3.77 – 6.93  b 1.05 (± 0.17) 288 
 
1
 Values followed by same letter are not significantly different (P>0.01). 
2
 Number of larvae used in bioassay, including control. 
 
 
Table A.1.2: MIC50 values of the NCSU population for 1st, 2nd, 3rd and 4th instar 
Heliothis virescens larvae to Vip3A in a diet incorporation assay after 7 days (linked 
to Figure 4.1). 
Larval instar MIC50 µg ml-1 95 % CI1 Slope (± se) n2 
1 0.18 0.04 – 0.96  a 0.38 (± 0.12) 336 
2 1.77 1.40 – 2.23  b 1.47 (± 0.25) 240 
3 1.44 1.14 – 1.81  b 1.49 (± 0.21) 288 
4 3.41 2.81 – 4.13  c 1.92 (± 0.29) 240 
 
1
 Values followed by same letter are not significantly different (P>0.01). 
2
 Number of larvae used in bioassay, including control. 
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Table A.1.3: LC50 values of the NCSU population for 1st, 2nd, 3rd and 4th instar 
Heliothis virescens larvae to Cry1Ab in a diet incorporation assay after 7 days (linked 
to Figure 4.2). 
Larval instar LC50 µg ml-1 95 % CI1 Slope (± se)  n2 
1 0.080 0.058 – 0.110  a 1.04 (± 0.13) 288 
2 0.071 0.036 – 0.137  a 0.70 (± 0.19) 120 
3 0.060 0.041 – 0.088  a 1.44 (± 0.31) 120 
4 0.092 0.057 – 0.153  a 0.86 (± 0.14) 240 
 
1
 Values followed by same letter are not significantly different (P>0.01). 
2
 Number of larvae used in bioassay, including control. 
 
 
Table A.1.4: MIC50 values of the NCSU population for 1st, 2nd, 3rd and 4th instar 
Heliothis virescens larvae Cry1Ab in a diet incorporation assay after 7 days (linked to 
Figure 4.2). 
Larval instar MIC50 µg ml-1 95 % CI1 Slope (± se) n2 
1 0.039 0.030 – 0.050  a 1.57 (± 0.19) 288 
2 0.029 0.017 – 0.049  a 1.09 (± 0.25) 120 
3 0.032 0.022 – 0.045  a 2.15 (± 0.47) 96 
4 0.030 0.017 – 0.052  a 0.86 (± 0.14) 240 
 
1
 Values followed by same letter are not significantly different (P>0.01). 
2
 Number of larvae used in bioassay, including control. 
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Table A.1.5: LC50 values of the WF06 population for 1st, 2nd, 3rd and 4th instar 
Heliothis virescens larvae to Vip3A in a diet incorporation assay after 7 days (linked 
to Figure 4.3). 
Larval instar LC50 µg ml-1 95 % CI1 Slope (± se)  n2 
1 2.63 1.87 – 3.70  a 0.83 (± 0.10) 384 
2 2.91 2.36 – 3.60  a 1.60 (± 0.19) 336 
3 3.76 2.46 – 5.77  a 0.76 (± 0.10) 288 
4 > 1003  0.86 (± 0.14) 240 
 
1
 Values followed by same letter are not significantly different (P>0.01). 
2
 Number of larvae used in bioassay, including control. 
3
 Mortality at 100µg ml-1 = 13 %. 
 
 
Table A.1.6: MIC50 values of the WF06 population for 1st, 2nd, 3rd and 4th instar 
Heliothis virescens larvae Vip3A in a diet incorporation assay after 7 days (linked to 
Figure 4.3). 
Larval instar MIC50 µg ml-1 95 % CI1 Slope (± se) n2 
1 0.90 0.69 – 1.18  a 1.10 (± 0.12) 384 
2 2.07 1.68 – 2.56  b 1.60 (± 0.18) 336 
3 1.88 1.39 – 2.56  b 1.08 (± 0.12) 336 
4 9.21 5.18 – 16.4  c 0.78 (± 0.16) 240 
 
1
 Values followed by same letter are not significantly different (P>0.01). 
2
 Number of larvae used in bioassay, including control. 
 
 
